# BugSigDB 2024-10-22_21:58_UTC, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/1_Colorectal-adenoma:conventional-adenoma-cases_vs_controls_UP	NA	57037
bsdb:1/2/1_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	57037
bsdb:1/6/1_Colorectal-adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	57037
bsdb:5/1/2_Chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1470358
bsdb:6/1/1_Non-alcoholic-fatty-liver-disease:advanced-fibrosis_vs_mild/moderate-fibrosis_DOWN	NA	40520	39491
bsdb:7/1/1_Autism:severely-autistic_vs_non-sibling-control_UP	NA	901	876	58621	821
bsdb:7/1/2_Autism:severely-autistic_vs_non-sibling-control_DOWN	NA	1683	1679	218538	1535
bsdb:9/1/1_Breast-carcinoma:Breast-Cancer_vs_Control_UP	NA	1445	219301	231049	28901	1771	1766
bsdb:9/1/2_Breast-carcinoma:Breast-Cancer_vs_Control_DOWN	NA	40216	562	329	33917
bsdb:10/2/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	1681	215580	2702
bsdb:11/1/1_Cervical-glandular-intraepithelial-neoplasia:HIV-patients-with-lesion-at-12-months_vs_HIV-pateints-with-normal-tissue-at-6-months_DOWN	NA	2702
bsdb:12/1/1_Human-papilloma-virus-infection:HPV-persistent_vs_HPV-clearance_UP	NA	387661
bsdb:12/2/1_Human-papilloma-virus-infection:HPV-clearance_vs_HPV-negative_UP	NA	2702	2130
bsdb:12/3/1_Human-papilloma-virus-infection:HPV-negative_vs_HPV-presistent-and-clearance_UP	NA	47770
bsdb:12/4/1_Human-papilloma-virus-infection:HPV-clearance_vs_HPV-presistent-and-negative_UP	NA	39485
bsdb:13/1/1_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_UP	NA	47770	817	1311	827
bsdb:13/1/2_Cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Neoplasis-+2_vs_Cervical-Intraepithelial-Neoplasis--1_DOWN	NA	38293	109790	82135
bsdb:13/2/1_Cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_UP	NA	1311	817	316	1261
bsdb:13/2/2_Cervical-glandular-intraepithelial-neoplasia:HPV-+ve_vs_HPV--ve-among-pateints-with-Cervical-Intraepithelial-Neoplasia-different-severity-status_DOWN	NA	1584
bsdb:14/1/1_Halitosis:Oral-Halitosis_vs_Control_UP	NA	739
bsdb:14/1/2_Halitosis:Oral-Halitosis_vs_Control_DOWN	NA	729	2047
bsdb:16/2/2_Obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	152490
bsdb:17/1/1_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	33038	1522
bsdb:17/1/2_Anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	39485	438033	39491
bsdb:17/2/1_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	33038	33039	1522
bsdb:17/2/2_Anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	290054	42322	39497	39485	438033	39491
bsdb:18/1/1_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	43305	154046	1351	658087	1605	168384	351091	106588	166486	360807	89153	29347	49118
bsdb:18/1/2_Obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239935	1735
bsdb:18/2/1_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	154046	1351	1352	1605	168384	166486	360807	29347	49118
bsdb:18/2/2_Obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	239935	1735
bsdb:18/3/2_Obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	239935	1535	1735	89152
bsdb:22/1/1_Parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	626937	270498	97478	40518	100176
bsdb:22/1/2_Parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	204516	536633	1470350	310298	40519	88431	357276	165179	310297	33043
bsdb:24/1/2_Chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	351
bsdb:26/1/1_Sex-design:female_vs_male_UP	NA	47678
bsdb:26/1/2_Sex-design:female_vs_male_DOWN	NA	310297
bsdb:26/2/2_Obesity:BMI->33-female_vs_male_DOWN	NA	310297
bsdb:31/1/1_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	105841	333367	106588	29347	1512	33038	100884
bsdb:31/1/2_Chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	28117	39488	40520	116085	39486	88431	39496	853	729	823	360807	1971605
bsdb:31/2/1_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	105841	208479
bsdb:31/2/2_Chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	39488	116085	410072	39486	88431	853	360807	1971605	40520
bsdb:31/3/1_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	351	100884	88431	84112	106588	29347	1512	33038	1506
bsdb:31/3/2_Chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	116085	823	39486
bsdb:32/1/1_Anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_UP	NA	2173
bsdb:33/1/1_Obesity:obese_vs_controls_UP	NA	53443	116085	39496	40518	40520
bsdb:33/1/2_Obesity:obese_vs_controls_DOWN	NA	292800	871325	818	418240	208479
bsdb:36/1/1_Obesity:obese-adolescent_vs_control-adult_UP	NA	74426	1747	853
bsdb:36/2/1_Obesity:obese-adult_vs_control-adolescent_UP	NA	1747	853
bsdb:36/2/2_Obesity:obese-adult_vs_control-adolescent_DOWN	NA	47678
bsdb:36/3/1_Obesity:control-adolescent_vs_control-adult_UP	NA	47678
bsdb:36/4/1_Obesity:obese-adolescent_vs_obese-adult_UP	NA	74426	853
bsdb:36/5/1_Obesity:obese-adolescent_vs_control-adolescent_UP	NA	74426	1747	853	29466
bsdb:36/5/2_Obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	47678
bsdb:36/6/1_Obesity:obese-adult_vs_control-adult_UP	NA	1747	853
bsdb:38/1/1_Body-odor-measurement:head-of-teenager_vs_head-of-child_UP	NA	1747
bsdb:38/1/2_Body-odor-measurement:head-of-teenager_vs_head-of-child_DOWN	NA	76773	1282	1290
bsdb:38/2/1_Body-odor-measurement:teen-neck_vs_child-neck_UP	NA	1747	76773
bsdb:38/2/2_Body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1290
bsdb:38/3/1_Body-odor-measurement:teen-underarm_vs_child-underarm_UP	NA	76773	1282
bsdb:38/3/2_Body-odor-measurement:teen-underarm_vs_child-underarm_DOWN	NA	1290
bsdb:39/1/1_Body-odor-measurement:youth-underarm-after-exercise_vs_youth-underarm-before_UP	NA	1282
bsdb:39/2/1_Body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	33011	108981
bsdb:40/1/1_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	28026	1679	1680	821	28116	820
bsdb:40/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	33043
bsdb:41/1/1_Psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	1579	197162	95486	885581	927	86304	622488	2039	36855	33959	2247	1598	133539	56426	529	1613	1624	1596	1689
bsdb:41/1/2_Psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	337090	370405	42353	1231	187878	264691	628	115778
bsdb:43/1/1_Behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	729
bsdb:43/1/2_Behcet's-syndrome:behcet's-disease_vs_controls_DOWN	NA	55565	671218	199	76123	979627	1382	104608	60133	2053611	102148	1926307
bsdb:43/2/1_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	41976
bsdb:43/2/2_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_DOWN	NA	305719	1969407
bsdb:44/1/1_Obesity:pediatric-obese_vs_controls_UP	NA	853
bsdb:44/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	821	46506
bsdb:46/1/1_Obesity:pediatric-obese_vs_controls_DOWN	NA	239935	853	4935	1853550
bsdb:46/1/2_Obesity:pediatric-obese_vs_controls_DOWN	NA	239935	853	4935	1983405	1853550
bsdb:46/2/1_Obesity:pediatric-obese_vs_controls_UP	NA	39491	5476	4932
bsdb:51/1/2_Colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	33038
bsdb:51/2/2_Colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	290054
bsdb:59/1/2_Titanium-dioxide-nanoparticle:pregnant-rats-exposed-to-titanium-dioxide-nanoparticles_vs_control-pregnant-rats-at-gestational-day-10_DOWN	NA	234266
bsdb:61/2/1_Obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-6-month_UP	NA	1498	1686
bsdb:61/4/1_Obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-6-months_UP	NA	1498
bsdb:62/1/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	1671661	1940338	290054	1946507	2613924	573	357276	1806836
bsdb:62/1/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	1235800	3068309
bsdb:62/2/2_Cognitive-impairment:Mild-Cognitive-Impairment-PD_vs_Cognitively-Unimpaired-PD-(PD-NC)_DOWN	NA	239935
bsdb:62/3/1_Parkinson's-disease:Mild-Cognitive-Impairment--PD-(PD-MCI)_vs_Control-Subjects_UP	NA	1671661	1940338	290054	1946507	2613924	573	357276	1806836
bsdb:62/3/2_Parkinson's-disease:Mild-Cognitive-Impairment--PD-(PD-MCI)_vs_Control-Subjects_DOWN	NA	1235800	3068309
bsdb:62/4/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	1671661
bsdb:62/4/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	3068309	1235800
bsdb:62/6/1_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_UP	NA	1946507	1806836	1671661	290054
bsdb:62/6/2_Parkinson's-disease:Cognitively-Unimpaired-PD-(PD-NC)_vs_Control-Subjects_DOWN	NA	3068309	1235800
bsdb:63/1/1_Cesarean-section:C-section-delivery_vs_vaginal-delivery-after-7-days-of-delivery_DOWN	NA	1596
bsdb:63/3/1_Cesarean-section:C-section-delivery_vs_vaginal-delivery-after-6-months-of-delivery_DOWN	NA	1598
bsdb:64/1/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_UP	NA	69823	1302
bsdb:64/1/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	1019	2718	194702	43768	840	484	1924944	135083
bsdb:64/2/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-negative-periodontitis_UP	NA	28112
bsdb:64/2/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-negative-periodontitis_DOWN	NA	1018	194702	43768	840	484
bsdb:64/3/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic-within-positive-periodontitis_UP	NA	1019
bsdb:64/4/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	143361	28124	837	28112	58231
bsdb:64/4/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	729	495	2047
bsdb:64/5/1_Periodontitis:periodontitis_vs_No-Periodontitis-within-both-positive-and-negative-diabetic-background_UP	NA	28131	158
bsdb:64/5/2_Periodontitis:periodontitis_vs_No-Periodontitis-within-both-positive-and-negative-diabetic-background_DOWN	NA	1655	1302	68892
bsdb:65/1/1_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	28037	851	29466	39778	539
bsdb:65/1/2_Type-II-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	143361	837	28112
bsdb:66/1/2_Neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_DOWN	NA	1690
bsdb:66/2/1_Neonatal-jaundice:infants-with-jaundice_vs_control_UP	NA	1502
bsdb:66/2/2_Neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	43675
bsdb:68/1/1_Obesity:obese_vs_normal-weight_UP	NA	31971	28116
bsdb:68/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	853
bsdb:68/2/1_Obesity:overweight_vs_normal-weight_UP	NA	853
bsdb:68/3/1_Obesity:obese-men_vs_normal-weight-men_UP	NA	823
bsdb:68/4/2_Obesity:overweight-men_vs_normal-weight-men_DOWN	NA	33038
bsdb:68/5/1_Obesity:obese-women_vs_normal-weight-women_UP	NA	33038
bsdb:68/5/2_Obesity:obese-women_vs_normal-weight-women_DOWN	NA	1898207
bsdb:68/6/1_Obesity:overweight-women_vs_normal-weight-women_UP	NA	33038
bsdb:70/1/1_Obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	28111	85831	28116	165179
bsdb:70/1/2_Obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	310297	363265	165179
bsdb:70/2/1_Obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_UP	NA	28111
bsdb:70/3/1_Obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_UP	NA	28111
bsdb:70/3/2_Obesity:male-pediatric-obese_vs_male-pediatric-normal-weight_DOWN	NA	310297
bsdb:74/1/1_Obesity:obese_vs_non-obese_UP	NA	39486	100176	1512
bsdb:74/1/2_Obesity:obese_vs_non-obese_DOWN	NA	76122	817	329854	28116	46506	820	28134	28118	823	310297	839
bsdb:74/2/1_Obesity:obese_vs_Nonobese-microbiota-cluster_UP	NA	1512	36835	39488
bsdb:74/2/2_Obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	817	329854	28118	119853
bsdb:74/3/1_Obesity:high-BMI_vs_low-BMI_UP	NA	39486	1736	548	573	33038	100176	166486	36835
bsdb:74/3/2_Obesity:high-BMI_vs_low-BMI_DOWN	NA	511	817	329854	820	100884	853	28134	28118	823	310297	821	839
bsdb:74/4/1_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	29370	100176	166486	214851
bsdb:74/4/2_Obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	329854	28118	823	310297	821
bsdb:78/1/2_Stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	31971	239935	248039
bsdb:79/1/1_Obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	469593	411489	40520	88431
bsdb:79/2/1_Obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	53443	556261	411486	1352	1736	84030	1512	100884
bsdb:81/1/1_Obesity:3-Months-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_UP	NA	562	573	1304	39777	29466	1343	1318	39778	1313	1308	113107	239935	1502	68892	1302	1328	46228	328814	28118	1689	1351	187326	169435
bsdb:81/1/2_Obesity:3-Months-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_DOWN	NA	853
bsdb:81/2/1_Obesity:one-year-after-Roux-en-Y-gastric-bypass-surgery_vs_baseline_UP	NA	573	562	1304	39777	29466	1343	1318	39778	1308	113107	68892	328814	46124	1660
bsdb:82/1/1_Obesity:before-surgery_vs_lean-controls_UP	NA	853
bsdb:82/1/2_Obesity:before-surgery_vs_lean-controls_DOWN	NA	29348	159	860
bsdb:83/1/1_Obesity:before-surgery_vs_after-surgery_UP	NA	40214	105841	159	410072	853	833	860	1579	173	1598	1768	53461	300	1282	500	160	29348
bsdb:83/1/2_Obesity:before-surgery_vs_after-surgery_DOWN	NA	69218	28901	621	39778	29466
bsdb:84/1/1_Obesity:after-surgery_vs_lean-controls_UP	NA	69218	29466	621
bsdb:84/1/2_Obesity:after-surgery_vs_lean-controls_DOWN	NA	29348	159	1598	105841	860	500	1282	833
bsdb:88/1/2_Schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	729
bsdb:89/1/2_Crohn's-disease:CD-patients_vs_Healthy-controls_DOWN	NA	871665	166486	33039	460384
bsdb:91/1/1_Cesarean-section:C-section_vs_vaginal-delivery_UP	NA	654	1390	1402	853	821	39491
bsdb:91/1/2_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1747	285
bsdb:94/1/1_Obesity:3-months_vs_baseline-participants_UP	NA	13335	74426	487175	166486	360807	214851	469610
bsdb:94/1/2_Obesity:3-months_vs_baseline-participants_DOWN	NA	81028	984	214856	156974	49338	1564	69823	169435	253239	351091	106588	61171	1398	1351	1352	61624	1496	333367	168384	443143	562	316	1902	84110	84112	239935	81462	651822
bsdb:94/2/1_Obesity:6-months_vs_3-months-participants_UP	NA	214856	156974	333367	84030	876	562	84112	471189	81462
bsdb:94/2/2_Obesity:6-months_vs_3-months-participants_DOWN	NA	13335	1358	349221	487175	360807	1308	29466	469610
bsdb:94/3/1_Obesity:24-months_vs_6-months-participants_UP	NA	984
bsdb:94/3/2_Obesity:24-months_vs_6-months-participants_DOWN	NA	239935	562	74426
bsdb:96/1/1_Obesity:obese_vs_controls_UP	NA	187327	1379	46124	573	1382	341694	821	301302	43675	52773	649756
bsdb:96/1/2_Obesity:obese_vs_controls_DOWN	NA	358743	853	61171	1547	39484	290055
bsdb:97/1/1_Obesity:obese-patients-prior-to-Sleeve-gastrectomy-SG0_vs_healthy-controls_UP	NA	850
bsdb:97/3/1_Obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	1308	214856
bsdb:97/4/2_Obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1308
bsdb:98/1/1_Chronic-kidney-disease:CKD_vs_controls_UP	NA	351	631
bsdb:98/1/2_Chronic-kidney-disease:CKD_vs_controls_DOWN	NA	378494
bsdb:99/1/1_Obesity:obese_vs_controls_UP	NA	40520	74426	410072	39486	88431	861	856	907	33038	33039	39488
bsdb:99/1/2_Obesity:obese_vs_controls_DOWN	NA	28116	371601	820	818	329854	328814	239935	28117	28118	28111	573	571	729	853
bsdb:101/1/2_Obesity:obese_vs_lean-controls_DOWN	NA	2173	28025	1597	1590
bsdb:108/1/1_Anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	817	1590	1532	1535
bsdb:110/1/1_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	562
bsdb:110/1/2_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1532
bsdb:111/1/2_Attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	39485
bsdb:113/1/1_Unipolar-depression:MDD_vs_controls_DOWN	NA	1603
bsdb:115/1/1_Unipolar-depression:MDD_vs_controls_UP	NA	562	907	351091	1680	28132	1689
bsdb:115/1/2_Unipolar-depression:MDD_vs_controls_DOWN	NA	729
bsdb:115/2/1_Bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	290053
bsdb:116/1/2_Type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	1532	39491
bsdb:117/1/1_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	257758
bsdb:117/1/2_Pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	28132	39778
bsdb:117/2/1_Pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	257758
bsdb:117/2/2_Pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	28132	39778
bsdb:118/1/1_Cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	1603	1898207
bsdb:119/1/2_Type-II-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_DOWN	NA	47678
bsdb:120/1/2_Physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	39491
bsdb:120/2/2_Physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	39491
bsdb:121/1/1_Gingivitis:gingivitis_vs_healthy-controls_UP	NA	241556	28124	837	28131
bsdb:122/1/1_Breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	31998
bsdb:122/1/2_Breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13690	48935	257758
bsdb:124/1/1_Diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_UP	NA	418240	550
bsdb:124/1/2_Diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1680	40519	47678	562
bsdb:124/2/2_Diet:body-builders-(high-protein)_vs_control_DOWN	NA	418240	39488	46506	40519	1679	562	1599
bsdb:124/3/2_Diet:distance-runners-(high-carb)_vs_control_DOWN	NA	550	1583	1522	47678	39488	418240
bsdb:129/1/1_Multiple-sclerosis:Multiple-sclerosis_vs_Healthy-controls_UP	NA	351
bsdb:131/4/1_Diet:Cara-Cara_vs_controls-at-time-7_UP	NA	31971
bsdb:131/6/1_Diet:Cara-Cara_vs_Bahia-at-time-7_UP	NA	31971
bsdb:134/1/1_Diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	39488
bsdb:134/2/1_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	39488	1579	562
bsdb:134/2/2_Diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	2173
bsdb:136/2/1_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	84112	404403	1358	1679	88431	1680	74426
bsdb:136/2/2_Diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	626929	28111	39485	626940	310297	301301	572010	46228	39492
bsdb:139/1/2_Head-and-neck-squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	327575	425941	69823
bsdb:139/2/1_Squamous-cell-carcinoma:Larynx-cancer-cases_vs_controls_DOWN	NA	502	1305
bsdb:139/3/1_Squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	544580	419208
bsdb:139/4/2_Squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_DOWN	NA	490	33033
bsdb:141/1/1_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	309120	33036	28125	386414
bsdb:141/1/2_Preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1633
bsdb:145/1/1_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	28132	1017	28037	1018
bsdb:145/1/2_Oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	40542	467210
bsdb:149/1/2_Obesity:Obese-children_vs_Normal-weight-children_DOWN	NA	649756	674529	28116	291644	371601	35833	410072	39486	358743	1308	29466	658087	457412
bsdb:150/1/1_Head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	351
bsdb:150/2/1_Head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	351
bsdb:151/1/1_Breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_UP	NA	562	624	584	621	666	564	623	470	40214	587	97478	281920	851	545	901	1353	28901	552	63612	40216	856	187327	419005	630	33037	24
bsdb:151/1/2_Breast-cancer:Postmenopausal-breast-cancer-patients_vs_controls_DOWN	NA	39485	208962	199	360807	29459	1633
bsdb:152/2/1_Cervical-cancer:cervical-cancer-patients_vs_healthy-controls_UP	NA	46506	562	823	310297	360807
bsdb:155/1/1_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	28112	181487
bsdb:155/1/2_Esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	61592	425941	1313	617123	1501329	102148	484	490
bsdb:155/2/1_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	425941	28091	69710
bsdb:155/2/2_Esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	732
bsdb:156/1/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	39491
bsdb:156/2/2_Gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	39491
bsdb:158/2/1_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	310297	821
bsdb:158/2/2_Lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	1898207
bsdb:159/2/2_Gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	1077464
bsdb:161/1/2_Lung-cancer:NSCLC_vs_Healthy-controls_DOWN	NA	28132
bsdb:166/1/1_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	33038	33039	1522
bsdb:166/1/2_Chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	39488	290054	39491
bsdb:167/1/1_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	739	1872471	419015	156456	28113	824	205	39950	539	562	143361	860	137732	727	104608	495	1107316	1969407	33033	1924944	2053611	69823	76860
bsdb:167/1/2_Squamous-cell-carcinoma:Stage-4_vs_healthy-controls_DOWN	NA	52769	46124	425941	28132	157692	52768
bsdb:167/2/1_Squamous-cell-carcinoma:Stage-1_vs_healthy-controls_UP	NA	205	143361	860	137732	727	1107316	33033	1924944	76860
bsdb:167/2/2_Squamous-cell-carcinoma:Stage-1_vs_healthy-controls_DOWN	NA	729	1583331	28132	1660	29466
bsdb:167/3/1_Squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	739	156456	824	205	143361	860	137732	727	33033	1924944	69823	76860
bsdb:167/3/2_Squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_DOWN	NA	729	1583331	28132	1660	28037	29466	1226342
bsdb:169/1/1_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	327575
bsdb:169/1/2_Gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	187326	142586	61235
bsdb:169/2/1_Gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_UP	NA	187326	69823	439703	35518
bsdb:169/2/2_Gastric-cancer:white-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	108980	1624
bsdb:169/3/1_Gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	84135	1019	729	479370
bsdb:169/4/1_Gastric-cancer:yellow-thin-coating-GC-patient_vs_other-coatings_DOWN	NA	1052096
bsdb:170/4/2_Lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_DOWN	NA	1898207
bsdb:170/5/2_Lung-cancer:contralateral-non-cancerous-site-with-no-antibiotics-(TNo)_vs_control-group-with-no-antibiotics-(No)_DOWN	NA	77133	1898207
bsdb:171/1/1_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_UP	NA	495	837	1660	1318	1305	1306
bsdb:171/1/2_Digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_DOWN	NA	55565	1583331	1924944	28132	2047	102148
bsdb:171/2/1_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_UP	NA	739	837	1318	1305
bsdb:171/2/2_Tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_DOWN	NA	28132	2047	113107
bsdb:171/3/1_Esophageal-cancer:esophageal-cancer-patients_vs_controls_UP	NA	739	157688	104608	187326	837	1306
bsdb:171/3/2_Esophageal-cancer:esophageal-cancer-patients_vs_controls_DOWN	NA	28132	2047	113107
bsdb:171/4/1_Colorectal-cancer:colorectal-cancer-patients_vs_controls_UP	NA	187326	237576	837	59823	1660	68251	1318
bsdb:171/4/2_Colorectal-cancer:colorectal-cancer-patients_vs_controls_DOWN	NA	1583331	28132	59823
bsdb:171/5/1_Gastric-cancer:gastric-cancer-patients_vs_controls_UP	NA	860	84135	729	837
bsdb:171/5/2_Gastric-cancer:gastric-cancer-patients_vs_controls_DOWN	NA	1924944
bsdb:172/1/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	55565	151416	80866	43675	39777
bsdb:172/1/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	1962306	425941
bsdb:174/1/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	28135	28129	470	287
bsdb:174/1/2_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	210	615	1580	1358
bsdb:174/2/1_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_UP	NA	55565	1655
bsdb:174/2/2_Gastric-cancer:H-pylori-sequencing-positive_vs_H-pylori-sequencing-negative_DOWN	NA	28131	287
bsdb:174/3/1_Gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	59823
bsdb:180/1/1_Gastric-carcinoma:gastric-carcinoma_vs_chronic-gastritis_UP	NA	134375	1871047	1896336	1506	1871046	306	1831
bsdb:180/1/2_Gastric-carcinoma:gastric-carcinoma_vs_chronic-gastritis_DOWN	NA	218	192066	59823	1306	1966354
bsdb:182/1/1_Acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_UP	NA	84135	29466	484
bsdb:182/1/2_Acetaldehyde:high-acetaldehyde-concentration-group_vs_low-acetaldehyde-concentration-group_DOWN	NA	1318	470565
bsdb:183/1/1_Crohn's-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_UP	NA	33039
bsdb:183/1/2_Crohn's-disease:crohn-disease-ASCA-positive-patients_vs_crohn-disease-ASCA-negative-patients_DOWN	NA	550	853
bsdb:186/2/1_Smoking-behavior:Smoke-exposed-group-intraperitoneally-injected-with-carcinogen,-AOM-(AOM-+-Smoking)_vs_Smoke-free-control-group-intraperitoneally-injected-with-carcinogen-azoxymethane-(AOM)-(10-mg/kg)_UP	NA	1428	492670	35760	84112	562	1841863	471189	1335613	2530390	1871022	29388
bsdb:186/2/2_Smoking-behavior:Smoke-exposed-group-intraperitoneally-injected-with-carcinogen,-AOM-(AOM-+-Smoking)_vs_Smoke-free-control-group-intraperitoneally-injected-with-carcinogen-azoxymethane-(AOM)-(10-mg/kg)_DOWN	NA	246787	2109688	2109692	1598	823	2025876	357276	821	1307
bsdb:188/1/1_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	257758	28130	2702
bsdb:188/1/2_Cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_DOWN	NA	47770
bsdb:189/1/1_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	1506
bsdb:189/1/2_Chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	1898207	1940338
bsdb:191/1/1_Equol:equol-producers_vs_equol-non-producers_UP	NA	394340	572010
bsdb:194/1/1_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	34062	13690	333965	28090	330920
bsdb:194/1/2_Ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	1364
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schönlein-Purpura_vs_controls_DOWN	NA	39485	39491
bsdb:202/2/1_Autism:children-with-autism-non-mental-regression-(ANMR)_vs_healthy-controls_UP	NA	208479
bsdb:202/3/1_Autism:children-with-autism-mental-regression-(AMR)_vs_healthy-controls_UP	NA	208479
bsdb:204/1/1_Premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-≥37-getastional-weeks_DOWN	NA	1596	33959	1679	1685	1579	47770	147802	305
bsdb:205/1/1_Human-papilloma-virus-infection:HPV-positive-women_vs_HPV-negative-women_UP	NA	2702	1596
bsdb:206/1/1_Gastric-cancer:patients-diagnosed-with-gastric-cancer_vs_patients-diagnosed-with-gastritis_UP	NA	179628	285729	851	1596	1598	187326	28131	28135	1302	1318
bsdb:210/1/1_Food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	59620
bsdb:212/1/1_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	31971	820
bsdb:212/1/2_Diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	853
bsdb:212/2/1_Diet:Higher-fiber-intake-from-FRUITS/-VEGETABLES_vs_low-fiber-intake-from-FRUITS/-VEGETABLES_DOWN	NA	820	40518
bsdb:212/3/1_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_UP	NA	853
bsdb:212/3/2_Diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_DOWN	NA	31971
bsdb:215/1/1_Eczema:infants-with-eczema_vs_healthy-control-infants_UP	NA	239935	626929	28141	853	745368	46503	310297	28126	33038
bsdb:215/1/2_Eczema:infants-with-eczema_vs_healthy-control-infants_DOWN	NA	817	1681	1679	1735	1304
bsdb:216/1/1_Cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	47678	817	28116	1686	1679	1502	821	1681	1596	1598
bsdb:217/1/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	40518	29361	46228	1535	29343
bsdb:217/1/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	817	28116	310297	46506	820	821	76122
bsdb:217/2/1_Age:infant-at-18-months_vs_infant-at-6-months_UP	NA	1532
bsdb:217/3/1_Age:infant-at-18-months_vs_infant-at-6-months_UP	NA	45851	100884	140626	33025	40518	40545	1512	220137
bsdb:217/3/2_Age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1590
bsdb:217/4/1_Lactobacillus-rhamnosus-GG:children-supplemented-with-LGG-at-18-months_vs_placebo-group-at-18-months_UP	NA	105841	39496
bsdb:217/4/2_Lactobacillus-rhamnosus-GG:children-supplemented-with-LGG-at-18-months_vs_placebo-group-at-18-months_DOWN	NA	1496
bsdb:218/1/2_Hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_DOWN	NA	39496
bsdb:218/3/1_Hepatocellular-carcinoma:non-HBV-non-HCV-patients_vs_HBV-related-HCC-patients_DOWN	NA	39496
bsdb:219/1/1_Diet:lower-fiber-(cracker),-at-baseline_vs_higher-fiber-(almonds)---at-baseline_UP	NA	817
bsdb:221/1/1_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	1468449	86664	333367	44009	536633
bsdb:221/1/2_Urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	1559	1260	729	386414	373040	1537
bsdb:222/1/1_Gastric-cancer:high-gastric-cancer-risk-patients-(Tuquerres-residents)_vs_low-gastric-cancer-risk-patients-(Tumaco-residents)_UP	NA	157687	1926307
bsdb:222/1/2_Gastric-cancer:high-gastric-cancer-risk-patients-(Tuquerres-residents)_vs_low-gastric-cancer-risk-patients-(Tumaco-residents)_DOWN	NA	29317	1017	239	484	192066	1924944	28135	1885016	29387	1303	1310087
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	33038	1343
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	821	165179
bsdb:223/2/1_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_UP	NA	1547
bsdb:223/2/2_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_DOWN	NA	165179
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	33038
bsdb:223/5/1_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_UP	NA	817	562	33038	1308
bsdb:224/1/1_Diet:barley-(WGB)_vs_baseline_UP	NA	418240	301302	166486	39491
bsdb:224/1/2_Diet:barley-(WGB)_vs_baseline_DOWN	NA	28118
bsdb:227/4/2_Atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1898207
bsdb:228/1/1_Diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	853
bsdb:228/2/1_Diet:day-3-of-INULIN-spike-in_vs_day-6-of-INULIN-spike-in_DOWN	NA	820	853
bsdb:234/1/1_Atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_UP	NA	1280
bsdb:234/1/2_Atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	36773	1747	1981334	1591	1909303	29387
bsdb:234/2/1_Psoriasis:adult-with-psoriasis_vs_healthy-control_UP	NA	1872515	161879	146827	1981334
bsdb:234/2/2_Psoriasis:adult-with-psoriasis_vs_healthy-control_DOWN	NA	36773	1591	1909303
bsdb:234/3/1_Atopic-eczema:adult-with-atopic-dermatitis_vs_healthy-control_UP	NA	1981334	376	1872515	34073	1591	1280
bsdb:234/4/1_Atopic-eczema:adults-with-psoriasis_vs_healthy-control_UP	NA	1981334	376	1720	161879
bsdb:235/1/1_Food-allergy:child-with-food-allergy_vs_healthy-control_UP	NA	1971605	351091
bsdb:235/1/2_Food-allergy:child-with-food-allergy_vs_healthy-control_DOWN	NA	1955243	729
bsdb:235/2/1_Food-allergy:child-with-food-allergy_vs_healthy-sibling_UP	NA	351091	1971605
bsdb:235/2/2_Food-allergy:child-with-food-allergy_vs_healthy-sibling_DOWN	NA	729	1955243	28117	1872444
bsdb:235/3/1_Food-allergy:healthy-sibling_vs_healthy-control_UP	NA	351091	1971605	28117	1872444
bsdb:235/3/2_Food-allergy:healthy-sibling_vs_healthy-control_DOWN	NA	1955243	729
bsdb:235/4/1_Age:7-18-years_vs_<7-years_UP	NA	351091
bsdb:237/1/1_Chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	1940338
bsdb:241/1/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	29466	39778	137838
bsdb:241/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	74426	39486	1681
bsdb:242/3/1_Iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_UP	NA	351
bsdb:243/1/2_Gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_DOWN	NA	12917	1833
bsdb:243/2/1_Gastric-cancer:current-H.pylori-infection-patients_vs_past-H.pylori-infection_UP	NA	820	165179
bsdb:243/3/1_Gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	28111	817	820	310298
bsdb:243/4/1_Gastric-cancer:gastritis-cases_vs_normal_UP	NA	562	877420	37628	2485925	3023528	2807717
bsdb:243/5/1_Gastric-cancer:subjects-with-metaplasia_vs_normal_UP	NA	290054	1898207
bsdb:243/6/2_Gastric-cancer:subjects-with-metaplasia_vs_subjects-with-gastritis_DOWN	NA	1898207
bsdb:244/1/1_Age:18-62-years_vs_2-12-years_UP	NA	1720	1747	1282
bsdb:244/1/2_Age:18-62-years_vs_2-12-years_DOWN	NA	1306
bsdb:244/4/1_Age:18-62-years_vs_2-12-years_UP	NA	1747	1282	147802
bsdb:244/5/1_Atopic-eczema:lesional-skin-in-young-children_vs_non-lesional-skin-in-young-children_UP	NA	1747	38303	29388	29380	28037	1303	1313	1305	45634
bsdb:244/6/1_Atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1280
bsdb:244/7/1_Age:18-62-years_vs_2-12-years_UP	NA	1747	147802	1282
bsdb:244/7/2_Age:18-62-years_vs_2-12-years_DOWN	NA	45634	43675
bsdb:245/1/1_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	53254	562	287	33038	2212467
bsdb:245/1/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	638849	1680	360807	328814	328813	310297
bsdb:245/2/2_Urolithiasis,Nephrolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	39488	42322
bsdb:246/2/1_Asthma:maternal-asthma_vs_no-asthma_UP	NA	817
bsdb:246/2/2_Asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1506
bsdb:248/1/1_Human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	351
bsdb:248/2/2_Human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	76761	351
bsdb:249/2/2_Hepatitis,-Alcoholic:HDC_vs_NAC_DOWN	NA	351
bsdb:249/3/2_Hepatitis,-Alcoholic:MAH_vs_NAC_DOWN	NA	351
bsdb:250/1/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_UP	NA	729	43675	114702	84135	237576	28129	1379	860	425941	1924944
bsdb:250/2/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	729	114702	84135	237576	425941
bsdb:250/3/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_UP	NA	729	84135
bsdb:250/4/1_Severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-100-days-after-the-transplant_vs_engraftment_DOWN	NA	43675
bsdb:252/1/1_Pemphigus-vulgaris:Pemphigus-vulgaris-(PV)--Patients_vs_healthy-control_UP	NA	1940338
bsdb:255/1/1_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	351
bsdb:255/2/2_Human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	147802
bsdb:255/3/1_HIV-infection:HIV+_vs_HIV-_UP	NA	727	1261	1328
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	1598
bsdb:256/1/1_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	239935	817
bsdb:256/1/2_Gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	1396	165179
bsdb:256/2/1_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	351	1396	28132	1328
bsdb:256/2/2_Gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	210
bsdb:256/3/1_Gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	239935	1747	28132	1328
bsdb:256/3/2_Gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	351	820	210	165179
bsdb:256/4/1_Gastric-cancer:early-stage-tumor_vs_early-stage-normal_UP	NA	1747	1328
bsdb:256/4/2_Gastric-cancer:early-stage-tumor_vs_early-stage-normal_DOWN	NA	165179	172044
bsdb:256/5/1_Gastric-cancer:early-stage-peritumor_vs_early-stage-normal_DOWN	NA	172044
bsdb:256/6/1_Gastric-cancer:late-stage-tumor_vs_late-stage-normal_UP	NA	1747	1328
bsdb:256/8/1_Gastric-cancer:late-stage-peritumor_vs_late-stage-normal_DOWN	NA	165179
bsdb:256/11/2_Gastric-cancer:tumor-HP+_vs_tumor-HP-_DOWN	NA	351
bsdb:259/1/1_Atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/1_Atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:259/2/2_Atopic-eczema:emollient-use_vs_no-emollient-use_UP	NA	1304
bsdb:260/1/1_Food-allergy:Allergic-Estonian-children._vs_Nonallergic--Estonian-children._UP	NA	1280
bsdb:260/2/1_Food-allergy:Allergic-Swedish-children_vs_Non-allergic-Swedish-children._UP	NA	1280
bsdb:261/1/1_Chronic-pancreatitis:autoimmune-pancreatitis-type-1_vs_chronic-pancreatitis_DOWN	NA	28116	205328	460384	113107	1302	160404
bsdb:262/7/1_Atopic-asthma:atopic-asthma-subjects_vs_healthy-controls_UP	NA	1282
bsdb:264/1/1_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	1872515	72409	309120	2023260	1258	1971214	1261	59823	2776143
bsdb:264/1/2_Human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	1879286	147802
bsdb:265/1/1_Human-papilloma-virus-infection,Age:two-months_vs_at-birth_UP	NA	43675	39778	1872515
bsdb:265/3/1_Human-papilloma-virus-infection:HPV+-at-two-months_vs_HPV--at-two-months_DOWN	NA	39778
bsdb:266/1/1_Diet:Healthy-vegetarian_vs_Healthy-non-vegetarian_UP	NA	573	28128
bsdb:267/1/1_Atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	76122	147802	28449	165179	117207	59892	39778
bsdb:267/1/2_Atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	71999	57037
bsdb:267/2/1_Atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	739	727	28132	425941	117207	59892	39778
bsdb:267/2/2_Atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	57037
bsdb:267/3/1_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	28449	28131
bsdb:267/3/2_Atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	739	817	1018	996	727	729	57037	165179	425941	117207	59892	33038
bsdb:267/4/2_Atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_DOWN	NA	351
bsdb:268/1/1_Cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	2702	33959	419005	187101
bsdb:269/1/1_Leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	820	817
bsdb:271/1/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	853	39488	253239	44749
bsdb:271/1/2_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	1659	1655	2047	43675	29361	1335
bsdb:271/3/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	853
bsdb:271/4/1_Acute-lymphoblastic-leukemia:males_vs_female_UP	NA	853
bsdb:271/5/1_Acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	39488
bsdb:271/6/1_Acute-lymphoblastic-leukemia:Age-less-than-65-years-old_vs_Age-greater-than-65-years-old_UP	NA	39488
bsdb:273/1/1_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	853
bsdb:273/1/2_Acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	134375	358	293
bsdb:274/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	40543
bsdb:274/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	33032	938288	851	1596	2052	1465756	1328
bsdb:274/2/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	82135	502393	2052	40543
bsdb:274/2/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1287640	827	1260	851	47770	1596	755172	507750	1465756	1328
bsdb:274/3/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	82135	28127	419005	40543	1311
bsdb:274/3/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	33032	1287640	308994	938288	1260	1596	755172	507750	1465756	33031	28125	28128	28130
bsdb:274/4/1_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_UP	NA	40543
bsdb:274/4/2_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	33032	308994	938288	851	47770	1596	755172	507750	1465756	28125	28128	1328	29318
bsdb:274/5/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1261
bsdb:274/5/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1287640	386414	1465756	28125
bsdb:274/6/1_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	33032	502393	28127	1596	147802	2052	1261	419005	28130	40543	29318
bsdb:274/6/2_Cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	47770	755172
bsdb:274/7/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	147802	419005	40543
bsdb:274/7/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	59505	33032	1287640	827	53374	46507	938288	28127	386414	755172	507750	1465756	33031	28125
bsdb:274/8/1_Cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	47770	1465756	28125
bsdb:274/9/1_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_UP	NA	851	2098	2052	419005	28130	40543	1311	187328
bsdb:274/9/2_Human-papilloma-virus-infection,Cervical-cancer:normal-pH_vs_abnormal-pH_DOWN	NA	1596
bsdb:274/10/1_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	82135	2052	40543	1328	187328
bsdb:274/10/2_Human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	33037	28127	1596
bsdb:276/2/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	28141
bsdb:276/2/2_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	39488
bsdb:276/3/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	4091
bsdb:276/4/1_Multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-relatives-control_UP	NA	287	1535
bsdb:280/1/1_Cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	1261	33036	40543
bsdb:280/1/2_Cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_DOWN	NA	109790	181675
bsdb:281/1/1_Acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Healthy-Control_UP	NA	51515
bsdb:283/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2702	1872650	87541	1258	1633
bsdb:283/1/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	82135	109790	47770
bsdb:284/2/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1655	200	44737	1624	1613	28037	1309	1310	56774
bsdb:284/2/2_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1151604	45243	726	43995	742463	936567	239138	28131	28132	425941	242668	157692
bsdb:284/4/1_Chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1309
bsdb:285/1/1_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	165179
bsdb:285/1/2_Multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	165179	1261
bsdb:285/3/1_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	239935	47678	28116	33035	853	729	823	310297	165179	363265	39778	33038
bsdb:285/3/2_Multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	165179	1623	823	820	52226	1261	239935	28111	853	817	387090	28116
bsdb:286/1/1_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_UP	NA	165179
bsdb:286/1/2_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	328814	39488	39496	1852369	204516
bsdb:286/2/1_Graves-ophthalmopathy:graves-orbitopathy_vs_healthy-controls_UP	NA	165179
bsdb:287/1/1_Human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_UP	NA	87541	33034	1681	1679	1322	449520	827	191610	2702	242750	405	406	485	54005	33030	501496	28132	28137	52773	1660	68569	160	187328
bsdb:287/1/2_Human-papilloma-virus-infection:Visit-1-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	185294	147802
bsdb:287/2/1_Human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_UP	NA	419005	29524	33033	487173	33034	54005	1496	84136	250	33043
bsdb:287/2/2_Human-papilloma-virus-infection:Visit-2-HPV-(progression)_vs_HPV-(clearance)_DOWN	NA	544581	1381	288965
bsdb:288/1/1_Phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	853
bsdb:289/1/1_Health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	1898207
bsdb:290/2/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	39777	39778	29317	55565	187326	1926307
bsdb:290/2/2_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1613	230143
bsdb:290/3/1_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	113107	1318	39777	39778	55565	1379	29391	84135
bsdb:290/3/2_Oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1280	29380	1282	1292	230143	1351
bsdb:291/1/1_Graves-disease:graves-disease_vs_healthy-controls_UP	NA	204	1926307	582
bsdb:291/1/2_Graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	1872444	1596
bsdb:293/4/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	134821
bsdb:293/4/2_Human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1852374	287
bsdb:293/5/1_Human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_UP	NA	76122	28133	28136	218538
bsdb:293/6/1_Human-papilloma-virus-infection:without-any-HPV-type-cleared_vs_with-any-HPV-type-cleared-in-a-year_UP	NA	502393	419005	1391654	1763509
bsdb:293/7/1_Human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_UP	NA	386414	420324	218538	410072	1182571	1297424
bsdb:293/7/2_Human-papilloma-virus-infection:at-least-one-HPV-type-persisted_vs_no-HPV-type-persisted_DOWN	NA	1584
bsdb:294/1/2_Acute-lymphoblastic-leukemia:post-induction-therapy_vs_baseline_DOWN	NA	1971605
bsdb:294/3/2_Acute-lymphoblastic-leukemia:post-re-induction-therapy_vs_baseline_DOWN	NA	1971605
bsdb:295/1/2_Human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	351
bsdb:296/1/1_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-control_UP	NA	573	244366	1303	1302	550	1308	1318	1304	1689	546	74426	28037	548	839	589436	1328	28132	1297617	1313	54291	1680	732	61645	907	351091
bsdb:296/1/2_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-control_DOWN	NA	197614	66219	1561	169679	43305	1496	185008	246787	36745	1869337	28116	1679721	818	823	39485	47678	1686	1520	1505	1491	649756	158847	1492	630129	28026	856
bsdb:296/2/1_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-controls_UP	NA	546	550	548	573	244366	54291	1302	1303	1313	1304	28037
bsdb:296/2/2_Multiple-myeloma:multiple-myeloma-patients_vs_healthy-controls_DOWN	NA	649756	84030	1492
bsdb:299/1/1_Acute-lymphoblastic-leukemia:induction-chemotherapy_vs_baseline_UP	NA	35783
bsdb:301/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2776143
bsdb:302/4/1_Asthma:asthma_vs_healthy-control_UP	NA	28127	218538	2702	208968
bsdb:302/5/1_Asthma:asthma_vs_healthy-control_UP	NA	28127	2702
bsdb:303/1/2_Non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	1898207
bsdb:304/1/1_Antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	105841	109327	40520	33043	39486	84112	853	140626	28052	29370	1590	100176	40518	29361	29343
bsdb:307/1/2_Antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	214856	328813	28117	328814	487174	1680	28026	35833	1955243	544645	1913682	1506	39486	853	729	261299	39485	28118	1945593	823	487175	360807	40519	1318
bsdb:307/2/1_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	823	35833	360807	28118	1955243	1506	853	40519	328814	487175	1913682	1680	328813	1945593	214856	544645	28117	487174	39485	39486	729	1288121
bsdb:307/3/2_Antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	35833	1680	261299	28026	292800
bsdb:308/2/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	2030927	2212467
bsdb:308/3/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	2030927	2049048
bsdb:308/3/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	2212467	2030927
bsdb:308/5/1_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1869337
bsdb:308/5/2_Air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1898207
bsdb:309/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	28111	1598	330
bsdb:309/2/1_Cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	351
bsdb:309/3/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	239935	1598
bsdb:309/3/2_Cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_DOWN	NA	239935	33035	1502	74426	28132	165179	1311
bsdb:314/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	386414	82135
bsdb:314/2/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	386414	2702
bsdb:314/3/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	2702	386414
bsdb:314/4/1_Cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	87541
bsdb:317/1/1_Obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_UP	NA	2485925
bsdb:317/2/1_Obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_UP	NA	1969407
bsdb:317/2/2_Obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_DOWN	NA	1904861
bsdb:317/3/2_Obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	2049031
bsdb:319/1/1_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	214856	2125	28139	1837329
bsdb:319/1/2_Air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	1970093	1235800	1003360	32025
bsdb:320/1/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/2/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	39778
bsdb:320/3/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotic-penicillin_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	28116
bsdb:320/4/1_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33038
bsdb:320/4/2_Antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	817
bsdb:320/5/1_Antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-multi-class-antibiotics_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_UP	NA	39778
bsdb:320/6/2_Antimicrobial-agent:infants-to-mothers-exposed-to-cephalosporins_vs_infants-to-mothers-unexposed-to-intrapartum-antibiotic_UP	NA	817
bsdb:324/1/1_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_UP	NA	39488	290054	42322	1970093	1410629
bsdb:324/1/2_Thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_DOWN	NA	33038
bsdb:326/1/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_UP	NA	239935	214856	626932	29523	1197717	1352	142586
bsdb:326/1/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders-(partial-response-or-stable-disease)_vs_Non-Responders-(progression-or-death)_DOWN	NA	1879010	626929	291645	1898207	1506	208479	823
bsdb:326/2/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	239935	1879010	47678	291645	371601	1506	142586	1263000	292800	41978
bsdb:326/2/2_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_DOWN	NA	169435	1879010	823
bsdb:326/3/1_Non-small-cell-lung-carcinoma,Renal-cell-carcinoma,Disease-progression-measurement:Responders_vs_Non-Responders_DOWN	NA	1283	169292
bsdb:327/3/1_Antimicrobial-agent:infants-received-long-term-(>5days)-antibiotic-treatment---week-1_vs_infants-received-short-term-(<3days)-antibiotic-treatment---week-1_DOWN	NA	1506
bsdb:330/1/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:330/2/1_Human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	147802
bsdb:331/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	39488	42322	438033	33039
bsdb:332/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	1265
bsdb:332/1/2_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	1596
bsdb:335/2/1_Air-pollution:IL-10−/−--mice-fed-mouse-chow-with-PM10_vs_healthy-mice_UP	NA	1409
bsdb:336/3/1_Antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_UP	NA	1940338
bsdb:337/1/2_Antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	239935	137838	227943	1660
bsdb:337/3/2_Antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	423477
bsdb:338/2/1_Obesity:obese-children_vs_normal-weight-children_UP	NA	2382	1502	31971	727	729	387090	165179	43675	39778	36835	33038
bsdb:338/2/2_Obesity:obese-children_vs_normal-weight-children_DOWN	NA	626932	820	1680	74426	847	304	676517	1302
bsdb:340/1/1_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_UP	NA	239935	53443	469610	1352	658657	469614	562	658089	33038	187326	487175	1311	39778	1522
bsdb:340/1/2_Inflammatory-bowel-disease:Pouchitis_vs_Normal-pouch_DOWN	NA	28026	40520	39486	88431	457422	853	249188	204516	360807	457412	102148	796942	1318	197614	1343	39778	46228	33039
bsdb:344/1/1_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_UP	NA	1945593	68766
bsdb:344/1/2_Air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-“blank”-filter_DOWN	NA	351	1306
bsdb:345/1/2_Response-to-diet:Female-hamsters-Low-protein-diet-(LPD)-group_vs_Female-hamsters-Normal-protein-diet-(NPD)-group_DOWN	NA	38286
bsdb:346/1/1_Unipolar-depression:severe-depression_vs_mild-depression_UP	NA	292800	41978	658655
bsdb:346/1/2_Unipolar-depression:severe-depression_vs_mild-depression_DOWN	NA	1288121	1680	847	707003
bsdb:346/2/1_Unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	116085	1328	1512
bsdb:346/3/1_Anxiety-disorder:severe-anxiety_vs_mild-anxiety_UP	NA	1328	658655
bsdb:346/3/2_Anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	39491	28117	1680	116085	39496	301301	360807	41978
bsdb:346/4/1_Anxiety-disorder:moderate-anxiety_vs_mild-anxiety_UP	NA	1358	84112	658081	457421
bsdb:346/5/1_Remission:Yes_vs_No_UP	NA	39491	291645	74426	116085	39486	290054	39496	853	301301	360807	3068309	40519	707003
bsdb:346/5/2_Remission:Yes_vs_No_DOWN	NA	41978	53443	261299	33038
bsdb:346/6/1_Remission:Yes_vs_No_UP	NA	39491	116085	665951	360807	40519	41978	707003
bsdb:346/6/2_Remission:Yes_vs_No_DOWN	NA	291645	53443	658657	1940338	261299	658081	1304
bsdb:347/1/1_Obesity:obese-children_vs_controls_UP	NA	209880	35833	437897	847	823	487175	310297	363265	1512
bsdb:347/1/2_Obesity:obese-children_vs_controls_DOWN	NA	239935	671218	645466	105841	817	28116	818	89014	418240	44008	1547	853	471189	341220	102148	76860	1304	1535	1549	143393
bsdb:348/1/1_Obesity:obese-children_vs_lean-children_UP	NA	817	1591
bsdb:348/1/2_Obesity:obese-children_vs_lean-children_DOWN	NA	41200
bsdb:348/2/1_Obesity:overweight-children_vs_lean-children_UP	NA	817	1591
bsdb:348/3/1_Obesity:obese-children_vs_lean-children_UP	NA	817
bsdb:348/3/2_Obesity:obese-children_vs_lean-children_DOWN	NA	41200
bsdb:348/4/1_Obesity:overweight-children_vs_lean-children_UP	NA	1591
bsdb:349/1/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure_vs_normal_UP	NA	2702	134821	2098
bsdb:349/2/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure_vs_normal_UP	NA	2702	134821
bsdb:349/3/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure-(age-<46)_vs_normal_UP	NA	2702	2098	134821
bsdb:349/4/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-before-procedure_vs_normal_UP	NA	2702	134821
bsdb:349/5/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-6-months-post-procedure_vs_normal_UP	NA	2702	2098	134821
bsdb:349/6/1_Cervical-glandular-intraepithelial-neoplasia:LEEP-group-12-months-post-procedure_vs_normal_UP	NA	2702	2098	134821
bsdb:350/1/1_Obesity:Obese-children-(O)_vs_Normal-weight-(NW)_UP	NA	1680	853
bsdb:350/2/1_Obesity:Obesity-with-metabolic-syndrome-(OMS)_vs_Normal-weight-(NW)_UP	NA	74426
bsdb:353/1/1_Obesity:obese_vs_non-obese_UP	NA	853
bsdb:354/1/2_Obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	239935
bsdb:355/1/1_Obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_UP	NA	1591
bsdb:355/1/2_Obesity:obese-(obese/overweight/morbidly-obese)_vs_control-(lean/normal-weight)_DOWN	NA	821
bsdb:356/1/2_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	1940338
bsdb:356/3/1_Air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1945593
bsdb:356/6/1_Air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1872530
bsdb:358/1/1_Cervical-glandular-intraepithelial-neoplasia,Cervical-cancer:CIN2/3-CC_vs_Healthy-controls_UP	NA	43770	1747	225324	851	88164	1599	286638	1270	419005	1313	165096
bsdb:361/3/1_Air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	59823
bsdb:361/4/1_Air-pollution:mice-exposed-to-smoke_vs_control_UP	NA	1872421
bsdb:361/4/2_Air-pollution:mice-exposed-to-smoke_vs_control_DOWN	NA	194843	2049031
bsdb:364/1/1_Smoking-behavior:smokers_vs_non-smokers_UP	NA	113107	228604	28132	43675	39777
bsdb:365/1/2_Methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	142586
bsdb:367/1/1_Obesity:obese_vs_normal-weight_UP	NA	1971605	1955243	2049024	2049040
bsdb:367/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	2053619	558
bsdb:368/1/1_Smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	43675	1306	52773	419015	227942	28037	1343	249188	484	29466	34026	554406	29317	1305	495
bsdb:368/1/2_Smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	539	1306	1501332	237576	104608
bsdb:371/2/1_Obesity:obese-and-overweight-subjects_vs_lean-and-anorexic-subjects_DOWN	NA	2173
bsdb:371/3/1_Obesity:obese-subjects_vs_lean-subjects_DOWN	NA	28025
bsdb:371/3/2_Obesity:obese-subjects_vs_lean-subjects_UP	NA	1598
bsdb:371/4/1_Obesity:overweight-subjects_vs_lean-subjects_UP	NA	1598
bsdb:371/5/1_Obesity:obese-subjects-(species-level)_vs_anorexic,-lean,-and-overweight-subjects-(species-level)_DOWN	NA	28025
bsdb:371/6/1_Obesity:obese-and-overweight-subjects_vs_lean-and-anorexic-subjects_UP	NA	1598
bsdb:372/1/2_Air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	1898207	1506
bsdb:373/1/1_Obesity:overweight-children_vs_normal-weight-children_UP	NA	39491	1681	1335	45851	1268254
bsdb:373/1/2_Obesity:overweight-children_vs_normal-weight-children_DOWN	NA	239935	1288121	649756	246787	28111	28116	818	820	487174	28025	35833	2317	454154	821	1473216	1586779
bsdb:373/2/1_Obesity:Overweight-children_vs_Adults_UP	NA	1680	28026	418240	100886	1898207	1506	88431	410072	2137877	1160721	84112	1335	1268254
bsdb:373/2/2_Obesity:Overweight-children_vs_Adults_DOWN	NA	1473216	33043	165179	40519	39496
bsdb:373/3/1_Obesity:normal-weight-children_vs_Adults_UP	NA	446660	338188	818	1680	28025	28026	418240	100886	88431	1260	261299	2317	310298	204516	1160721	877428	2028282
bsdb:373/3/2_Obesity:normal-weight-children_vs_Adults_DOWN	NA	166486	40519	331630
bsdb:375/1/1_Obesity:obese_vs_normal-weight_UP	NA	1535
bsdb:375/1/2_Obesity:obese_vs_normal-weight_DOWN	NA	562
bsdb:376/2/1_Antimicrobial-agent:patients-that-took-levofloxacin_vs_before-antibiotic-exposure_UP	NA	310297
bsdb:377/1/1_Smoking-behavior:e-cigarette-smokers_vs_non-smokers_DOWN	NA	860	68766	979627	47671	1501329	2049038	59823	1303	1583331
bsdb:377/1/2_Smoking-behavior:e-cigarette-smokers_vs_non-smokers_UP	NA	419015	143361	651822	851	1358	2049034	267212	1969407	33033	28124	281920	310514	28135	59823	671224	135079	84109	29388	39778	152509
bsdb:377/2/1_Smoking-behavior:cigarette-smokers_vs_never-smokers_UP	NA	46125	52769	1017	45243	327575	1019	2718	43997	61592	539	860	137732	726	735	740	979627	47671	1107316	192066	1501329	1898956	2049038	341694	1583331	59823	43675	102148	1303	423477
bsdb:377/2/2_Smoking-behavior:cigarette-smokers_vs_never-smokers_DOWN	NA	114702	419015	895	143361	651822	851	1596	1358	187326	2023260	2049034	1969407	33033	33031	28124	281920	28129	28131	439703	310514	28134	28135	28136	59823	28137	638849	230143	671224	135079	84109	1318	158	51160	166	39777	39778	1926307
bsdb:377/3/1_Smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_UP	NA	1017	45243	1019	2718	43997	61592	539	860	726	740	47671	1107316	192066	2049038	341694	1583331	59823	43675	423477
bsdb:377/3/2_Smoking-behavior:E-cigarette-smoker_vs_cigarette-smoker_DOWN	NA	114702	419015	1940337	187326	59823	1318
bsdb:378/1/1_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	59823
bsdb:378/2/2_Graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	1547	1946507
bsdb:379/1/1_Obesity:non-obese_vs_obese_UP	NA	1679	158787	77635	1613	47493	227945
bsdb:379/2/1_Obesity:obese_vs_non-obese_UP	NA	29317	46124	45634
bsdb:379/2/2_Obesity:obese_vs_non-obese_UP	NA	712149
bsdb:382/1/1_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	87541
bsdb:382/2/1_Chlamydophila-infectious-disease,Human-papilloma-virus-infection:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	813
bsdb:385/1/1_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_UP	NA	490	28037	1303	1313	28124	739
bsdb:385/1/2_Gastric-adenocarcinoma:Gastric-adenocarcinoma-(GC)_vs_Superficial-gastritis-(SG)_DOWN	NA	55565	1884818	1382	237576	28129	43675	13690	1328	113107	45634	1318	1305	56774	121428
bsdb:386/1/1_Pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_UP	NA	208479
bsdb:386/1/2_Pulmonary-tuberculosis:Tuberculosis-(TB)-patients_vs_healthy-controls_DOWN	NA	39491	239935	1680	1679	28026	40520	74426	410072	2049024	751585	39486	88431	729	39485	437897	158847	491921	301301	166486	360807	40545	46228
bsdb:389/1/2_Schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	28449
bsdb:389/2/2_Schizophrenia:mania_vs_healthy-controls_DOWN	NA	28449
bsdb:390/1/1_Schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	707003
bsdb:390/1/2_Schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	707003
bsdb:390/2/1_Schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	707003
bsdb:397/1/1_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	1280	146827	172044
bsdb:397/1/2_Atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	425941	28132	43675
bsdb:399/1/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	68766	740	2044938
bsdb:399/2/1_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	1898207
bsdb:399/2/2_Age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	2137877
bsdb:403/2/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	29466	137838
bsdb:403/2/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1679
bsdb:403/4/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	29466	817
bsdb:403/4/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1681
bsdb:403/6/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	853	1679
bsdb:414/1/1_Epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	39491	216816	1680
bsdb:414/1/2_Epilepsy:before-keto-diet_vs_after-keto-diet_DOWN	NA	562
bsdb:415/4/1_Coinfection,Age:aging-HIV-infected-women-with-coinfections_vs_young-HIV-infected-group-without-coinfection_UP	NA	885	1591	1598	248039	1965233	44273
bsdb:415/4/2_Coinfection,Age:aging-HIV-infected-women-with-coinfections_vs_young-HIV-infected-group-without-coinfection_DOWN	NA	102148	2704657	29466
bsdb:416/1/1_HIV-infection,Antimicrobial-agent:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_UP	NA	371601	562	28118	328812	387661	166486	2585118
bsdb:416/1/2_HIV-infection,Antimicrobial-agent:continue-cotrimoxazole-prophylaxis_vs_stop-cotrimoxazole-prophylaxis_DOWN	NA	729	1735	1318	853	1304	328813	261299	84112	1309	1343
bsdb:424/1/1_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_UP	NA	1898203
bsdb:424/1/2_Pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_DOWN	NA	1506	2485925	77133
bsdb:424/4/1_Pancreatic-carcinoma:NBO-PC_vs_Healthy-control_DOWN	NA	1970093
bsdb:428/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	357276	821	33038	33039	28116	47678	239935
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1680	39491	40518	28026	853	74426	40520	88431	410072	39486
bsdb:428/2/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	1689	88431	208479	1623	823	1869337	165179	457412	1304	29466	1512
bsdb:428/2/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	28117	1679	28026	74426	410072	39486	39491	853	40518	40520
bsdb:428/3/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	1689	1623	823	1351	208479	1512	29466
bsdb:428/3/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	39491	40518	853	28026	74426	1679	457412	40520	165179	410072	39486	88431	28117	1304	39488
bsdb:428/4/1_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	1680	39486	88431	853	40520	2053618	573	446660	1535	410072	665956	33945	39496	1896336
bsdb:428/4/2_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_UP	NA	39488	47678	28116	457412	78259	1747	84163	177972	78258	1353	936594	652706	658089	2049041	138595	116085	1383	1280	172042	46125	360807	796942	1282	649756	39490	230143	40545	328813	133926	1869337
bsdb:429/1/1_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_UP	NA	197
bsdb:429/1/2_Gastric-cancer:gastric-cancer-patients_vs_healthy-controls_DOWN	NA	1179787	28131	28132	28133	1343	1306
bsdb:430/1/1_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_DOWN	NA	46506	1898203	46503	328813
bsdb:430/1/2_COVID-19:Patients-with-high-SARS-CoV-2-infectivity_vs_Patients-with-low-to-none-SARS-CoV-2-infectivity_UP	NA	74426	626935	582	68892
bsdb:431/2/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-HSIL_vs_transient-HPV+-with-LSIL_DOWN	NA	1522
bsdb:431/3/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	1522
bsdb:431/5/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_UP	NA	1311
bsdb:431/5/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	38304	1671	169292	33039	28130	755172	1689	1280	53345	1624	309120
bsdb:431/6/1_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-LSIL_vs_transient-HPV+-with-HSIL_UP	NA	33039
bsdb:431/6/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-LSIL_vs_transient-HPV+-with-HSIL_DOWN	NA	6337	206041	1217282
bsdb:431/7/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-HSIL_vs_transient-HPV+-with-LSIL_UP	NA	311235	206041	1217282
bsdb:431/8/1_Cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	46914
bsdb:431/9/2_Cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	28132	420645	33031	28130
bsdb:434/2/1_Cervical-glandular-intraepithelial-neoplasia:LSIL_vs_healthy-control_UP	NA	419005
bsdb:434/3/1_Cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_UP	NA	386414
bsdb:434/4/1_Cervical-cancer:cervical-cancer_vs_healthy-control_UP	NA	372463	281920
bsdb:435/1/1_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_UP	NA	68569	310298	29362
bsdb:435/1/2_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls-and-HPV+-transient-patients_DOWN	NA	147802
bsdb:435/2/1_Human-papilloma-virus-infection:HPV+-transient_vs_HPV--controls-and-HPV+-persistent-patients_UP	NA	147802
bsdb:435/3/1_Human-papilloma-virus-infection:HPV+-persistent_vs_HPV+-transient_UP	NA	68569
bsdb:435/3/2_Human-papilloma-virus-infection:HPV+-persistent_vs_HPV+-transient_DOWN	NA	147802
bsdb:435/4/1_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls_UP	NA	40543	68569
bsdb:435/4/2_Human-papilloma-virus-infection:HPV+-persistence_vs_HPV--controls_DOWN	NA	147802
bsdb:436/1/1_Cervical-glandular-intraepithelial-neoplasia:CIN2+/cervical-cancer_vs_healthy-controls_UP	NA	218538	82135	1260	2702	28127	386414
bsdb:437/1/1_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_UP	NA	33036	1393034	813	218538	309120	851	2702	502393	1276	884684	2051	37327	133926	266	33033	363849	54005	33031	1261	419005	28125	28128	28130	28132	131111	102148	114687	316	187328	66851	31281	203908	252598	1392244	76775	5476	114525	4932	114524	931244
bsdb:437/1/2_Human-papilloma-virus-infection:HPV-16+_vs_Healthy-control_DOWN	NA	1579349	1485682	5478	91626	27978
bsdb:439/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	425254	1492	29363
bsdb:439/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	901	36841	46228
bsdb:440/1/1_Rosacea:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_UP	NA	76122	827	161879	66228	28131
bsdb:440/1/2_Rosacea:Participants-with-papulopustular-rosacea-(PPR)_vs_Healthy-controls_DOWN	NA	227476	281091	33011	156974	588	38313
bsdb:440/2/1_Rosacea:Participants-with-erythematotelangiectatic-rosacea_vs_Healthy-controls_DOWN	NA	281091	28124	588	207340	38313	33038
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	39488	33039
bsdb:441/2/1_Influenza-A-(H1N1):H1N1-cases_vs_Healthy-controls_DOWN	NA	39488	33039	41978
bsdb:441/3/1_COVID-19:COVID-19-patients_vs_H1N1-patients_UP	NA	39488	33038	33039
bsdb:442/1/1_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	887091	5599	749840	29918	5480
bsdb:442/1/2_Type-II-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	5551	76775
bsdb:443/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	1532	33035	287
bsdb:443/2/1_Irritable-bowel-syndrome:IBS-C_vs_Health-Control_UP	NA	1532	33035	287
bsdb:443/2/2_Irritable-bowel-syndrome:IBS-C_vs_Health-Control_DOWN	NA	1686
bsdb:443/3/1_Irritable-bowel-syndrome:IBS-D_vs_Health-Control_UP	NA	49118	287
bsdb:443/3/2_Irritable-bowel-syndrome:IBS-D_vs_Health-Control_DOWN	NA	1686
bsdb:443/5/2_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome,-constipation-predominant-(IBS-C)_vs_Irritable-Bowel-Syndrome,-diarrhea-predominant-(IBS-D)_DOWN	NA	49118
bsdb:443/6/1_Irritable-bowel-syndrome:Visible-abdominal-distension_vs_No-Visible-abdominal-distension_UP	NA	1532	49118	287	818
bsdb:443/7/1_Irritable-bowel-syndrome:Abdominal-Bloating_vs_No-Abdominal-Bloating_UP	NA	1532
bsdb:446/1/1_COVID-19:COVID-19-cases_vs_COVID-19-negative-controls_DOWN	NA	38284
bsdb:449/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1852377	2696063	28446	1396	1813611	57706	546	2077147	1898207	2109688	1520	217159	32013	285	61645	881260	69218	550	2027919	158836	208224	2478464	1812935	885040	399742	2596949	1827481	2707174	853	477680	292800	1134687	571	66219	84030	29370	1590	1584	33959	28038	83655	2714951	2681307	1920114	2282309	61646	1907578	2153385	1624	1613	1598	2081964	1421	2100	2067957	189425	1473112	2575375	450367	28101	61647	237609	47885	76760	306	1338689	1611770	1636610	2069256	34038	329	172042	43675	867	52773	1933220	2003121	2219696	1904944	1304	1305	712624	83771	2036206	436515	34073	434009	2126319	55601	33038	114708
bsdb:449/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	203	204	221027	66219
bsdb:452/1/1_Gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	297314
bsdb:453/3/1_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	877428
bsdb:453/4/1_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_UP	NA	1506
bsdb:454/1/1_Colorectal-cancer:colorectal-cancer-(CRC)_vs_healthy-controls_UP	NA	1940338
bsdb:455/3/1_Gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	713051	56142	712991	713049	712739	51123	43997	51160	143361	651822	28112	53418	712725	712459	714	671227	158	2699746
bsdb:455/3/2_Gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_DOWN	NA	29466	1655	1304	46124	2047	1226342	712124	712118	505	712414	712362	712538	712503	55565	1382
bsdb:455/4/1_Pregnancy:pregnant-women_vs_non-pregnant-women_UP	NA	55565	1872471	76122	45243	651822	2699746	860	157692	157691	104608	187326	56142	837	305719	52227	28129	28132	189723	59823	230143	2053611	69823	28112	158	166	29466	1926307	51123
bsdb:455/4/2_Pregnancy:pregnant-women_vs_non-pregnant-women_DOWN	NA	712187	29391	740	267212	172042	1306	217202
bsdb:456/1/2_Diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1940338
bsdb:457/1/1_Periodontitis:Individuals-diagnosed-with-Periodontitis-group_vs_Healthy-controls-group_UP	NA	28124	165179	58231	671218	59892	853
bsdb:457/2/1_Periodontitis:Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_vs_Healthy-controls_UP	NA	671218	165179	329	234908
bsdb:457/4/1_Periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Healthy-controls_UP	NA	33033	341694	28129	1177574	60133	228604	102148	59892	58231
bsdb:457/5/1_Periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_DOWN	NA	671218	28101	165179	329	234908
bsdb:457/5/2_Periodontitis:Individuals-diagnosed-with-both-Periodontitis-and-Type-2-Diabetes-and-treated-with-metformin-(Met-group)_vs_Individuals-diagnosed-with-Periodontitis-and-Type-2-Diabetes-Mellitus-(DAP)_UP	NA	1177574	34105	1309
bsdb:458/1/1_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_UP	NA	1909303
bsdb:461/1/1_Smoking-behavior:Healthy-Current-Smokers_vs_Never-smokers_UP	NA	470	106649	29430	40214	108981	156456	895	309120	143361	77917	851	907	187326	349094	330	113287
bsdb:461/1/2_Smoking-behavior:Healthy-Current-Smokers_vs_Never-smokers_DOWN	NA	1659	1656	46124	137732	729	28449	1303	1318	1305	272548
bsdb:464/1/1_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_DOWN	NA	2080739	2044938	443342
bsdb:464/1/2_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_UP	NA	41978
bsdb:464/3/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	1869227	707003
bsdb:465/1/1_Diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_UP	NA	1940338	33039
bsdb:466/1/1_Chewing-tobacco-behavior:smokeless-tobacco-users_vs_age-matched-controls_UP	NA	1922
bsdb:468/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1940338
bsdb:469/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-19-controls_DOWN	NA	1379	824	157688	29391	40324
bsdb:470/1/1_Colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	1287640	1872531	1898207	1955814	208479	851	76859	155615	68766	29391	154046	33033	1944660	1904861	341694	28123	322095	281920	28131	28133	102148	2053618	1512	33039
bsdb:470/1/3_Colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	1287640	1872531	1955814	208479	851	76859	155615	68766	29391	154046	33033	1944660	341694	28123	322095	281920	28131	28133	102148	2053618	1512	33039	1898207	1904861
bsdb:471/1/1_Colorectal-cancer:colorectal-cancer-cases_vs_controls_UP	NA	328813	76122	1287640	33037	1872531	817	291644	1929485	35833	824	204	827	876	539	562	1736	292800	850	859	851	29391	46124	658086	1383	104608	2173	66852	33033	1944660	54005	1261	1262	341694	28123	322095	281920	28131	181487	69823	84109	2049041	102148	76860	1334	315405	1077464	1512	56774	33039
bsdb:471/1/2_Colorectal-cancer:colorectal-cancer-cases_vs_controls_DOWN	NA	658081	457412	306	1679	39488	446660	1308	853	166486	471189	1686
bsdb:471/1/3_Colorectal-cancer:colorectal-cancer-cases_vs_controls_UP	NA	851	33033	29391	341694	102148	28131	76860	46124	539	204	76122	56774	824	28133	1077464
bsdb:471/1/4_Colorectal-cancer:colorectal-cancer-cases_vs_controls_DOWN	NA	1304	113107
bsdb:472/1/1_Gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_UP	NA	1898207	40518	59201	36835
bsdb:476/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	39488	41978	2485925
bsdb:477/2/2_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-controls_DOWN	NA	172788
bsdb:478/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	712414	2419515	1750
bsdb:478/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	82688
bsdb:478/2/1_COVID-19:COVID-19-patients_vs_Flu-patients_DOWN	NA	1613	712414	419005	2419515	1750
bsdb:478/3/1_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	82688	1613	419005
bsdb:478/3/2_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	2419515	712414	1750
bsdb:479/4/1_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_DOWN	NA	29317
bsdb:479/4/2_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_UP	NA	2137877
bsdb:481/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	33038	1547	84112	658082	658655
bsdb:481/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	1470347	166486	469610	39488	487175	626932	1099853	39485	2030927	291644	28118	328814	40518	204516
bsdb:481/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_UP	NA	29466	1547
bsdb:481/2/2_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_DOWN	NA	2053618	360807	301301	487175	2683689	853	39486	116085	74426	821
bsdb:481/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	61592	43675	1352	824	39791	172042	419015	33945	37734	1246	1583	2766967	199	546	548	68892	187326
bsdb:481/3/2_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_DOWN	NA	39491
bsdb:483/1/1_COVID-19:Antibiotic-naive-COVID-19-patients_vs_Uninfected-controls,-pneumonia-patients,-antibiotics-treated-COVID-19-patients_UP	NA	1656	154046	291645
bsdb:483/1/2_COVID-19:Antibiotic-naive-COVID-19-patients_vs_Uninfected-controls,-pneumonia-patients,-antibiotics-treated-COVID-19-patients_DOWN	NA	39496
bsdb:483/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients,-pneumonia-patients,-uninfected-controls_DOWN	NA	39486	853	39491	40520	658089	39496
bsdb:483/3/1_COVID-19:Pneumonia-controls_vs_Uninfected-controls,-COVID-19-patients_DOWN	NA	1352	1547	658089	39496
bsdb:484/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients-with-fever-and-cough_UP	NA	1759399	1311	1307	197	839	59823
bsdb:484/2/1_COVID-19:COVID-19-positive-patients_vs_Healthy-controls_UP	NA	119206	199	204	1491	2663009	729	617123	157687	837	28129	28131	1177574	28132	28135	43675	113107	1302	2382163	28037	1318	1313	1304	1305	1307	1308	1349	39777	39778	29466	248315
bsdb:484/4/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-patients-with-fever-and-cough_UP	NA	1759399	39485	119206	197	617123	837	199	1156431	839	113107	1379	652716	39777	2663009	204	2714929	162	1019	1111760	1514105	1316408	1307	1156433	1318	29466	519472	2382163	2698804	81028	1585976	28129	1305	1265445	2756	36874	1825069	1304	1308	2748	1562970	28135	2751	45634	66219	712357	28123	28113	827	1349	1311
bsdb:485/2/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	208479	4932	729	546	1896336	1351
bsdb:485/2/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	328814	658087	469614	818	817	246787	371601	658086	39490	487175	821	649756	469610	658089	658082
bsdb:486/1/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	74426	1262234	358743	1587	823	622	33038	1898207	1506	41978	35783
bsdb:486/1/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1680	1531	729	52226	165179	301302	360807	40519
bsdb:486/2/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	106649	358743	1587	33970	624	35783	1591
bsdb:486/2/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1531	28052
bsdb:486/3/1_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_UP	NA	624	1587	358743	622
bsdb:486/3/2_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1531	28052
bsdb:487/2/1_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_DOWN	NA	877420	877428
bsdb:487/2/2_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_UP	NA	1946507
bsdb:487/3/1_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_DOWN	NA	290054	39485	877420	877428	512316
bsdb:487/3/2_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_UP	NA	39488
bsdb:488/1/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	28026	1898207	1852370	310297
bsdb:488/1/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	817	562
bsdb:489/1/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_UP	NA	1352	43765	54007	156978	178214	851	1354	762845	28127	337317	302449	1587	146482	1647712	2049041	1270	938293	161902	38286	1219629	45851	1831	1473216	29466	404403	37734	571	371143	69833	35783	1720
bsdb:489/1/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_DOWN	NA	28117	39488	649756	169435	1393034	626929	28111	817	291645	291644	29523	46506	2049021	1506	1099853	88431	208479	1531	460384	853	1971605	938288	292800	1969407	119853	204516	28125	638849	29348	411567	1755609	537298	598660	702963	1870999	1647714	361492	243905	1619234	59505	319644	397283	1261637	598552	184870	1150298	169136	1640371	338188	1572655	712495
bsdb:489/2/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_UP	NA	156978	537280	2049041	68766	1596	69833	1647712	169292	938293	1280	38286	53345	1831	302449	46228	1219629	298389	45851	1473216	404403	37734	371143	29387	1282
bsdb:489/2/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_DOWN	NA	1870997	361500	649756	76517	74426	100884	1099853	309120	1531	39490	1971605	938288	1472764	28052	1689303	1870999	387661	204516	1703337	28130	537298	301302	1177728	39492	537274	706562	853	28125	2049040	548	28901	88431	39488	1227508	242750	1308	1330241	1299485	1261637	1816688	1572655	1648956	549	624	1852369	2049024	111292	598552	2049028	1805476	1871036	550
bsdb:489/3/1_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_UP	NA	28130	1703337	309120	1261	54007	387661	507844	1870997	1288121	712430	1647711	1285934	537274	100884	1735	1287640	1472764	2023260	1352	1872650	28127	1308	178214	1354	1330241	28123	1299485	1816688	43765	624	549	51197	1805476	1290	1795816	1232428	487173	615	187327	1577797	1871009	337315	1871036	571	1720203	1648956	454154	971	146482	1328	28141	2049040	290054	29387
bsdb:489/3/2_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_DOWN	NA	28111	291644	598660	28117	1647714	584	702963	35830	46506	1619234	59505	438033	817	1547	1506	397283	298389	1640371	169136	1470355	29347	328814	342942	338188	1150298	169435	1647678	712495	460384	68766	29523	1550024	291645	1227507	1569942	208479	319644	1924109	29361	1720294	47246	1544	40520	320882	39950	357276	818
bsdb:491/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	562
bsdb:491/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	821
bsdb:498/1/1_COVID-19:Symptomatic,-mild-to-moderate-COVID-19-patients_vs_Asymptomatic-uninfected-controls_UP	NA	1872515	1871086	76517	156978	1720	2049028	33031	1971214	821	165179	258
bsdb:498/1/2_COVID-19:Symptomatic,-mild-to-moderate-COVID-19-patients_vs_Asymptomatic-uninfected-controls_DOWN	NA	649756	1720	192066	28130	1283
bsdb:498/2/1_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_UP	NA	1872515	76517	1720	35783	853	1971214	165179
bsdb:498/2/2_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_DOWN	NA	1720	29394	137732	192066	28130	1283	1306
bsdb:499/1/1_Irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_DOWN	NA	76122	817	329854	310297	820	821
bsdb:499/1/2_Irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_UP	NA	1496	33043	29370	40519	1338	29361	1512	33038	46228	244328
bsdb:499/2/1_Irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_DOWN	NA	76122	817	329854	28116	310297	820	821	28134	839	152509
bsdb:499/2/2_Irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_UP	NA	1496	33043	292800	40518	29361	29343	1535	1512	33038
bsdb:499/3/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	76122	329854	310297	821	28134
bsdb:499/3/2_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	1496	292800	29361	1512	33038	46228
bsdb:499/4/1_Irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_DOWN	NA	817	329854	28116	46506	820	310297	821	28134	839	76122	152509	244328
bsdb:499/4/2_Irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_UP	NA	1338	1535	292800	1496	29361	1512	33043	33038	46228
bsdb:500/1/1_COVID-19:COVID-19-patients_vs_COVID-19-negative-patients-with-pneumonia_UP	NA	108981	89152	43263
bsdb:500/1/2_COVID-19:COVID-19-patients_vs_COVID-19-negative-patients-with-pneumonia_DOWN	NA	1476577	727	729	425941	57037	28132	60133	43675	423432	163601	39778	29466	2044938
bsdb:502/1/1_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	79880	1396	1680	1685	216816	1496	1352	1581	1624	39491
bsdb:502/2/1_Irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_UP	NA	79880
bsdb:502/3/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	79880	1396	1680	1685	216816	1496	1352	1624	39491
bsdb:502/4/1_Irritable-bowel-syndrome:IBS-M_vs_Healthy-Control_UP	NA	79880	1352	1581
bsdb:505/1/2_Irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1686	1537
bsdb:506/1/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	562
bsdb:509/1/1_Smoking-behavior:Smoking_vs_Non-smoking_UP	NA	1940338
bsdb:509/2/1_Smoking-behavior:Smoking_vs_Non-smoking_UP	NA	100233	1940338
bsdb:509/2/2_Smoking-behavior:Smoking_vs_Non-smoking_DOWN	NA	257462
bsdb:510/1/1_Periodontitis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	714	35519	33033	33031	52227	470565	310514	228604	287	671224	1872413
bsdb:510/1/2_Periodontitis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_DOWN	NA	189722	52773	1328	166
bsdb:510/2/1_Rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	671218	156456	1689	1018	43768	1383	157688	157691	157687	114528	35519	28126	52227	28129	470565	439703	28132	310514	28133	28136	60133	228604	228603	287	230143	135080	135083	163583	69823	712711
bsdb:510/2/2_Rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_DOWN	NA	180282	137732	505	431059	407975	163559	638849	172042	52773	1328	325787
bsdb:511/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	729	43675	28449
bsdb:511/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	28131	59892
bsdb:511/2/1_COVID-19:COVID-19-patients-(severe/critical)_vs_COVID-19-patients-(mild/moderate)_DOWN	NA	739	28131	1328	59892
bsdb:511/3/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	28449	43675	39778
bsdb:511/3/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	28131
bsdb:511/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	358743	216816	43675
bsdb:511/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	47678	40520	36835	387090
bsdb:511/5/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	358743	1328
bsdb:511/5/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	28111	387090	40520	33035	36835
bsdb:512/2/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	287
bsdb:512/3/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_UP	NA	287
bsdb:512/3/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_DOWN	NA	292
bsdb:512/4/1_Viral-load:low-Ct-CoV+-patients_vs_high-Ct-CoV+-patients_UP	NA	287
bsdb:512/6/1_Viral-load:low-Ct-CoV+-patients_vs_mid-Ct-CoV+-patients_UP	NA	287
bsdb:518/1/1_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	39488	33038	35517
bsdb:518/1/2_Endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	39485	877420	41978	1452070	707003	297314
bsdb:520/2/2_Endometriosis:patients-with-rASRM-stages-3---4_vs_patients-with-rASRM-stages-1---2_UP	NA	1940338
bsdb:522/1/1_Endometriosis:Endometriosis-patients_vs_Controls-Subject-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	147802	33069	306
bsdb:522/1/2_Endometriosis:Endometriosis-patients_vs_Controls-Subject-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	1591	33038	28128	37734	69966	28454
bsdb:523/1/1_Endometriosis:Endo-mice_vs_Non-endo-mice_DOWN	NA	877420
bsdb:524/1/1_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_UP	NA	1898203
bsdb:524/1/2_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_DOWN	NA	2485925
bsdb:524/2/2_Non-alcoholic-steatohepatitis:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_DOWN	NA	2053608
bsdb:526/1/1_Adenomyosis,Endometriosis:Endometriosis/-adenomyosis-patients-(AMEM)_vs_Endometriosis-patients-(EM)-and-Patients-without-endometriosis(Control-CT)_UP	NA	1940338
bsdb:529/1/1_Rheumatoid-arthritis,Osteoarthritis:arthritis-patient_vs_healthy-controls_UP	NA	39778	28132
bsdb:529/1/2_Rheumatoid-arthritis,Osteoarthritis:arthritis-patient_vs_healthy-controls_DOWN	NA	293	172044
bsdb:529/2/1_Rheumatoid-arthritis,Osteoarthritis:rheumatoid-arthritis_vs_Osteoarthritis_UP	NA	735	76122	39778	729	28449
bsdb:529/2/2_Rheumatoid-arthritis,Osteoarthritis:rheumatoid-arthritis_vs_Osteoarthritis_DOWN	NA	2047	33038
bsdb:530/1/1_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_UP	NA	216816	47770	1596	1382	1613	1632	47493	1598	55565	1660	43675	652722	712621	187326	114702	158
bsdb:530/1/2_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_DOWN	NA	502	1107316	425941	1019	56774	617123	29434	28449	735	736	45634
bsdb:530/2/1_Smoking-status-measurement:Former-Smokers_vs_Never-Smokers_UP	NA	216816	47770	1596	1613	1632	47493	1598	712621	43675	735	45634	114702
bsdb:530/2/2_Smoking-status-measurement:Former-Smokers_vs_Never-Smokers_DOWN	NA	1019	502	617123	1107316	671226	158	56774	55565	1382	29434	28449	736	45634
bsdb:530/3/1_Smoking-status-measurement:Current-Smokers_vs_Former-Smokers_UP	NA	55565	114702	216816	47770	1596	1382	1613	1632	47493	1598	187326	652722	43675	712621	671226	158
bsdb:530/3/2_Smoking-status-measurement:Current-Smokers_vs_Former-Smokers_DOWN	NA	1019	735	736	502	617123	495	1107316	29434	47658	425941	45634	56774
bsdb:532/1/2_Rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_DOWN	NA	1971605
bsdb:533/2/1_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_UP	NA	1506
bsdb:535/1/1_Antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	41200
bsdb:536/1/1_Azithromycin:The-group-given-an-azithromycin-oral-solution_vs_The-group-given-a-placebo_DOWN	NA	165187
bsdb:537/1/1_Parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	47201
bsdb:539/1/1_Nephrolithiasis:Patients-with-kidney-stones_vs_Healthy-Controls_DOWN	NA	301301	39483	1496	351091	1161942	1352	253239	1736	1264	43305	1307	167	884684	881	1314	1491	876	84110	197	1351	195	1502	28025
bsdb:540/2/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	1409
bsdb:541/1/1_Schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_DOWN	NA	1579	1502	310297
bsdb:541/1/2_Schizophrenia:Schizophrenic-patients-(ARSCZ,-FESCZ)_vs_Healthy-controls_UP	NA	187327	239935	1352	1613	106588	1343	29466	39492
bsdb:541/2/1_Schizophrenia:Schizophrenic-patients-(38-participant-subsample)-at-baseline_vs_Healthy-controls-at-baseline_DOWN	NA	39492
bsdb:541/3/1_Schizophrenia:3-Month-Follow-up-Schizophrenic-patients-(38-participant-subsample)_vs_Baseline-Healthy-controls_UP	NA	88688	155892	341694	548	384638	39492	244366	239935	158836	550	328814	69218	28118	310297
bsdb:541/3/2_Schizophrenia:3-Month-Follow-up-Schizophrenic-patients-(38-participant-subsample)_vs_Baseline-Healthy-controls_DOWN	NA	2811711	457412	245014
bsdb:541/4/1_Antipsychotic-drug:3-Month-Follow-up-Schizophrenic-patients-(38-participant-subsample)_vs_Baseline-Schizophrenic-patients-(38-participant-subsample)_UP	NA	550	548
bsdb:542/1/1_Hidradenitis-suppurativa:Hidradenitis-suppurativa-patients_vs_Healthy-controls_UP	NA	411577	1287640	33037	43770	1260	755172	507751	33031
bsdb:542/1/2_Hidradenitis-suppurativa:Hidradenitis-suppurativa-patients_vs_Healthy-controls_DOWN	NA	40214	1747
bsdb:542/2/1_Hidradenitis-suppurativa:Lesional-skin-of-Hidradenitis-suppurativa-patients_vs_Non-lesional-skin-of-Hidradenitis-suppurativa-patients_UP	NA	1287640	33037	827	501496	322095	470
bsdb:542/2/2_Hidradenitis-suppurativa:Lesional-skin-of-Hidradenitis-suppurativa-patients_vs_Non-lesional-skin-of-Hidradenitis-suppurativa-patients_DOWN	NA	470	40215	487316	1747	164759	1270
bsdb:543/1/1_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_DOWN	NA	572010	1898207	1506	853
bsdb:543/1/2_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_UP	NA	84112	35833
bsdb:544/1/1_Colorectal-cancer:CRC-patients_vs_healthy-controls_UP	NA	203	39950	84112	851	29391	33033	341694	28123	60404	102148	29347	1512	33039
bsdb:544/1/2_Colorectal-cancer:CRC-patients_vs_healthy-controls_DOWN	NA	39484	39488	649756	871665	410072	1150298	39485	301302	1304	46228
bsdb:545/1/2_Antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	2137877	1898207
bsdb:545/2/2_Antimicrobial-agent:7-week-old-(young)-mice-6-months-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	2137877
bsdb:545/4/1_Antimicrobial-agent:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	1898207
bsdb:547/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	358742	208479	261299	1547	292800	1686	501571
bsdb:547/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	35833	871665	40520	218538	88431	853	1150298	1297617	1368474	360807	40518
bsdb:550/1/1_Juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_UP	NA	1872471	979627	172042	102148	796942	425941	114527	39777	44737	713054	712365
bsdb:550/1/2_Juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_DOWN	NA	729	712363	28129	249188	1423	712411	735	2047	712464	712187
bsdb:550/2/1_Temporomandibular-joint-disorder:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_DOWN	NA	43675	1382	237576	157692	671226	1423
bsdb:550/2/2_Temporomandibular-joint-disorder:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_UP	NA	1924944	652722	1226342	1501329	539	228603	1226341	1872471	712200	505	425941	1583331	495	60133	1962306	729
bsdb:553/1/1_Spontaneous-abortion:First-or-second-trimester-miscarriage_vs_Viable-control-pregnancy_DOWN	NA	1591
bsdb:553/2/1_Spontaneous-abortion:First-trimester-miscarriage_vs_Viable-control-pregnancy_DOWN	NA	1591
bsdb:553/2/2_Spontaneous-abortion:First-trimester-miscarriage_vs_Viable-control-pregnancy_UP	NA	59823
bsdb:553/3/1_Spontaneous-abortion:complete/incomplete-miscarriage_vs_missed-miscarriage_DOWN	NA	1591
bsdb:554/2/8_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_UP	NA	290054	39496
bsdb:554/2/9_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_DOWN	NA	39488
bsdb:554/2/10_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_UP	NA	2173	46503	165179	360807	40519	33039
bsdb:554/2/11_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_DOWN	NA	1596
bsdb:557/1/2_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	59823
bsdb:557/2/1_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_UP	NA	290054	877420	59823	2053608	707003	77133
bsdb:557/2/2_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_DOWN	NA	877420	59823	2053608	707003
bsdb:557/3/1_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	1946507	707003
bsdb:557/3/2_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	33039
bsdb:557/4/1_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_UP	NA	33039	707003
bsdb:557/4/2_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_DOWN	NA	707003
bsdb:557/5/1_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	39498	290054
bsdb:557/5/2_Urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	1940338	59823	33039	256318
bsdb:557/6/1_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_UP	NA	39496
bsdb:557/6/2_Urinary-tract-infection:Follow-up-(visit-around-Day-28 ± 3 days)._vs_Day-1-(pre-dose)_DOWN	NA	290054	33039	256318
bsdb:558/1/1_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	1680	1694
bsdb:558/1/2_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_DOWN	NA	820	40520	853	823
bsdb:558/1/3_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	1680	1689	41200	1849603	437898	40545	818
bsdb:558/2/1_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	1680	1689	41200	1849603	437898	40545
bsdb:558/2/2_Antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_DOWN	NA	165179	820	626933	2485925	853	46228	1322	41978	53443	1872530	40518	1161942	33038
bsdb:559/1/1_Diet:no-fiber-liquid-omnivore-diet_vs_regular-fiber-omnivore-diet_UP	NA	33038	33039
bsdb:559/1/2_Diet:no-fiber-liquid-omnivore-diet_vs_regular-fiber-omnivore-diet_DOWN	NA	28116	853	46503	165179	1308	39491
bsdb:560/1/1_Parkinson's-disease:Men-with-Parkinson's-Disease._vs_Healthy-men-without-Parkinsons's-Disease._UP	NA	239935	328814	84030	142586
bsdb:560/1/2_Parkinson's-disease:Men-with-Parkinson's-Disease._vs_Healthy-men-without-Parkinsons's-Disease._DOWN	NA	1735	165179
bsdb:561/1/1_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._UP	NA	28025	1689	216816	5476	42374	28188	28447	2702	581038	1590	1579	1623	1624	1613	1598	78258	78259	1309	4950
bsdb:561/1/2_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._DOWN	NA	1404	511435	1721091	531844	402384	890041	1790137	827
bsdb:562/1/3_Health-study-participation:healthy-adult-vagina-50%-up_vs_NA_NA	NA	47770
bsdb:562/2/1_Health-study-participation:healthy-adult-skin-50%-up_vs_none_NA	NA	55196
bsdb:562/2/2_Health-study-participation:healthy-adult-skin-50%-up_vs_none_NA	NA	38303	1747	33011	1574624	1260	76773	76775	1270	34062	29388	1282	1290	28037	1303
bsdb:562/3/2_Health-study-participation:feces-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	853	1150298	820	39491	418240	649756	1628085	88431	39488	39486	74426	821	40520	360807	823	745368	410072	1550024	301301	39485	33039	301302	28116	28118	28117	116085	1262992	1304	216816	818	214856	39490	1897011	328814	166486	292800	40518	46503	446660	1262911	47678	1160721	487174	471189	1680	371601	357276	1262889	562	39492	1318	35833	28052	39496	1535	239935	1262948	487175	544645	147207	165179	1263000	261299	4628
bsdb:562/4/2_Health-study-participation:nasal-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1747	1282	38284	76775	33011
bsdb:562/5/2_Health-study-participation:oral-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1303	29466	28037	729	2047	1379	1305	43675	84135	29391	851	544580	68892	28132	1660	484	490	199	322095	860	47671	1318	327575	157687	172042	39778	1019	1017	726	43768	46124	1911679	154688	1302	204	712710	712359	39777	28133	1304	45634	712148	1739406	467210	739	28135	495	33033	1382	936548	28449	60133	712357	113107	237576	1383	61592	257758	1018	2027459	1655	55565	228604	28124	76122	796942	1739309	102148	712469	1581061	470565	488	45242	28136	35517	114527	1078480	1759399	671213	2718	46125	187326	1739491	1177574	539	712461	123834	1227267	143393	341694	40542	28129
bsdb:562/8/2_Health-study-participation:healthy-adult-skin-70%-up_vs_none_NA	NA	1747	1282	76775	29388	33011
bsdb:562/9/2_Health-study-participation:feces-from-healthy-adult_vs_none---70%-prevalence-threshold_NA	NA	853	1150298	820	39491	418240	649756	1628085	88431	39488	39486	74426	821	40520	360807	823	745368	410072	1550024	301301	39485	33039	301302	28116	28118	28117	116085	1262992	1304	216816	818	214856	39490	1897011	328814	166486	292800
bsdb:562/10/1_Health-study-participation:feces-from-healthy-adult_vs_none---0%-prevalence-threshold_NA	NA	282472	283377	2955291	712363	1651279	5335
bsdb:564/1/1_Antimicrobial-agent:IAP-group-(@7-days)_vs_Control-group-(@7-days)_DOWN	NA	41200
bsdb:566/1/2_Juvenile-idiopathic-arthritis:HLAB27+_vs_HLAB27-_UP	NA	1506
bsdb:566/2/2_Juvenile-idiopathic-arthritis:JIA-patients-in-remission_vs_JIA-patients-with-active-disease_UP	NA	1506
bsdb:566/3/1_Juvenile-idiopathic-arthritis:JIA-ERA-patients_vs_Healthy-subjects_UP	NA	1506
bsdb:569/1/1_Colorectal-cancer:colorectal-cancer-patients_vs_healthy-controls_UP	NA	851
bsdb:569/1/2_Colorectal-cancer:colorectal-cancer-patients_vs_healthy-controls_DOWN	NA	1591	41200	1506
bsdb:571/2/2_Osteoarthritis,-knee:Knee-osteroarthritis-with-vit-D-deficiency_vs_Vitamin-D-deficiency_UP	NA	1898207
bsdb:572/1/1_Arthritis:New-onset-rheumatoid-arthritis---NORA_vs_Healthy-controls_UP	NA	1926307
bsdb:575/1/1_Antimicrobial-agent:perinatal-antibiotics_vs_Control-group_UP	NA	562
bsdb:577/1/1_Asthma:Male_vs_Female_DOWN	NA	1304
bsdb:577/2/1_Asthma:Female-participants-with-asthma_vs_Female-normal-controls_DOWN	NA	1304
bsdb:579/3/2_Major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Middle-aged-HC-(aged-30-59-years)_DOWN	NA	2137877
bsdb:579/4/1_Major-depressive-disorder:Young-MDD-(aged-18-29-years)_vs_Young-HC-(aged-18-29-years)_DOWN	NA	2485925	1506
bsdb:580/1/1_HIV-infection:HIV+-individuals_vs_HIV-uninfected-individuals_DOWN	NA	1486938	28121
bsdb:580/3/2_Abnormality-on-pulmonary-function-testing:HIV+-patients-with-reduced-DLCO_vs_HIV+-patients-with-normal-DLCO_DOWN	NA	192066	1944660
bsdb:583/1/1_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_UP	NA	5476	5480
bsdb:583/1/2_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_DOWN	NA	42374	4959	93612	82525	4932
bsdb:589/1/1_Colorectal-cancer:Colorectal-Cancer-patients-(CRC)_vs_Healthy-controls_UP	NA	239935	67824
bsdb:589/1/2_Colorectal-cancer:Colorectal-Cancer-patients-(CRC)_vs_Healthy-controls_DOWN	NA	338188	329854	40520	218538	39950	39486	140626	28052	158847	165179	28135	46206	106588	1264
bsdb:591/1/1_HIV-infection:HIV+-individuals_vs_HIV–-individuals_UP	NA	2049021	33039	358743	39486	84112
bsdb:591/2/1_HIV-infection:MSM-(men-who-have-sex-with-men)_vs_non-MSM_UP	NA	33043	39486
bsdb:593/1/2_Polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_DOWN	NA	3068309
bsdb:595/1/1_Colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_UP	NA	76859	76856	76857	155615	28123	28133	106588	707003	341694	157688	860	33033	817	35833	203	69823	40542	89153	1512
bsdb:595/1/2_Colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_DOWN	NA	39488	39496	39485	166486	40518	1304	39491
bsdb:595/2/1_Colorectal-carcinoma:CRC-patients_vs_Adenoma-patients_UP	NA	76859	76856	76857	155615	28123	28133	341694	33033	133926	1328
bsdb:595/2/2_Colorectal-carcinoma:CRC-patients_vs_Adenoma-patients_DOWN	NA	39491
bsdb:595/4/1_Colorectal-carcinoma:CRC_vs_Neoplasia-free-control_UP	NA	76859	341694	817	1512	33033	155615	35833	106588	154046	860	849	28135	28133	28123
bsdb:595/4/2_Colorectal-carcinoma:CRC_vs_Neoplasia-free-control_DOWN	NA	2317	1304	39488	39485	39491	166486	39496
bsdb:601/2/1_Parkinson's-disease:Participants-with-idiopathic-Parkinson's-Disease_vs_Healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	550	333367	471189	2049028	61171	1898203	1624	454154	1328	1304	1308	1535
bsdb:602/1/1_Irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1898207
bsdb:603/1/1_Colorectal-cancer:CRC-patients_vs_Non-disease-controls_DOWN	NA	39488	649756	410072	658089	166486	1680	291645	310297	46506	2030927	626933	328812	28117	1288121	328814	246787	818	1535	384638	39492	39496	116085	301301	360807	46228	1512	1898203	40518	158847
bsdb:603/1/2_Colorectal-cancer:CRC-patients_vs_Non-disease-controls_UP	NA	1470347	328813	76122	169435	1872531	817	291644	35833	457421	876	333367	208479	358743	457422	851	29391	46124	154046	658086	658087	2023260	33033	1944660	1261	1262	341694	28123	322095	281920	28131	552398	2049041	102148	1328	665956	457415	1522	1512	33039	214856	1872444	1318	1303	649756	1898207	33037	292800	33038	39777	546	1896336	562	571	576
bsdb:605/2/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-with-tremor-subtypes_vs_Participants-with-Parkinson's-Disease-with-non-tremor-subtypes_UP	NA	2137877
bsdb:607/1/1_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_UP	NA	239935	169435	626937	40518	33039
bsdb:607/1/2_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_DOWN	NA	166486	154288
bsdb:608/1/2_Health-study-participation:healthy-child-oral-50%-up_vs_none_NA	NA	28037	43675	1318	1303	28132	1379	68892	84135	484	1304	39778
bsdb:608/2/1_Health-study-participation:healthy-child-stool-50%-up_vs_none_NA	NA	90956
bsdb:608/2/2_Health-study-participation:healthy-child-stool-50%-up_vs_none_NA	NA	216816	1304	562	1318
bsdb:609/1/1_Colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_UP	NA	1940338	1591
bsdb:609/1/2_Colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_DOWN	NA	1898207	68766	2049031
bsdb:611/1/1_Colorectal-cancer:Colorectal-Cancer-patients_vs_healthy-controls_UP	NA	1940338
bsdb:611/1/2_Colorectal-cancer:Colorectal-Cancer-patients_vs_healthy-controls_DOWN	NA	290054	1732
bsdb:613/1/1_Colorectal-cancer:CRC-patients_vs_healthy-individuals_DOWN	NA	28116	820	33035	1898207	853	310297	301302	1265	39778	29466	33038	152509
bsdb:614/1/2_Colorectal-cancer:CRC_vs_Healthy-Controls_DOWN	NA	1940338
bsdb:615/1/1_Rheumatoid-arthritis:rheumatoid-arthritis_vs_healthy-controls_UP	NA	2702	322095	419005	28128	28129	28130	189722	671267
bsdb:618/1/1_Dementia:Severe-dementia_vs_Control,-mild,-and-moderate-dementia_UP	NA	2778071	820	1531	290054	1550024	2021466	1304	1535	35518	33039	1308	1944639	2485925	1946507
bsdb:618/2/1_Dementia:Patients-with-dementia_vs_Controls-without-cognitive-impairments_UP	NA	649756	1898207	1531	357276	33039
bsdb:618/2/2_Dementia:Patients-with-dementia_vs_Controls-without-cognitive-impairments_DOWN	NA	2021311	1755642	877420	331630	297314	707003
bsdb:618/3/1_Dementia:moderate-dementia_vs_control,-mild,-and-severe-dementia_UP	NA	1604	74426	29523
bsdb:618/4/1_Dementia:mild-dementia_vs_control,-moderate,-and-severe-dementia_UP	NA	853	39485
bsdb:620/1/1_Colorectal-cancer:Invasive-cancer-group_vs_Early-cancer-group_UP	NA	155615	68766
bsdb:620/1/2_Colorectal-cancer:Invasive-cancer-group_vs_Early-cancer-group_DOWN	NA	1501329	1898207
bsdb:621/1/1_Colorectal-cancer:Aspirin_vs_Placebo_UP	NA	2049031
bsdb:621/1/2_Colorectal-cancer:Aspirin_vs_Placebo_DOWN	NA	641107
bsdb:621/2/1_Colorectal-cancer:Aspirin_vs_Placebo_UP	NA	2049031
bsdb:622/1/2_Colorectal-cancer:CRA-and-CRC-groups_vs_Negative-control-group_UP	NA	1940338
bsdb:624/2/1_Colorectal-cancer:Patients-with-early-CRC_vs_Healthy-Individuals_UP	NA	851	29391	341694
bsdb:624/3/1_Colorectal-cancer:Patients-with-advanced-CRC_vs_Healthy-Individuals_UP	NA	76122	39950	851	29391	33033	1261	341694	28123	837	28131	102148
bsdb:626/1/2_Ethnic-group:East-Asian-(EA)_vs_White-(W)_DOWN	NA	1883427
bsdb:629/1/1_Colorectal-cancer:Adjacent-Non-Tumor-Tissue-of-Colorectal-Cancer-Cases_vs_Tumor-Tissue-of-Colorectal-Cancer-Cases_UP	NA	851
bsdb:630/1/1_Colorectal-cancer:stage-I/II-(SI/II)_vs_healthy-control-(normal-and-a-few-polyps)_UP	NA	74426	851	29391	1382	33033	1261	341694	281920	1660	102148
bsdb:630/1/2_Colorectal-cancer:stage-I/II-(SI/II)_vs_healthy-control-(normal-and-a-few-polyps)_DOWN	NA	1679	39485	28051
bsdb:630/2/1_Colorectal-cancer:stage-III/IV-(SIII/IV)_vs_healthy-control-(normal-and-a-few-polyps)_UP	NA	74426	1382	1660	102148	281920	851	69823	29391	1328	1625	33033	88431	1261	341694	35833	201571
bsdb:630/2/2_Colorectal-cancer:stage-III/IV-(SIII/IV)_vs_healthy-control-(normal-and-a-few-polyps)_DOWN	NA	39485	28051
bsdb:630/3/1_Colorectal-cancer:S0_vs_healthy-control-(normal-and-a-few-polyps)_UP	NA	1382	74426	281920	851	1656	1660	102148	626940	29391	1625	33033	341694	29505
bsdb:630/3/2_Colorectal-cancer:S0_vs_healthy-control-(normal-and-a-few-polyps)_DOWN	NA	1679	28051	39485
bsdb:630/4/1_Colorectal-cancer:MP_vs_healthy-control-(normal-and-a-few-polyps)_UP	NA	1382	851	1660	626940	69823	201571
bsdb:630/4/2_Colorectal-cancer:MP_vs_healthy-control-(normal-and-a-few-polyps)_DOWN	NA	1679	28051	39485
bsdb:631/1/1_Colorectal-adenoma:Advanced-Colorectal-Adenoma_vs_Healthy-Controls_UP	NA	454154	357276	204516
bsdb:631/1/2_Colorectal-adenoma:Advanced-Colorectal-Adenoma_vs_Healthy-Controls_DOWN	NA	28025	1309
bsdb:631/2/1_Colorectal-cancer:Colorectal-Cancer_vs_Healthy-Controls_DOWN	NA	1656	1506	1309	1308	28025
bsdb:631/2/2_Colorectal-cancer:Colorectal-Cancer_vs_Healthy-Controls_UP	NA	357276	29523	28111	46503	204516	823	371601	821	28117	28118	35833	1898203	1512	214856	47678	454154	1891238	40545	562	187327	39777
bsdb:631/3/1_Colorectal-cancer:Colorectal-Cancer_vs_Advanced-Colorectal-Adenoma_DOWN	NA	1506	1308	28025	1656
bsdb:631/3/2_Colorectal-cancer:Colorectal-Cancer_vs_Advanced-Colorectal-Adenoma_UP	NA	371601	204516	823	28116	29523	28118	35833	46503	28117	1891238	1898203	1512	187327	562	214856	47678	28111	40545	39777
bsdb:633/1/1_Colorectal-cancer:Colorectal-Cancer-Patients_vs_Healthy-controls_UP	NA	1940338
bsdb:633/3/1_Sigmoid-neoplasm:Distal-Colorectal-Cancer_vs_Proximal-Colon-Cancer_UP	NA	1940338
bsdb:633/3/2_Sigmoid-neoplasm:Distal-Colorectal-Cancer_vs_Proximal-Colon-Cancer_DOWN	NA	1943581
bsdb:634/1/1_Smoking-behavior:smokers_vs_non-smokers_UP	NA	187326	837	1318	1304	56774	1662275	1662277
bsdb:634/1/2_Smoking-behavior:smokers_vs_non-smokers_DOWN	NA	43997	1501332	102148	159275
bsdb:637/2/2_Colorectal-adenoma:CRA_vs_Healthy-Individuals_DOWN	NA	205
bsdb:638/1/1_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_UP	NA	292800	658087	649756
bsdb:638/1/2_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_DOWN	NA	936595	384638	245014	658083	261299	658088	665950	658081	658085	658086	31971	2683689	1496	457422	658659
bsdb:640/1/1_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_UP	NA	1304	43675	135080
bsdb:640/1/2_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_DOWN	NA	28124	29466	137732	860	28132	1898104
bsdb:640/2/1_Sensory-perception-of-bitter-taste:rheumatoid-arthritis-patients-with-the-homozygous-PAV/PAV-(“supertasters”)_vs_rheumatoid-arthritis-patients-carrying-the-AVI/AVI-genotype-(“non-tasters”)_DOWN	NA	203	671224	61592	1019	3018262	104608
bsdb:640/2/2_Sensory-perception-of-bitter-taste:rheumatoid-arthritis-patients-with-the-homozygous-PAV/PAV-(“supertasters”)_vs_rheumatoid-arthritis-patients-carrying-the-AVI/AVI-genotype-(“non-tasters”)_UP	NA	1304
bsdb:640/3/1_Sensory-perception-of-bitter-taste:Non-rheumatoid-arthritis-patients-with-the-homozygous-PAV/PAV-(“supertasters”)_vs_Non-rheumatoid-arthritis-patients-carrying-the-AVI/AVI-genotype-(“non-tasters”)_DOWN	NA	1382
bsdb:640/3/2_Sensory-perception-of-bitter-taste:Non-rheumatoid-arthritis-patients-with-the-homozygous-PAV/PAV-(“supertasters”)_vs_Non-rheumatoid-arthritis-patients-carrying-the-AVI/AVI-genotype-(“non-tasters”)_UP	NA	470565	187326	228604	43997	423477	1501332
bsdb:640/4/1_Sensory-perception-of-bitter-taste:All-participants-with-the-homozygous-PAV/PAV-(“supertasters”)_vs_All-participants-carrying-the-AVI/AVI-genotype-(“non-tasters”)_DOWN	NA	46125
bsdb:640/4/2_Sensory-perception-of-bitter-taste:All-participants-with-the-homozygous-PAV/PAV-(“supertasters”)_vs_All-participants-carrying-the-AVI/AVI-genotype-(“non-tasters”)_UP	NA	824
bsdb:641/1/1_Arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_DOWN	NA	1583331	860	29466	425941	484	28449	1458253	1303	68892	28037
bsdb:641/1/2_Arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_UP	NA	1304	1343	1305	228604	43675	1317	1310
bsdb:643/1/1_Colorectal-cancer:yCRC_vs_yControl_UP	NA	292800
bsdb:643/1/2_Colorectal-cancer:yCRC_vs_yControl_DOWN	NA	39488	39496	39491
bsdb:643/2/1_Colorectal-cancer:oCRC_vs_oControls_DOWN	NA	1955243	1492	290054	39496	853	39485	301301	166486	1160721	1161942	39491
bsdb:643/2/2_Colorectal-cancer:oCRC_vs_oControls_UP	NA	84112	208479	1946507	2086584	29347
bsdb:644/1/1_Colorectal-adenoma:colorectal-adenoma_vs_healthy-controls_UP	NA	820	1955243	1894999	562	1966354	1944660	1262	28131
bsdb:644/1/2_Colorectal-adenoma:colorectal-adenoma_vs_healthy-controls_DOWN	NA	29523	820	40520	1955243	2049024	853	59823
bsdb:644/2/1_Colorectal-cancer:colorectal-cancer-(adenocarcinoma)_vs_healthy-controls_UP	NA	739	817	28116	205	68766	1966354	2049028	1944660	1262	28124	28131	59823	76761
bsdb:644/2/2_Colorectal-cancer:colorectal-cancer-(adenocarcinoma)_vs_healthy-controls_DOWN	NA	29523	1955243	562	853	76761
bsdb:644/3/1_Colorectal-cancer:colorectal-cancer_vs_colorectal-adenoma_UP	NA	28117	817	28116	29523	1955243	1898207	68766	1966354	1869337	1944660	188932	1262	28124	28131	59823	363265	41978
bsdb:644/3/2_Colorectal-cancer:colorectal-cancer_vs_colorectal-adenoma_DOWN	NA	1894999	562	188932	76761	396015
bsdb:644/4/1_Colorectal-cancer:carcinoma-mucosae_vs_carcinoma-adjacent-mucosae_DOWN	NA	1955243	76761
bsdb:644/4/2_Colorectal-cancer:carcinoma-mucosae_vs_carcinoma-adjacent-mucosae_UP	NA	68766
bsdb:644/5/1_Colorectal-cancer:adenocarcinoma-mucosae_vs_adenoma-adjacent_DOWN	NA	1409	1894999	562	188932	76761	396015
bsdb:644/5/2_Colorectal-cancer:adenocarcinoma-mucosae_vs_adenoma-adjacent_UP	NA	817	1955243	205	1898207	68766	1966354	2049028	1869337	1944660	1262	28124	28131	59823	363265
bsdb:644/7/1_Colorectal-adenoma:adenoma-adjacent_vs_healthy-controls_DOWN	NA	1955243	2049024	1531	853
bsdb:644/7/2_Colorectal-adenoma:adenoma-adjacent_vs_healthy-controls_UP	NA	1894999	68766	188932
bsdb:644/8/1_Colorectal-cancer:carcinoma-adjacent_vs_healthy-controls_UP	NA	817	28116	68766	1966354	2049028	1262	28124	59823
bsdb:644/9/1_Colorectal-cancer:carcinoma-adjacent-tissue_vs_colorectal-adenoma-tissue_UP	NA	28117	817	28116	29523	820	40520	1955243	1898207	2049024	853	68766	1966354	1944660	1262	28124	28131	59823	363265	41978
bsdb:644/9/2_Colorectal-cancer:carcinoma-adjacent-tissue_vs_colorectal-adenoma-tissue_DOWN	NA	1894999
bsdb:646/1/2_Colorectal-adenoma:Adenoma_vs_Non-Adenoma_DOWN	NA	68904
bsdb:648/1/1_Ethnic-group,Gut-microbiome-measurement:Gut-microbiome-of-African-American-children-(AA)_vs_Gut-microbiome-of-European-American-children-(EA)_UP	NA	707003
bsdb:650/1/1_Gut-microbiome-measurement:Children-of-high-SES_vs_Children-of-low-SES_UP	NA	2049031
bsdb:650/1/2_Gut-microbiome-measurement:Children-of-high-SES_vs_Children-of-low-SES_DOWN	NA	1940338	877420	2137877
bsdb:652/1/1_Colorectal-cancer:Intramucosal-CRC_vs_Healthy_DOWN	NA	860	852
bsdb:652/1/2_Colorectal-cancer:Intramucosal-CRC_vs_Healthy_UP	NA	856
bsdb:652/3/1_Colorectal-adenoma:CRA-(colorectal-adenoma)_vs_Healthy_UP	NA	856
bsdb:652/3/2_Colorectal-adenoma:CRA-(colorectal-adenoma)_vs_Healthy_DOWN	NA	860	851
bsdb:655/1/1_Ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_UP	NA	28129
bsdb:655/1/2_Ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_DOWN	NA	46124	43675	45634	712621
bsdb:656/1/1_Socioeconomic-status:Children-living-in-slum-(Low-SES)_vs_Private-school-children-(High-SES)_UP	NA	562	1591	2173
bsdb:656/1/2_Socioeconomic-status:Children-living-in-slum-(Low-SES)_vs_Private-school-children-(High-SES)_DOWN	NA	1496	1502	599
bsdb:657/1/1_Oral-squamous-cell-carcinoma:pre-treatment-oral-squamous-cell-carcinoma-patients_vs_Healthy-controls_UP	NA	76860	46125	327575	1328	76859	43675	1303
bsdb:657/1/2_Oral-squamous-cell-carcinoma:pre-treatment-oral-squamous-cell-carcinoma-patients_vs_Healthy-controls_DOWN	NA	28132	1304	484	729	39778	113107	29466	43675	712118	860	55565	60133
bsdb:657/2/1_Oral-squamous-cell-carcinoma:Nonsmoking,-nondrinking,-and-dentate-pre-treatment-OSCC-patients_vs_Nonsmoking,-nondrinking,-and-dentate-healthy-controls_UP	NA	712530	713053	712364	1358	1328	137732	46125	732	671211	157691	34026	84135	1303
bsdb:657/2/2_Oral-squamous-cell-carcinoma:Nonsmoking,-nondrinking,-and-dentate-pre-treatment-OSCC-patients_vs_Nonsmoking,-nondrinking,-and-dentate-healthy-controls_DOWN	NA	39778	113107	470565	28137	712118	28136	712362
bsdb:657/3/1_Oral-squamous-cell-carcinoma:post-treatment-OSCC-patients_vs_pre-treatment-OSCC-patients_UP	NA	102148	114527	1306	104608	166	712187	712911	28124	1382	47671	712365	341694	33033	652722	554406	327575	155615	423477	28137	46125	651609	1305	1458253
bsdb:657/3/2_Oral-squamous-cell-carcinoma:post-treatment-OSCC-patients_vs_pre-treatment-OSCC-patients_DOWN	NA	2047	1597	47715	52769
bsdb:658/1/1_Colorectal-cancer:Responders-(Partial-Response-or-Stable-Disease)_vs_Non-responders-(Progressive-Disease)_UP	NA	2161821
bsdb:658/1/2_Colorectal-cancer:Responders-(Partial-Response-or-Stable-Disease)_vs_Non-responders-(Progressive-Disease)_DOWN	NA	68766	529385
bsdb:659/1/2_Gastric-cancer:Mice-kept-in-original-breeding-environment_vs_Mice-quarantined-to-a-different-breeding-environment_DOWN	NA	2292890
bsdb:660/1/1_Smoking-behavior:Smokers_vs_Never-smokers_UP	NA	28132	60133	2047	102148	39778
bsdb:660/1/2_Smoking-behavior:Smokers_vs_Never-smokers_DOWN	NA	729	1107316	28449	172042	735
bsdb:661/1/1_Meningeal-tuberculosis:Tuberculosis-Meningitis-(TBM)_vs_Healthy-Control-(HC)_UP	NA	1940338
bsdb:661/2/1_Meningeal-tuberculosis:Pulmonary-tuberculosis-(PTB)_vs_Healthy-Control-(HC)_UP	NA	1940338
bsdb:661/3/1_Meningeal-tuberculosis:Tuberculosis-Meningitis-(TBM)_vs_Pulmonary-tuberculosis-(PTB)_UP	NA	1940338
bsdb:663/5/1_Ethnic-group:India_vs_Jakun_UP	NA	216816	1686
bsdb:663/5/2_Ethnic-group:India_vs_Jakun_DOWN	NA	1463165
bsdb:665/1/1_Response-to-immunochemotherapy:Responders,-Colitis_vs_Resistance,-Non-responders,-No-colitis_UP	NA	28116	40520	1898207	1150298	745368	360807
bsdb:665/1/2_Response-to-immunochemotherapy:Responders,-Colitis_vs_Resistance,-Non-responders,-No-colitis_DOWN	NA	59823	29523	820	853	2778071	823
bsdb:666/1/1_Socioeconomic-status:Low-income-country-(Malawi)_vs_High-Income-country-(Finland)_UP	NA	1681	216816
bsdb:666/1/2_Socioeconomic-status:Low-income-country-(Malawi)_vs_High-Income-country-(Finland)_DOWN	NA	239935	1680	1686	1532	1496	1502	1280	1535
bsdb:667/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	853	33025	1583331	48256	40518
bsdb:667/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	147206	1841856	58180	470565	2702
bsdb:668/1/1_Bacterial-vaginosis:cesarean-section_vs_vaginal-delivery_UP	NA	28125
bsdb:668/1/2_Bacterial-vaginosis:cesarean-section_vs_vaginal-delivery_DOWN	NA	109790	147802
bsdb:669/1/1_Ethnic-group,Place-of-residence-measurement:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_UP	NA	185297	185299	28113	643958	1680	28025	302911	1681	1685	216816	28026	78448	78346	180216	33905	853	363265	81582	596085	28129	59823	165179	185294	166	83231	185293	839	245005	340481	340484
bsdb:669/1/2_Ethnic-group,Place-of-residence-measurement:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_DOWN	NA	214856	626932	328813	28117	47678	28111	817	329854	28116	93974	371598	818	820	1680	1681	1685	216816	28026	78346	138809	308029	853	310298	204516	310297	821	537421	330061	245005	340481	340484	621345	621352
bsdb:670/1/2_Ethnic-group,Socioeconomic-status:Bangladesh-Children-(Household-income-<-$61)_vs_US-children_DOWN	NA	818	853
bsdb:671/1/1_Seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_UP	NA	1340	853	1898207
bsdb:671/1/2_Seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_DOWN	NA	39491	1898207	46124	817	818
bsdb:672/24/1_Spontaneous-preterm-birth:Twins-(4M)_vs_Singletons-(4M)_UP	NA	84112
bsdb:672/25/1_Spontaneous-preterm-birth:Middlemore-Hospital-(4M)_vs_Auckland-city-hospital-(4M)_UP	NA	1280
bsdb:675/1/1_Socioeconomic-status:higher-monthly-household-income_vs_lower-monthly-household-income_UP	NA	84112	817	31971
bsdb:676/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	28117	216816	165179
bsdb:677/1/1_Survival-time:Short-term-surviviors_vs_Long-term-survivors_UP	NA	1940338
bsdb:678/1/1_Smoking-behavior:Cigarette-Smokers_vs_Nonsmokers_UP	NA	290252
bsdb:678/3/2_Smoking-behavior:Shisha-Smokers_vs_Nonsmokers_DOWN	NA	1912928	2044938
bsdb:678/4/1_Smoking-behavior:Mutiple-Smokers_vs_Nonsmokers_UP	NA	290252
bsdb:678/5/1_Cotinine-measurement:Cotinine-positive_vs_Cotinine-negative_DOWN	NA	1912928	2044938
bsdb:678/5/2_Cotinine-measurement:Cotinine-positive_vs_Cotinine-negative_UP	NA	290252
bsdb:678/8/2_Smoking-behavior:CIigarettes_vs_Shisha_UP	NA	290252
bsdb:679/2/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	1352	74426	1680	573	29466	46503	1591	216816
bsdb:679/2/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	40520	166486
bsdb:679/3/1_Response-to-immunochemotherapy:Responders,-group-A_vs_Non-responders,-group-B_UP	NA	74426	216816	1591	573	46503
bsdb:679/3/2_Response-to-immunochemotherapy:Responders,-group-A_vs_Non-responders,-group-B_DOWN	NA	166486
bsdb:680/1/1_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_UP	NA	1926307	2049033
bsdb:680/1/2_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_DOWN	NA	1955243
bsdb:681/1/1_Colorectal-cancer:Colorectal-cancer_vs_Healthy-Controls(HC)_UP	NA	43675
bsdb:681/3/1_Colorectal-cancer:Old-(≥-65-yrs)_vs_Young_UP	NA	837	1302
bsdb:681/3/2_Colorectal-cancer:Old-(≥-65-yrs)_vs_Young_DOWN	NA	43675
bsdb:681/4/1_Colorectal-cancer:Current-Smokers_vs_Non-Smokers_UP	NA	1898207	39777
bsdb:681/4/2_Colorectal-cancer:Current-Smokers_vs_Non-Smokers_DOWN	NA	488
bsdb:682/1/2_Small-intestine-enteropathy:IBS.sibo+_vs_IBS.sibo-_DOWN	NA	1924
bsdb:683/4/1_Colorectal-adenoma:adenoma-group-post-polypectomy_vs_adenoma-group-pre-polypectomy_UP	NA	39488
bsdb:683/5/1_Colorectal-adenoma:control-group-post-endoscopy_vs_control-group-pre-endoscopy_UP	NA	39488
bsdb:684/1/3_Colorectal-cancer:Colorectal-cancer-patients_vs_Healthy-control_UP	NA	239935	28111	76517	545	1353	29391	571	1633	2173	28118	487175	281920	28125	360807	1303	1305	626929	817	329854	562	292800	823	33033	1318	29466	341694
bsdb:684/1/4_Colorectal-cancer:Colorectal-cancer-patients_vs_Healthy-control_DOWN	NA	905	28117	39488	47678	820	1680	1689	45851	285	410072	88431	84112	39496	856	249188	1604	52226	165179	166486	68892	167	1535	853	1623	907	39491
bsdb:686/1/1_Colorectal-cancer:Colorectal-cancer-(CRC)_vs_Healthy-controls_DOWN	NA	329854	1680	853	39485	216816
bsdb:686/1/2_Colorectal-cancer:Colorectal-cancer-(CRC)_vs_Healthy-controls_UP	NA	582	571	562	363265	1512
bsdb:686/2/1_Colorectal-cancer:Adenomas_vs_Healthy-controls_DOWN	NA	239935	39485
bsdb:686/3/1_Colorectal-cancer:Carcinoma-(CRC)_vs_Adenoma_UP	NA	28118
bsdb:686/3/2_Colorectal-cancer:Carcinoma-(CRC)_vs_Adenoma_DOWN	NA	1686	74426
bsdb:687/2/1_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-KRAS-mutation_vs_colorectal-cancer-patients-without-KRAS-mutation_UP	NA	1872444	39488	208479	1849041	61171	1926283	583272	165185	517604	159272
bsdb:687/2/2_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-KRAS-mutation_vs_colorectal-cancer-patients-without-KRAS-mutation_DOWN	NA	1689	216816	28026	765944	165187	630129
bsdb:687/3/1_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-TP53-mutation_vs_colorectal-cancer-patients-without-TP53-mutation_UP	NA	290054
bsdb:687/5/2_Colorectal-adenocarcinoma:colorectal-cancer-patients-with-PIK3CA-mutation_vs_colorectal-cancer-patients-without-PIK3CA-mutation_UP	NA	1686	281992	887631	371674	159275
bsdb:688/2/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	1898207	853	40518	1583331	48256	33025
bsdb:688/2/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	147206	58180	1841856	470565	2702
bsdb:689/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders-(Progressive-disease)_UP	NA	47678	818	39486	853	61171	1318
bsdb:689/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders-(Progressive-disease)_DOWN	NA	1656	33037	28111	1596	1382	115778	1245	1660	84109	102684	1309
bsdb:691/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	328814	28111	818	901	562	39496	729	1735	658082	626940	204516	1304	29466	1535	39492	33038
bsdb:691/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	239935	1288121	246787	817	46506	371601	487174	216816	751585	658657	457422	39490	61171	658087	665951	454154	310297	165179	40519	1660	1318	1343	46228
bsdb:692/3/1_Nutraceutical,Colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(postoperative-fecal-sample)_vs_colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_UP	NA	1940338
bsdb:693/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	239935	39488	169435	246787	1689	40520	1968796	410072	218538	39486	861	658087	1596	97478	1632	1633	187326	40518	1308
bsdb:693/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	732	28111	626930	291645	820	1680	1681	208962	856	249188	548	1624	907	39777	39778
bsdb:694/1/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_UP	NA	1159214	584	1522
bsdb:694/1/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_DOWN	NA	29387	876091
bsdb:694/2/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_UP	NA	1159214	1622	584	1522	512314
bsdb:694/2/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_DOWN	NA	194843	1945593
bsdb:694/3/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)-+-PD-1_vs_control_UP	NA	85831	1898207	1898203	165185	707003	39497
bsdb:694/3/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)-+-PD-1_vs_control_DOWN	NA	1872531	28025	2049040	194843	1983405	458253	172733	1757166	2485925	1898207
bsdb:694/4/1_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_control_UP	NA	39497
bsdb:694/4/2_Colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_control_DOWN	NA	35517
bsdb:694/5/1_Colorectal-cancer:PD-1-group_vs_control_UP	NA	39496
bsdb:695/2/1_Antimicrobial-agent:Vanc_vs_control_UP	NA	1940338
bsdb:695/3/1_Antimicrobial-agent:Vanc_vs_Coli_UP	NA	1940338
bsdb:695/4/1_Antimicrobial-agent:Coli_vs_control_UP	NA	2212467	28116	371601	1869337	198431
bsdb:695/4/2_Antimicrobial-agent:Coli_vs_control_DOWN	NA	626931	1262741	1262744	328812	204516	671267	77133	1262740
bsdb:695/5/1_Antimicrobial-agent:Vanc_vs_control_UP	NA	239935	469589	820	823	1676614
bsdb:695/5/2_Antimicrobial-agent:Vanc_vs_control_DOWN	NA	1262753	1378168	397291	204516	1262917	1262936
bsdb:695/6/1_Antimicrobial-agent:Vanc_vs_coli_UP	NA	1262927	823	239935	820	487175
bsdb:695/6/2_Antimicrobial-agent:Vanc_vs_coli_DOWN	NA	1262753	1262917	1262936	1262924	821	397291	1378168
bsdb:696/1/1_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_CGT-group---colorectal-cancer-patients-perioperative-placebo_UP	NA	1940338
bsdb:696/2/1_Nutraceutical:PGT-group---colorectal-cancer-patients-perioperative-probiotics_vs_HGT-Group---Healthy-controls_UP	NA	1940338	391
bsdb:697/2/1_Hepatocellular-carcinoma:Disease-control-with-Immune-checkpoint-inhibitors_vs_Non-Disease-control-with-Immune-checkpoint-inhibitors_UP	NA	40520	29347
bsdb:697/3/1_Hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_DOWN	NA	1872471
bsdb:698/1/1_Crohn's-disease:Patients-with-Crohn's-disease_vs_Healthy-controls_UP	NA	70463
bsdb:698/2/2_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_DOWN	NA	59823
bsdb:698/3/1_Crohn's-disease:Patients-with-Crohn's-disease_vs_Patients-with-ulcerative-colitis_UP	NA	46125
bsdb:698/3/2_Crohn's-disease:Patients-with-Crohn's-disease_vs_Patients-with-ulcerative-colitis_DOWN	NA	1753
bsdb:699/1/1_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_DOWN	NA	39488	290054	1535	39492	33038	512316	423410
bsdb:699/1/2_Ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_UP	NA	28123	1502	33038	1940338
bsdb:701/1/1_Crohn's-disease:CD_vs_Non-IBD_UP	NA	33038
bsdb:701/1/2_Crohn's-disease:CD_vs_Non-IBD_DOWN	NA	40518
bsdb:701/3/1_Crohn's-disease:CD_vs_UC_UP	NA	33038
bsdb:702/1/2_Rheumatoid-arthritis:Active-(RA)-Rheumatoid-Arthritis_vs_Rheumatoid-Arthritis-(RA)-Remission_DOWN	NA	1898207
bsdb:702/2/2_Rheumatoid-arthritis:Prednisolone_vs_No-prednisolone_DOWN	NA	2137877
bsdb:703/1/1_Rheumatoid-arthritis:All-Matched-(AM)-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	1328	158
bsdb:703/1/2_Rheumatoid-arthritis:All-Matched-(AM)-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	729	1305
bsdb:703/2/1_Rheumatoid-arthritis:Periodontally-diseased-(PD)-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	1328
bsdb:703/2/2_Rheumatoid-arthritis:Periodontally-diseased-(PD)-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	226910
bsdb:704/1/1_Arthritis:Rheumatoid-Arthritis_vs_Healthy-Non-RA-Controls_UP	NA	52773	1318
bsdb:704/1/2_Arthritis:Rheumatoid-Arthritis_vs_Healthy-Non-RA-Controls_UP	NA	29391	502	28132
bsdb:705/1/1_Arthritis:Rheumatoid-Arthritis-(RA)_vs_Osteoarthritis-(OA)_DOWN	NA	1898207	282402	59823	166
bsdb:706/1/1_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	28112	1328
bsdb:706/1/2_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	29317	61592	1596	104608	2047	1302
bsdb:709/1/1_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	76122	76857	327575	712464	28124	155615	495	28131	407975	28137	1872413	158	824	143361	33033	713051	633701	166	439703	52227	118748	2699746
bsdb:709/1/2_Rheumatoid-arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_DOWN	NA	29317	199	43997	47671	237576	423477	1662277
bsdb:710/1/1_Psoriasis:Psoriasis-patient_vs_orally-healthy-individuals_UP	NA	1872413	44737	729	33053	33031	28132	43675
bsdb:710/1/2_Psoriasis:Psoriasis-patient_vs_orally-healthy-individuals_DOWN	NA	29317	1750	44737	1596	496	1309	1310	39777	1926307
bsdb:710/2/1_Psoriasis:Psoriasis_vs_periodntitis_UP	NA	1872413	28121	199	44737	68766	29391	502	157691	104608	114528	33053	28449	1924944	60133	59823	1306
bsdb:710/2/2_Psoriasis:Psoriasis_vs_periodntitis_DOWN	NA	2699746	158	77917	166	651822	76860	837	2047	895	28112	35519	56142	407975	53419	1309	143361	28131	28124	1660	43675
bsdb:710/3/1_Periodontitis:Periodontitis-patients_vs_orally-healthy-individuals_UP	NA	544580	76122	118748	205	1898207	895	143361	651822	2699746	851	68766	729	407975	227945	56142	35519	1904861	28124	837	52227	28131	59823	2047	43675	1328	76860	28112	59892	158	53418	53419	166
bsdb:710/3/2_Periodontitis:Periodontitis-patients_vs_orally-healthy-individuals_DOWN	NA	1017	137732	419208	192066	1898203	104608	633701	2049034	2020713	1898956	114528	40542	1750	1872413	53345	2485925	1107316	86333	102148	496	470565
bsdb:711/1/1_Systemic-lupus-erythematosus:SLE_vs_HC_UP	NA	1940338	1522	33038
bsdb:711/1/2_Systemic-lupus-erythematosus:SLE_vs_HC_DOWN	NA	290054	1410626	877420	39485
bsdb:712/1/1_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_healthy-controls_UP	NA	181487	272548	1659	544581	1655	544580	111015	156456	1382	1383	1685	1689	216816	158787	84163	218538	1955814	651822	2699746	979627	467210	1613	1598	554406	157691	157687	187326	56142	2121	2124	133926	652706	78258	52227	28129	470565	439703	28136	28134	228604	556499	230143	135080	713030	671225	712533	135083	69823	84109	102148	1328	1317	712711	713049	138851	53419	69710	39778	671229	713066	713068	713069	671234	671235	713070
bsdb:712/1/2_Rheumatoid-arthritis:Rheumatoid-Arthritis_vs_healthy-controls_DOWN	NA	470	712104	712148	712150	739	671218	712462	79880	712187	204	45243	1019	712233	712234	43997	285	132132	539	246144	41997	1379	29391	84135	46124	726	712309	712310	727	729	43995	505	502	712319	712320	504	47770	1596	712353	712357	28031	267212	34026	484	487	489	1658672	1944660	713008	671215	713019	41976	712438	712439	28131	228603	1747	2047	43675	294	316	330	29380	1282	1292	40324	113107	1338	28037	1303	1314	1304	1343	217202	712731	423477
bsdb:713/1/2_Arthritis:Juvenile-Idiopathic-Arthritis_vs_healthy-controls_UP	NA	729
bsdb:714/1/1_Response-to-ketogenic-diet:Overweight/Obese-Men-on-Ketogenic-Diet-(KD)_vs_Overweight/Obese-Men-on-Baseline-Diet-(BD)_UP	NA	1940338	1486937
bsdb:714/1/2_Response-to-ketogenic-diet:Overweight/Obese-Men-on-Ketogenic-Diet-(KD)_vs_Overweight/Obese-Men-on-Baseline-Diet-(BD)_DOWN	NA	41978
bsdb:714/2/1_Response-to-ketogenic-diet:Mice-fed-on-Ketogenic-Diet-(KD)_vs_Mice-fed-on-High-fat-Diet-(HFD)_UP	NA	1506
bsdb:714/2/2_Response-to-ketogenic-diet:Mice-fed-on-Ketogenic-Diet-(KD)_vs_Mice-fed-on-High-fat-Diet-(HFD)_DOWN	NA	877420
bsdb:714/3/2_Response-to-ketogenic-diet:Mice-fed-High-fat-Diet-+-Ketone-Ester-(HFD-KE)_vs_Mice-fed-on-High-fat-Diet-(HFD-control)_DOWN	NA	1940338
bsdb:717/4/1_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-baseline_vs_Tremor-dominant-phenotype-(TD)-at-baseline_DOWN	NA	1940338
bsdb:718/1/2_Polycystic-ovary-syndrome:Letrozole-treated_vs_Placebo-treated_DOWN	NA	823
bsdb:719/3/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	1535	1532
bsdb:719/4/1_REM-sleep-behavior-disorder:idiopathic-rapid-eye-movement-sleep-behavior-disorder_vs_Healthy-Controls_UP	NA	1532
bsdb:720/3/2_Bacterial-vaginosis:bacterial-vaginosis_vs_Healthy-Controls_UP	NA	1001126
bsdb:721/1/2_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-6-weeks_vs_HIV-unexposed-infants-(HUU)-at-6-weeks_DOWN	NA	2080739
bsdb:721/2/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)-at-28-weeks_vs_HIV-unexposed-infants-(HUU)-at-28-weeks_UP	NA	2384
bsdb:722/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	39496
bsdb:723/1/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	1694
bsdb:723/3/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Healthy-Controls_DOWN	NA	1694
bsdb:723/4/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_vs_Healthy-Controls_UP	NA	84112
bsdb:723/4/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_vs_Healthy-Controls_DOWN	NA	89152	301302	1265	1280
bsdb:723/5/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_UP	NA	40518	74426
bsdb:723/5/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_DOWN	NA	562	84112	853	44008
bsdb:724/1/1_Parkinson's-disease:Parkinson's-disease-patients-with-normal-cognition_vs_Healthy-spouses-and-Parkinson's-disease-patients-with-mild-cognitive-impairment_UP	NA	707003	328812	40519	33035
bsdb:724/2/1_Parkinson's-disease:Parkinson's-disease-patients-with-mild-cognitive-impairment_vs_Healthy-spouses-and-Parkinson's-disease-patients-with-normal-cognition_UP	NA	1637508	573	33039	28118
bsdb:724/3/1_Parkinson's-disease:Parkinson's-disease-patients-with-mild-cognitive-impairment-and-Parkinson's-disease-patients-with-normal-cognition_vs_Healthy-spouses_DOWN	NA	187326
bsdb:727/2/2_Tobacco-smoke-exposure-measurement:Alternative-Tobacco-Smokers_vs_Never-Smokers_DOWN	NA	77133
bsdb:727/3/1_Tobacco-smoke-exposure-measurement:participants-who-only-smoked-hookah_vs_Never-Smokers_DOWN	NA	77133
bsdb:729/1/2_Schizophrenia:Elderly-Schizophrenia-Patients_vs_healthy-control_DOWN	NA	1150298
bsdb:730/1/1_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_DOWN	NA	1898207	1940338	39497	1898203	39492
bsdb:730/2/1_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_DOWN	NA	1940338
bsdb:731/2/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	360807	1926283
bsdb:732/4/1_Ethnic-group:LAB_vs_USB-(US-born)_DOWN	NA	4903	5082	4911	1187941	467934	1052097	264096
bsdb:732/4/2_Ethnic-group:LAB_vs_USB-(US-born)_UP	NA	45579
bsdb:732/5/1_Obesity:Individuals-who-were-obese_vs_Individuals-with-a-healthy-body-mass-index_DOWN	NA	1853546
bsdb:734/1/1_COVID-19:COVID-19-infection-cases._vs_Control-group_UP	NA	2292890	1262929	1262948	363265
bsdb:734/1/2_COVID-19:COVID-19-infection-cases._vs_Control-group_DOWN	NA	1263005	301302	154288
bsdb:735/1/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	29466	739	39778	729
bsdb:735/1/2_Crohn's-disease:Crohn's-disease_vs_Healthy-control_DOWN	NA	853	820	31971	1735	1680	116085	301302	40518	239935
bsdb:735/2/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	33035	33039
bsdb:735/3/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	1328	33035	31971	33038
bsdb:735/3/2_Crohn's-disease:Crohn's-disease_vs_Healthy-control_DOWN	NA	817	43675
bsdb:736/1/1_Alzheimer's-disease:Alzheimer’s-disease-patients_vs_healthy-controls_UP	NA	48257	185693	641107
bsdb:737/2/2_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	28465
bsdb:737/3/1_Smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	2030927
bsdb:738/1/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_DOWN	NA	437897	360807	39485
bsdb:738/2/2_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_DOWN	NA	820	189723	29348	1322	301302	166486
bsdb:740/1/1_Alzheimer's-disease:Alzheimer’s-disease_vs_healthy-controls_DOWN	NA	1898207	1409
bsdb:740/3/2_Alzheimer's-disease:aMCI-patients_vs_Alzheimers-patients-in-dementia-stage_UP	NA	1898207
bsdb:741/1/1_Parkinson's-disease:Parkinson's-Disease-patients-without-constipation_vs_Healthy-Controls-and-Parkinson's-Disease-patients-with-constipation_UP	NA	437898	1221381
bsdb:741/2/1_Parkinson's-disease:Parkinson's-Disease-patients-without-constipation-and-Parkinson's-Disease-patients-with-constipation_vs_Healthy-Controls_DOWN	NA	204516
bsdb:741/3/1_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Healthy-Controls-and-Parkinson's-Disease-patients-without-constipation_UP	NA	2485925	665956
bsdb:741/4/1_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Parkinson's-Disease-patients-without-constipation_DOWN	NA	363265
bsdb:741/4/2_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Parkinson's-Disease-patients-without-constipation_UP	NA	2485925	665956	1304
bsdb:742/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_UP	NA	1470347	626932	28117	169435	1689	35833	53443	544644	457421	333367	358743	658657	457422	154046	658086	1596	33968	1624	1226322	847	328812	2047	78259	230143	665956	214851	89153
bsdb:742/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_DOWN	NA	469592	411489	31973	856	1379	658088	310298	552398	197614	1535	1512	447455
bsdb:746/1/1_Parkinson's-disease:Parkinson's-Disease-subjects._vs_Healthy-controls._UP	NA	1689	544580	1309	1535	187327	1432052	2173	626932	1681	562	552398	216816	154046	1550024	823	214856	573	1522
bsdb:746/1/2_Parkinson's-disease:Parkinson's-Disease-subjects._vs_Healthy-controls._DOWN	NA	166486	418240	1150298	649756	301302	853	1160721	46228	360807	28128	1322	39490	1506	1981510	218538	39485
bsdb:748/1/1_Colorectal-cancer:Colorectal-cancer-patients_vs_control_UP	NA	626932	817	422289	13373	508460	457421	908340	665941	360316	665942	39486	143361	859	851	712288	856	29391	154046	665950	658086	658085	665951	40542	76773	266	33033	671230	713008	33030	1261	341694	28131	102148	34105	76860	1334	1336	1335	361101	665956	1001764	457415	1512
bsdb:748/1/2_Colorectal-cancer:Colorectal-cancer-patients_vs_control_DOWN	NA	469610	39496	299567	751585	245014	729	1735	853	33039	573	39485	626929	40520	411489	166486	39491
bsdb:749/1/1_Down-syndrome:Down-Syndrome-children-with-primary-dentition-(PD)_vs_Controls-children-with-primary-dentition-(PD)_UP	NA	1379	495	172042	2047	490
bsdb:749/1/2_Down-syndrome:Down-Syndrome-children-with-primary-dentition-(PD)_vs_Controls-children-with-primary-dentition-(PD)_DOWN	NA	1078480	29317	113107	1303	68892	163599	230122	860
bsdb:749/2/1_Down-syndrome:Down-Syndrome-children-with-mixed-dentition-(PD)_vs_Controls-children-with-mixed-dentition-(PD)_UP	NA	1379	46125	1305	1313	45634	172042	47671	61592	2047	1655	495	544580	104608	1656	739
bsdb:749/2/2_Down-syndrome:Down-Syndrome-children-with-mixed-dentition-(PD)_vs_Controls-children-with-mixed-dentition-(PD)_DOWN	NA	163586	712461	713054	102148	242672	60133	936548	470565	425941	29317	52773	1105029	55565	671228	84135	1177577	1304
bsdb:750/2/2_Aging:Elderly_vs_Adults_DOWN	NA	2902634
bsdb:750/3/2_Gingival-bleeding:Participants-with-gingival-bleeding_vs_Participants-without-gingivitis-bleeding_DOWN	NA	2572088
bsdb:751/1/2_Alcohol-drinking:Moderate-drinkers_vs_Non-drinkers_DOWN	NA	46124	137732
bsdb:751/2/1_Alcohol-drinking:Heavy-drinkers_vs_Non-drinkers_UP	NA	55565	137732
bsdb:751/2/2_Alcohol-drinking:Heavy-drinkers_vs_Non-drinkers_DOWN	NA	46124	137732
bsdb:754/1/1_Smoking-behavior:Smokers_vs_Non-smokers_UP	NA	199	204	43768	143361	851	28134	979627	467210	1107316	490	305719	28126	439703	228604	39778
bsdb:754/1/2_Smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	544581	1656	739	1018	1019	285729	46124	52229	47671	40542	109328	187326	35519	267212	495	484	488	33053	28129	28131	28132	28133	28136	60133	172042	2047	1660	135083	45634	1303	257758	1305	59892	53418	29466	248315	35517	35518	51123	39498
bsdb:757/1/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-+-Lacrimal-Dysfunction_vs_Meibomian-Gland-Dysfunction_UP	NA	303
bsdb:757/1/2_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-+-Lacrimal-Dysfunction_vs_Meibomian-Gland-Dysfunction_DOWN	NA	38284	38290	146827
bsdb:757/2/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-+-Lacrimal-Dysfunction_vs_Healthy-Control_UP	NA	303
bsdb:757/2/2_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-+-Lacrimal-Dysfunction_vs_Healthy-Control_DOWN	NA	1755241
bsdb:757/3/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction_vs_Control_UP	NA	38284	38290	146827
bsdb:757/3/2_Dry-eye-syndrome:Meibomian-Gland-Dysfunction_vs_Control_DOWN	NA	1755241
bsdb:757/4/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-+-Lacrimal-Dysfunction_vs_Meibomian-Gland-Dysfunction_UP	NA	871203	47878	301
bsdb:757/4/2_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-+-Lacrimal-Dysfunction_vs_Meibomian-Gland-Dysfunction_DOWN	NA	161879	38290
bsdb:757/5/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-+-Lacrimal-Dysfunction_vs_control_UP	NA	871203	47878	301
bsdb:757/6/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction_vs_control_UP	NA	161879	38290
bsdb:760/1/2_Colorectal-cancer:Probio-group_vs_Placebo-control-group_DOWN	NA	1935934
bsdb:760/2/1_Colorectal-cancer:Probio-group_vs_CRC-[colorectal-cancer]--Patients-Pre-treatment-group_UP	NA	1898204
bsdb:760/2/2_Colorectal-cancer:Probio-group_vs_CRC-[colorectal-cancer]--Patients-Pre-treatment-group_DOWN	NA	794903
bsdb:760/3/1_Colorectal-cancer:Placebo-group_vs_CRC-[colorectal-cancer]-Patients-Pre-treatment-group_UP	NA	1935934
bsdb:761/1/1_Breast-cancer:Breast-Health-Condition_vs_Control_UP	NA	1486937
bsdb:761/2/1_Breast-cancer:Breast-Health-Condition_vs_Control_UP	NA	1486937
bsdb:762/1/2_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_UP	NA	70775
bsdb:762/2/1_Dry-eye-syndrome:MGD_vs_Non-MGD_UP	NA	1408
bsdb:762/2/2_Dry-eye-syndrome:MGD_vs_Non-MGD_DOWN	NA	290054
bsdb:763/1/1_Age-at-assessment:Old_vs_Young_UP	NA	33034	169292	38289	258224	43771	33010	1299	562	1260	40542	1270	485	486	28132	2047	43675	28068	1283	28035	1292	1302	1303	1318	1313	257758	1305	1306	955	956
bsdb:763/1/2_Age-at-assessment:Old_vs_Young_DOWN	NA	2107	47770	1096	1639	1351	84378	28903	287	529	2100	1747
bsdb:763/2/1_Biological-sex:Female_vs_Male_UP	NA	562	1270	721785	1283	470
bsdb:763/2/2_Biological-sex:Female_vs_Male_DOWN	NA	1747	1282
bsdb:764/1/1_Type-II-diabetes-mellitus:diabetic_vs_healthy-controls_UP	NA	342873
bsdb:765/1/1_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_UP	NA	77133
bsdb:765/1/2_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_DOWN	NA	77133
bsdb:767/1/1_Alzheimer's-disease:Alzheimer's-disease-patients_vs_Non-demented-Controls_UP	NA	1940338	1869337
bsdb:767/2/2_Alzheimer's-disease:Mild-Cognitive-Impairment-group_vs_Non-demented-Controls_DOWN	NA	3068309	59620	331630	297314	2049037
bsdb:768/1/1_Mismatch-repair-cancer-syndrome:deficient-DNA-mismatch-repair-(dMMR)-CRC_vs_proficient-DNA-mismatch-repair-(pMMR)-CRC_UP	NA	1758194	160808	1842533	1470176	239935	83263	374606	1804986	28446	1590041	1784714	356837	748247	146939	192	652764	2202148	492670	1400053	397865	1683	1416806	1355477	1437360	1325090	722472	2571746	95485	57975	864051	511435	1725232	45243	1679497	1063	2126553	536	1493872	2039166	279113	74426	33871	38289	1348774	119219	106590	164546	1768108	218208	1986146	897	873	899	1565	876	631220	881	1736675	556	1778540	94254	539	172045	106592	61645	881260	2027919	158836	1351	160453	39960	44012	143361	191579	1335048	851	483547	443143	443144	35554	1203471	442	2059875	1841863	471189	1335613	1570	210	76123	1484116	2496028	1411621	1356852	1385663	1385664	1810504	1307763	2018025	1589	47671	55518	84159	2743	1821621	1486262	945844	1593482	2045208	879	39645	381	2082387	2082949	57480	1300914	1796646	326522	487	1193713	2014	158500	28118	58180	794903	79263	1870820	172713	1464	2707005	1406	1532905	1387353	573737	2518599	549	470934	311230	36873	256618	1768242	554	29543	1100	54006	60890	1868589	2488560	1636152	36874	393921	52227	28131	182210	57320	2072590	930166	312306	294	65741	1392877	380021	2479392	29449	1312183	1850250	1076	2026787	2047	1379910	2259595	146919	1229727	927083	69823	47917	615	380	382	1842534	1131703	1332080	46355	2057025	1379870	2490858	1336	1338	150055	1305	379067	2184053	2049881	68246	2153485	316	1972068	119484	29542	712710	1134435	36861	926	171437	1903704	1712675	1034889	2126319	2094242	280	343
bsdb:768/1/2_Mismatch-repair-cancer-syndrome:deficient-DNA-mismatch-repair-(dMMR)-CRC_vs_proficient-DNA-mismatch-repair-(pMMR)-CRC_DOWN	NA	292800	1379
bsdb:768/2/1_Colorectal-cancer:deficient-DNA-mismatch-repair-(dMMR)-CRC_vs_Healthy-controls-(CTRL)_UP	NA	492670	397865	876	851	76123	1796646	28118	36874	28131
bsdb:768/3/1_Colorectal-cancer:proficient-DNA-mismatch-repair-(pMMR)-CRC_vs_Healthy-controls-(CTRL)_UP	NA	292800
bsdb:768/3/2_Colorectal-cancer:proficient-DNA-mismatch-repair-(pMMR)-CRC_vs_Healthy-controls-(CTRL)_DOWN	NA	28446	74426	471189
bsdb:769/1/1_Dental-caries:T2---Timepoint-2_vs_T1---Timepoint-1---(T1.-edentulous-(no-teeth))_DOWN	NA	2005703	1888195	1825069	1348	82348	149016
bsdb:769/2/1_Dental-caries:T3---Timepoint-3_vs_T1---Timepoint-1---(T1.-edentulous-(no-teeth))_UP	NA	29317	1656
bsdb:769/2/2_Dental-caries:T3---Timepoint-3_vs_T1---Timepoint-1---(T1.-edentulous-(no-teeth))_DOWN	NA	2005703	1888195	1825069	1348	82348	149016
bsdb:769/3/1_Dental-caries:T3---Timepoint-3_vs_T2---Timepoint-2_UP	NA	29317	1656
bsdb:770/2/1_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_UP	NA	38304
bsdb:771/1/1_Health-study-participation:Bejing-healthy-volunteers_vs_Guangzhou-healthy-volunteers_UP	NA	1396	529	1063	169292	38289	43771	80866	1886637	1351	562	84595	1276	1270	487	837	287	329	391
bsdb:771/1/2_Health-study-participation:Bejing-healthy-volunteers_vs_Guangzhou-healthy-volunteers_DOWN	NA	1639	300	84378	40324	28903	1872122	721785	2100	1747
bsdb:772/3/1_Diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T1(end-of-baseline-feeding)_UP	NA	89152
bsdb:772/3/2_Diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T1(end-of-baseline-feeding)_DOWN	NA	310297
bsdb:772/4/1_Diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T2-(end-of-intervention)_UP	NA	853	33038	89152
bsdb:772/4/2_Diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T2-(end-of-intervention)_DOWN	NA	310297
bsdb:774/1/1_Irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_DOWN	NA	39488	42322	39496	39497	39485	877420	438033	39492	1451755	331630	297314	707003	1452070
bsdb:774/1/2_Irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_UP	NA	2137877	1940338	1522
bsdb:774/2/1_Irritable-bowel-syndrome:IBS-D-(IBS-Diarrhea)_vs_Non-IBS2-(Non-irritable-bowel-syndrome-2)_DOWN	NA	2137877	42322	39497	39492	1452070	331630	297314	707003	244328
bsdb:774/2/2_Irritable-bowel-syndrome:IBS-D-(IBS-Diarrhea)_vs_Non-IBS2-(Non-irritable-bowel-syndrome-2)_UP	NA	1940338	33038	39488
bsdb:774/3/1_Irritable-bowel-syndrome:IBS-U-(IBS-Unclassified)_vs_Non-IBS3-(Non-irritable-bowel-syndrome-3)_DOWN	NA	39488	42322	666559	297314
bsdb:774/3/2_Irritable-bowel-syndrome:IBS-U-(IBS-Unclassified)_vs_Non-IBS3-(Non-irritable-bowel-syndrome-3)_UP	NA	1940338	33039
bsdb:775/1/1_Breast-cancer:Breast-cancer-(BC)_vs_Healthy-controls-(HC)_UP	NA	261299
bsdb:775/1/2_Breast-cancer:Breast-cancer-(BC)_vs_Healthy-controls-(HC)_DOWN	NA	1872444	853	1926283	28052	1945593	46503	331630	297314
bsdb:776/3/1_Depressive-disorder:Overactive-Bladder-(OAB)-with-depression_vs_Overactive-Bladder-(OAB)-without-depression_DOWN	NA	507843
bsdb:777/1/1_Ulcerative-colitis:ulcerative-colitis-(UC)_vs_healthy-controls_DOWN	NA	39491	649756	2212467	2030927	46506	39486	328812	454154	310298	165179	36087
bsdb:777/1/2_Ulcerative-colitis:ulcerative-colitis-(UC)_vs_healthy-controls_UP	NA	28116	1322	1898204	1496	1502	225992	218538	309120	308994	39486	53345	1884818	437897	387661	28123	28135	22663	2053632	1201630
bsdb:777/2/1_Crohn's-disease:Crohn's-disease-(CD)_vs_healthy-controls_DOWN	NA	649756	28116	46506	74426	39486	1579	1596	363265	821	2049047	22663	165179	36087
bsdb:777/2/2_Crohn's-disease:Crohn's-disease-(CD)_vs_healthy-controls_UP	NA	28116	1322	1898204	1496	1492	1502	218538	309120	308994	39486	53345	1884818	437897	387661	28123	22663	150055	2053632	1201630
bsdb:777/3/2_Crohn's-disease:Crohn's-disease-(CD)_vs_ulcerative-colitis-(UC)_DOWN	NA	2054177	290054	446043	77133
bsdb:779/1/1_Post-COVID-19-disorder:long-COVID-19_vs_healthy-controls-and-mild-COVID-19-patients_DOWN	NA	729	28132	484	28037	1872471	28449	322095	712469	2663009	76122	28131	1303	1161412	60133	1313	1110546	2026720	68892	936548	997829
bsdb:779/2/1_Post-COVID-19-disorder:long-COVID-19_vs_healthy-controls-and-mild-COVID-19-patients_UP	NA	1583331	28449	484	28132	423477	729	1110546	60133	47671	1304	1177574	43675	495	837
bsdb:784/1/1_Gut-microbiome-measurement:Severe-COVID-19_vs_Moderate-COVID-19_UP	NA	1351
bsdb:784/1/2_Gut-microbiome-measurement:Severe-COVID-19_vs_Moderate-COVID-19_DOWN	NA	544580	1203556	446660	394340	39491	1628085	39488	649756	1680	216816	28026	40520	418240	74426	147206	116085	410072	39486	88431	39490	39496	853	1262989	1262988	1150298	84135	745368	39485	1358	1981510	301302	301301	166486	360807	43675	1160721	40518	1660	1302	28037	1303	1318	1304	1308	1535	39492	33039
bsdb:785/1/1_Ulcerative-colitis:Ulcerative-colitis-patient_vs_Healthy-control-individual_UP	NA	1689	40520	1531	292800	729	39485	585	39778
bsdb:785/1/2_Ulcerative-colitis:Ulcerative-colitis-patient_vs_Healthy-control-individual_DOWN	NA	491921	28117	1694	40518	88431	46503	78344	74426	1735	214851	592978	1623	1473216	239935
bsdb:785/2/1_Crohn's-disease:Crohn's-disease-patient_vs_Healthy-control-individual_UP	NA	1689	35833	1531	562	1912855	1596	1246	33038	907	296	315405	29466	39778
bsdb:785/2/2_Crohn's-disease:Crohn's-disease-patient_vs_Healthy-control-individual_DOWN	NA	28117	1694	78344	74426	88431	853	1735	592978	46503	1776391	842	360807	40518	214851	39492
bsdb:785/3/1_Ulcerative-colitis:Patients-with-moderate-to-severe-ulcerative-colitis_vs_Patients-with-mild-ulcerative-colitis_UP	NA	1496	1624
bsdb:785/3/2_Ulcerative-colitis:Patients-with-moderate-to-severe-ulcerative-colitis_vs_Patients-with-mild-ulcerative-colitis_DOWN	NA	85831	47678	35833	404403	40519	1313	1522
bsdb:785/4/1_Ulcerative-colitis:Patients-with-moderate-to-severe-ulcerative-colitis_vs_Patients-with-remission-ulcerative-colitis-(symptoms-of-UC-are-reduced-or-inapparent)_UP	NA	1358	261299	1496	1583	649756	29348	1246	1365
bsdb:785/4/2_Ulcerative-colitis:Patients-with-moderate-to-severe-ulcerative-colitis_vs_Patients-with-remission-ulcerative-colitis-(symptoms-of-UC-are-reduced-or-inapparent)_DOWN	NA	328813	28117	85831	47678	246787	35833	1472417	28118	823	40519	1305
bsdb:785/5/1_Pancolitis,Distal-colitis:patients-with-left-sided-or-extensive-ulcerative-colitis_vs_patients-with-proctitis-ulcerative-colitis_UP	NA	1681	261299	292800	649756	1597	33038
bsdb:785/5/2_Pancolitis,Distal-colitis:patients-with-left-sided-or-extensive-ulcerative-colitis_vs_patients-with-proctitis-ulcerative-colitis_DOWN	NA	2585118	1288121	404403	363265	1623	28118	46503	454154	487175	165179	1473216	572010	1299998
bsdb:785/6/1_Crohn's-disease:patients-with-active-Crohn's-disease_vs_patients-with-remission-Crohn's-disease_UP	NA	626940	1624	97478	28123	116085
bsdb:785/6/2_Crohn's-disease:patients-with-active-Crohn's-disease_vs_patients-with-remission-Crohn's-disease_DOWN	NA	820	84112	1522	292800	1547	1532	88431	33038	310297	649756	823	1531	342942
bsdb:785/7/1_Ileocolitis:patients-with-ileocolonic-Crohn's-disease_vs_patients-with-small-bowel-Crohn's-disease_UP	NA	1596	28116	1583
bsdb:785/7/2_Ileocolitis:patients-with-ileocolonic-Crohn's-disease_vs_patients-with-small-bowel-Crohn's-disease_DOWN	NA	1532	35833	1531
bsdb:786/1/1_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls---based-on-GA--map_UP	NA	1940338
bsdb:786/1/2_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls---based-on-GA--map_DOWN	NA	166486	853	218538	40545
bsdb:786/2/1_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-Controls---based-on-LUMI--Seq-data_UP	NA	1720294	1776382
bsdb:786/2/2_Type-II-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-Controls---based-on-LUMI--Seq-data_DOWN	NA	351091	310298
bsdb:786/3/1_Type-II-diabetes-mellitus:Type-2-Diabetes---T2D_vs_Healthy-Controls---based-on-LUMI--Seq-data_UP	NA	39486	88431	154288
bsdb:786/4/1_Type-II-diabetes-mellitus:Type-2-Diabetes---T2D-Patients_vs_Pre--Type-2-Diabetes-individuals_UP	NA	39486	88431	154288
bsdb:786/4/2_Type-II-diabetes-mellitus:Type-2-Diabetes---T2D-Patients_vs_Pre--Type-2-Diabetes-individuals_DOWN	NA	1720294	1776382
bsdb:788/1/1_Response-to-heat:Holstein-cows-under-heat-stress-condition_vs_Holstein-cows-under-normal-condition_UP	NA	56448
bsdb:788/1/2_Response-to-heat:Holstein-cows-under-heat-stress-condition_vs_Holstein-cows-under-normal-condition_DOWN	NA	1200751
bsdb:788/2/1_Ruminative-stress-response:Jersey-cows-under-heat-stress-condition_vs_Jersey-cows-under-normal-condition_UP	NA	1396	1491	56448
bsdb:788/2/2_Ruminative-stress-response:Jersey-cows-under-heat-stress-condition_vs_Jersey-cows-under-normal-condition_DOWN	NA	1945890
bsdb:789/1/1_Breast-cancer:Prediagnostic-(PD)_vs_Healthy-(H)_UP	NA	1306
bsdb:789/2/1_Breast-cancer:Adjacent-normal-(AN)_vs_Healthy-(H)_UP	NA	512	1872652	35783	1890675	1871622	306	41274
bsdb:789/2/2_Breast-cancer:Adjacent-normal-(AN)_vs_Healthy-(H)_DOWN	NA	472	48221	1720	1915058	306	29387
bsdb:789/3/1_Breast-cancer:Tumor-(T)_vs_Healthy-(H)_UP	NA	35783	1890675	306	29387
bsdb:789/3/2_Breast-cancer:Tumor-(T)_vs_Healthy-(H)_DOWN	NA	376	1993875	48221	1720	1915058	306	29387
bsdb:790/1/1_Inflammatory-bowel-disease:Inflammatory-bowel-disease-patients_vs_Healthy-controls_DOWN	NA	1683	1681	1686	216816	28026	626937	1535	29347	39485	39491	39496	1579	1597	2173	454154	166486	360807	301301	40518	1305	1308	214856	328814	328813	649756	47678	357276	487174	261299	239935
bsdb:790/2/1_Inflammatory-bowel-disease:Non-inflammatory-bowel-disease-symptomatic-controls_vs_Healthy-children_DOWN	NA	1683	410072	39485	39492	40518	1308	328814	47678	357276
bsdb:790/2/2_Inflammatory-bowel-disease:Non-inflammatory-bowel-disease-symptomatic-controls_vs_Healthy-children_UP	NA	1352	545
bsdb:790/3/1_Inflammatory-bowel-disease:inflammatory-bowel-disease-patients_vs_non-inflammatory-bowel-disease-symptomatic-controls_DOWN	NA	454154	1680	1683	1681	626937	1535	901	39491	39492	39496	1579	1597	166486	360807	301301	40518	214856	310297	46506	239935
bsdb:790/3/2_Inflammatory-bowel-disease:inflammatory-bowel-disease-patients_vs_non-inflammatory-bowel-disease-symptomatic-controls_UP	NA	729
bsdb:790/4/1_Phenotype:Crohn's-Disease-patients-with-stricturing-and/or-penetrating-phenotypes_vs_Crohn's-Disease-patients-with-inflammatory-phenotypes_DOWN	NA	626937	29347	39485	301301
bsdb:790/4/2_Phenotype:Crohn's-Disease-patients-with-stricturing-and/or-penetrating-phenotypes_vs_Crohn's-Disease-patients-with-inflammatory-phenotypes_UP	NA	562
bsdb:790/5/1_Treatment:Inflammatory-bowel-disease-patients-treated-with-biological-therapy_vs_Inflammatory-bowel-disease-patients-treated-with-conventional-therapy_DOWN	NA	1680	1681	39491	301301	360807	40518	338188	329854	246787	454154
bsdb:790/5/2_Treatment:Inflammatory-bowel-disease-patients-treated-with-biological-therapy_vs_Inflammatory-bowel-disease-patients-treated-with-conventional-therapy_UP	NA	33038	821
bsdb:790/6/1_Increased-inflammatory-response:Inflammatory-bowel-disease-patients-with-fecal-calprotectin-levels->-1000-mg/kg_vs_Inflammatory-bowel-disease-patients-with-fecal-calprotectin-levels-<-1000-mg/kg_DOWN	NA	301301	360807	166486	214856	487174
bsdb:790/7/1_Increased-inflammatory-response:Inflammatory-bowel-disease-patients-receiving-second-class-of-biologic-drug_vs_Inflammatory-bowel-disease-patients-receiving-one-biologic-or-conventional-therapy_DOWN	NA	1681	301301	371601
bsdb:791/1/1_Spontaneous-preterm-birth:Preterm-Birth_vs_Full-term-Birth_UP	NA	87541	1588753	309120	82135	2914925	2702	1703337	386414	1898203	699218	419005	28125	470565	230143	40543	187101	1588751	1284775
bsdb:791/1/2_Spontaneous-preterm-birth:Preterm-Birth_vs_Full-term-Birth_DOWN	NA	1685	47770	1596	33959
bsdb:791/2/1_Spontaneous-preterm-birth:Risk-Group_vs_Low-risk-controls_UP	NA	1685
bsdb:791/2/2_Spontaneous-preterm-birth:Risk-Group_vs_Low-risk-controls_DOWN	NA	908809	1834109	40324
bsdb:791/3/1_Spontaneous-preterm-birth:Previous-Preterm-birth_vs_No-Previous-Preterm-birth_UP	NA	246787	908809	1834109	40324	47715	2024555	38815
bsdb:791/3/2_Spontaneous-preterm-birth:Previous-Preterm-birth_vs_No-Previous-Preterm-birth_DOWN	NA	1685	1682
bsdb:793/1/1_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_UP	NA	1960653	358742	119853
bsdb:793/2/1_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_UP	NA	358742
bsdb:793/2/2_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_DOWN	NA	487174	100886	1960653	1763509	46228
bsdb:793/3/1_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_UP	NA	1960653	74426	358742	460384
bsdb:793/3/2_Cerebral-small-vessel-disease:High-burden-(Unhealthy)_vs_Lower-burden-(Healthy)_DOWN	NA	46228
bsdb:794/1/1_Colorectal-cancer:EOCRC-(Early-onset-Colorectal-cancer)-patients_vs_Healthy-controls_UP	NA	33038
bsdb:794/3/1_Colorectal-cancer:LOCRC-(Late-onset-colorectal-cancer)_vs_Healthy-controls_UP	NA	707003
bsdb:795/1/1_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._UP	NA	1313	257758	28037	727	851	33033
bsdb:795/1/2_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._DOWN	NA	735	490	28035	28127
bsdb:795/2/1_Streptococcus-pneumoniae:Smokers_vs_non--smokers_UP	NA	28132	39777	859
bsdb:795/2/2_Streptococcus-pneumoniae:Smokers_vs_non--smokers_DOWN	NA	735	1078480	43769	1528099	230310	29394	851	33033	28127
bsdb:795/3/1_Streptococcus-pneumoniae:Contact-with-children_vs_No-contact-with-children_UP	NA	1313	28037	480	727	851
bsdb:795/3/2_Streptococcus-pneumoniae:Contact-with-children_vs_No-contact-with-children_DOWN	NA	28035	2219696	1274
bsdb:795/4/1_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._UP	NA	1313	33033	204	45242	297314	1019
bsdb:795/4/2_Streptococcus-pneumoniae:Pneumococcal-carriers_vs_Pneumococcal-non-carriers._DOWN	NA	76122	77133
bsdb:795/5/1_Streptococcus-pneumoniae:Smokers_vs_Non--smokers_UP	NA	1313	69823	736
bsdb:795/5/2_Streptococcus-pneumoniae:Smokers_vs_Non--smokers_DOWN	NA	735	76122	228603	204	2490857
bsdb:795/6/1_Streptococcus-pneumoniae:Contact-with-children_vs_No-Contact-with-Children_UP	NA	1313	735	851	43675	739	729	28132	1501332
bsdb:795/6/2_Streptococcus-pneumoniae:Contact-with-children_vs_No-Contact-with-Children_DOWN	NA	837	671218	28132
bsdb:797/1/2_Smoking-status-measurement:Active-smokers_vs_Never-smokers_UP	NA	36773	1221567
bsdb:797/2/1_Smoking-status-measurement:former-smokers_vs_Never-smokers_UP	NA	1221567
bsdb:797/2/2_Smoking-status-measurement:former-smokers_vs_Never-smokers_UP	NA	59823
bsdb:797/6/1_Smoking-status-measurement:Never-smokers_vs_Active-smokers-&-former-smokers_UP	NA	59823
bsdb:797/7/1_Smoking-status-measurement:never-smokers_vs_Active-smokers-&-former-smokers_UP	NA	59823
bsdb:798/1/1_Urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_UP	NA	28125
bsdb:798/1/2_Urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_DOWN	NA	877420	1596	33129	1313
bsdb:799/1/1_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_UP	NA	2026720	1869227	179883	2722	142586
bsdb:799/1/2_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_DOWN	NA	142586	59823	244328	100235	2093824
bsdb:799/2/1_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-(without-COPD)_vs_HIV-negative-individuals-(without-COPD)_UP	NA	59823	179883	100235	2093824
bsdb:799/2/2_Chronic-obstructive-pulmonary-disease:HIV-positive-individuals-(without-COPD)_vs_HIV-negative-individuals-(without-COPD)_DOWN	NA	2026720	142586
bsdb:801/1/1_Respiratory-system-disease:Diseased-individuals-(D)_vs_Non-diseased/-healthy-individuals-(ND)_UP	NA	43675
bsdb:802/1/1_Cachexia:cachexia-induced-mice_vs_Healthy-controls_UP	NA	877428
bsdb:803/1/1_Colorectal-cancer:Egyptian-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	1817405	1694	161879	1747	1587	79681
bsdb:803/1/2_Colorectal-cancer:Egyptian-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	71999	33069	172042
bsdb:803/2/1_Colorectal-cancer:African-American-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	1502
bsdb:803/3/2_Colorectal-cancer:European-American-Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	745368	165179	33038
bsdb:803/4/1_Population:Tumor-samples-of-European-American_vs_KeNyaN,-African-American-and-Egyptians-patients_UP	NA	28116	1502	84112	147802
bsdb:803/5/1_Population:Tumor-samples-of-kenyans_vs_Egyptian,-African-American-and-European-American-Patients_UP	NA	239935	285091	28133	507843
bsdb:803/6/1_Population:Tumor-samples-of-African-Americans_vs_Egyptian,-Kenyan-and-European-American-patients_UP	NA	29536	2047
bsdb:803/7/1_Population:Tumor-samples-of-Egyptians_vs_African-American,-Kenya-and-European-American-patients_UP	NA	28090	108981	293	209389	615	86188
bsdb:804/1/1_Response-to-transplant:CON-FMT:-receiving-control-microbiota-FMT-mice_vs_SD-FMT-AND-SD+MEL-FMT_UP	NA	1506	877420	248039	297314	1112285
bsdb:804/2/1_Response-to-transplant:SD-FMT:-receiving-Sleep-deprivation--FMT-mice_vs_CON-FMT:(-receiving-control-microbiota-FMT-mice)-and-SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota--FMT-mice)_UP	NA	1796652	1283315	1263098
bsdb:804/2/2_Response-to-transplant:SD-FMT:-receiving-Sleep-deprivation--FMT-mice_vs_CON-FMT:(-receiving-control-microbiota-FMT-mice)-and-SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota--FMT-mice)_DOWN	NA	39497	877420	397290
bsdb:804/3/1_Response-to-transplant:SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota-FMT-mice)_vs_CON-FMT-and-SD-FMT_UP	NA	1159215	538949	1983405	165186	538969	3076055	39496	39497	220137	1470347
bsdb:805/1/1_Psychiatric-disorder:Individuals-with-comorbid-PTSD-+-depression-+-state-+-trait-anxiety-symptoms-(Comorbidity-with-Psychiatric-Symptoms)_vs_Individuals-without-the-comorbid-state_DOWN	NA	1150298
bsdb:805/2/1_Psychiatric-disorder:PTSD-+-depression-+-state-+-trait-anxiety-symptoms-(Comorbidity-with-Psychiatric-Symptoms)_vs_Healthy-controls-(good-mental-health)_DOWN	NA	1150298
bsdb:805/4/1_Childhood-trauma-measurement:Individuals-who-experienced-life-threatening-childhood-trauma_vs_Individuals-who-did-not-experience-life-threatening-childhood-trauma_UP	NA	154288
bsdb:806/1/1_Mood-disorder:bipolar-disorder-(BD)_vs_healthy-controls-(HCs)_UP	NA	33038	1922	2053632
bsdb:806/2/1_Mood-disorder:Major-depressive-disorder-(MDD)_vs_healthy-controls-(HCs)_UP	NA	33038	33039	41978
bsdb:806/3/1_Mood-disorder:Major-depressive-disorder-(MDD)_vs_bipolar-disorder-(BD)_UP	NA	39491	39488	1940338	59823	2049024
bsdb:806/3/2_Mood-disorder:Major-depressive-disorder-(MDD)_vs_bipolar-disorder-(BD)_DOWN	NA	59823
bsdb:809/3/1_Retinopathy:diabetes-retinopathy-(DR)_vs_healthy-controls-(HC)_UP	NA	35517
bsdb:810/1/1_Preterm-premature-rupture-of-the-membranes:Preterm-premature-rupture-of-membranes-(PPROM)_vs_Control(term-delivery)_UP	NA	2702	386414	147802	42190	28125	134821
bsdb:810/1/2_Preterm-premature-rupture-of-the-membranes:Preterm-premature-rupture-of-membranes-(PPROM)_vs_Control(term-delivery)_DOWN	NA	47770	1596
bsdb:811/1/1_Psoriasis:Psoriasis-patients_vs_Healthy-controls_UP	NA	165179	29466
bsdb:811/1/2_Psoriasis:Psoriasis-patients_vs_Healthy-controls_DOWN	NA	239935
bsdb:812/1/1_Urinary-tract-infection:rUTI-History,-UTI-(-)_vs_No-UTI-History_UP	NA	33032	33037	47770	1633	1376
bsdb:812/1/2_Urinary-tract-infection:rUTI-History,-UTI-(-)_vs_No-UTI-History_UP	NA	33029	33034	820	479117	2137877	38303	1351	178214	1260	66228	386414	33031	131111	1282	1290	134821
bsdb:812/2/1_Hormone-replacement-therapy:EHT+-Group-(Premenopausal-women-in-the-'No-UTI-History-and-rUTI-History(-UTI(−)-cohorts'-who-used-estrogen-hormone-therapy-(EHT))_vs_EHT--Group-(Premenopausal-women-in-the-'No-UTI-History-and-rUTI-History(-UTI(−)-cohorts'-who-did-not-use-estrogen-hormone-therapy-(EHT))_UP	NA	47770	1633
bsdb:812/2/2_Hormone-replacement-therapy:EHT+-Group-(Premenopausal-women-in-the-'No-UTI-History-and-rUTI-History(-UTI(−)-cohorts'-who-used-estrogen-hormone-therapy-(EHT))_vs_EHT--Group-(Premenopausal-women-in-the-'No-UTI-History-and-rUTI-History(-UTI(−)-cohorts'-who-did-not-use-estrogen-hormone-therapy-(EHT))_UP	NA	82135	68892	28037	1303	1313
bsdb:814/1/2_Diet-measurement:Adult-Systemic-Sclerosis-patients-on-a-non-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._vs_Adult-Systemic-Sclerosis-patients-on-a-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._DOWN	NA	2049024	1946507	2053632	297314
bsdb:814/2/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with-increased-GIT-2.0-score_vs_Not-Applicable_UP	NA	1946507
bsdb:814/2/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with-increased-GIT-2.0-score_vs_Not-Applicable_DOWN	NA	1898207	1671661	1262798	2049024	2053618	147711	2065077	331630	404784	707003
bsdb:814/3/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with-more-severe-diarrhoea_vs_NA_UP	NA	1671661
bsdb:814/3/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with-more-severe-diarrhoea_vs_NA_DOWN	NA	1935934	1898207	2485925	2065077	297314	707003
bsdb:814/4/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with--worsened-social-functioning_vs_NA_UP	NA	1946507	1940338
bsdb:814/4/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with--worsened-social-functioning_vs_NA_DOWN	NA	1263031	331630	707003	1930013
bsdb:817/1/1_Granulomatosis-with-Polyangiitis:Kidneys-with-calcification_vs_Healthy/Healthy-with-no-visible-granuloma_UP	NA	2578121
bsdb:817/2/1_Granulomatosis-with-Polyangiitis:Sick-with-Kidney-calcification_vs_Systemic-Granulomatosis-(SG)-affected_UP	NA	2578121
bsdb:818/1/1_Asthma,Allergic-rhinitis,Dermatitis,Food-allergy:Allergic-Children_vs_Healthy-controls_DOWN	NA	39488	649756	418240	1150298
bsdb:818/1/2_Asthma,Allergic-rhinitis,Dermatitis,Food-allergy:Allergic-Children_vs_Healthy-controls_UP	NA	84112	1351	562	1522	29361
bsdb:819/2/1_Response-to-antiviral-drug:Week-24-samples_vs_Baseline-samples_UP	NA	53418
bsdb:819/2/2_Response-to-antiviral-drug:Week-24-samples_vs_Baseline-samples_DOWN	NA	1796646
bsdb:819/3/1_CD4-positive-T-lymphocyte-count:Baseline-CD4+-high-samples_vs_Baseline-CD4+-low-samples_UP	NA	729
bsdb:819/4/1_CD4-positive-T-lymphocyte-count:week-24-CD4+-high-samples_vs_week-24-CD4+-low-samples_DOWN	NA	729
bsdb:820/2/2_Antimicrobial-agent,Amoxicillin:Mouse-after-antibiotic-treatment_vs_Mouse-before-antibiotic--treatment_UP	NA	1940338
bsdb:821/1/2_Temperature:Warm-Gut_vs_Cool-Gut_DOWN	NA	1940338
bsdb:823/1/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-(MGD)-Groups_vs_Healthy-controls_UP	NA	1282	152682
bsdb:824/1/1_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_UP	NA	77133
bsdb:824/1/2_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_DOWN	NA	163601	39498
bsdb:824/2/2_Gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_DOWN	NA	1262798	163601	35518	77133
bsdb:825/1/1_Urolithiasis:urinary-stone-disease-patients_vs_healthy-controls_UP	NA	1898207
bsdb:826/1/1_Colorectal-adenoma:HRA-(high-risk-adenoma)_vs_Healthy-controls_DOWN	NA	1896971	1940338
bsdb:826/4/1_Colorectal-adenoma:HRA-(high-risk-adenoma)_vs_Healthy-controls_UP	NA	84030
bsdb:826/5/1_Colorectal-cancer:CRC-(participants-diagnosed-with-colorectal-cancer)_vs_Healthy-controls_UP	NA	187327	33043	1262988	706562	626940
bsdb:826/5/2_Colorectal-cancer:CRC-(participants-diagnosed-with-colorectal-cancer)_vs_Healthy-controls_DOWN	NA	338188	1981510	1262944	29466
bsdb:826/6/1_Colorectal-adenoma,Colorectal-cancer:HRA-(high-risk-adenoma)-group-combined-with-CRC-(colorectal-cancer)-group_vs_Healthy-controls_UP	NA	84030
bsdb:828/3/1_COVID-19,Respiratory-failure-requiring-assisted-ventilation:Intubated_vs_Non-intubated_UP	NA	428712	384677
bsdb:830/1/2_Biological-sex:male-patients-with-dry-eye-disease_vs_female-patients-with-dry-eye-disease_DOWN	NA	2080419	287
bsdb:830/2/1_Biological-sex:Healthy-male_vs_Healthy-female_UP	NA	287	76773
bsdb:830/3/1_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-(MGD)-DED_vs_Aqueous-tear-deficient-(ATD)-DED_UP	NA	1280	29388
bsdb:830/3/2_Dry-eye-syndrome:Meibomian-Gland-Dysfunction-(MGD)-DED_vs_Aqueous-tear-deficient-(ATD)-DED_DOWN	NA	1290
bsdb:830/4/1_Dry-eye-syndrome:Mixed-DED_vs_Aqueous-tear-deficient-(ATD)-DED_UP	NA	1280	29388	29382
bsdb:830/6/1_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_UP	NA	40216	2004644	739	1871047	536441	43768	317577	2080419	851	262209	147802	76773	75385	28449	147645	33033	43675	1280	1290	1305	712633	29466
bsdb:830/7/1_Dry-eye-syndrome:Dry-Eye--ATD_vs_Dry-Eye--nonATD_UP	NA	262209
bsdb:830/7/2_Dry-eye-syndrome:Dry-Eye--ATD_vs_Dry-Eye--nonATD_DOWN	NA	1017
bsdb:830/8/1_Dry-eye-syndrome:Dry-Eye--MGD_vs_Dry-Eye--nonMGD_UP	NA	2004644	2080419	1280	29388	29382
bsdb:830/8/2_Dry-eye-syndrome:Dry-Eye--MGD_vs_Dry-Eye--nonMGD_DOWN	NA	74426
bsdb:833/1/1_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome_vs_Healthy-controls_UP	NA	626930	53443	43997	84112	626940	357276	386414	89153
bsdb:833/1/2_Irritable-bowel-syndrome:Irritable-Bowel-Syndrome_vs_Healthy-controls_DOWN	NA	35833	360807	28025	310297	376804
bsdb:834/1/1_Vitiligo:Non-segmental-Vitiligo-patients_vs_Healthy-controls_UP	NA	39491	28117	31971	39488	649756	817	46506	820	487174	28026	418240	562	853	1150298	2293831	1870991	437897	310298	357276	310297	821	301302	166486	360807	40518	671231	33039	2582419
bsdb:834/1/2_Vitiligo:Non-segmental-Vitiligo-patients_vs_Healthy-controls_DOWN	NA	1105030	209880	1841855	28111	2044939	2292205	1501392	410072	876	88431	1972561	139208	2485925	33033	2049048	1653434	1661	423477	1308	290055	1912855	1288121	2093856	2041842	1470347	1735
bsdb:835/1/1_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_UP	NA	108980	257708
bsdb:835/1/2_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_DOWN	NA	59617
bsdb:835/2/1_Response-to-vaccine:High-IgA-mothers-at-Baseline_vs_Low-IgA-mothers-at-Baseline_UP	NA	461393	33011	1181271	495	470565	40519	74829
bsdb:835/2/2_Response-to-vaccine:High-IgA-mothers-at-Baseline_vs_Low-IgA-mothers-at-Baseline_DOWN	NA	161879
bsdb:835/3/1_Response-to-vaccine:High-IgA-mothers-at-one-week-post-second-dose_vs_Low-IgA-mothers-at-one-week-post-second-dose_UP	NA	1681	2044504	1501662
bsdb:835/3/2_Response-to-vaccine:High-IgA-mothers-at-one-week-post-second-dose_vs_Low-IgA-mothers-at-one-week-post-second-dose_DOWN	NA	487316
bsdb:835/4/1_Response-to-vaccine:Mothers-at-one-week-post-first-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_UP	NA	40216	487316	108980	35841	247	39496	726	735	257708	1780378
bsdb:835/4/2_Response-to-vaccine:Mothers-at-one-week-post-first-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_DOWN	NA	470	151781
bsdb:835/5/1_Response-to-vaccine:Mothers-at-one-week-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_UP	NA	470	487316	108980	657642	420404	34059	1288392	44252	28202	28132	257708	244328	1822466	1898207
bsdb:835/5/2_Response-to-vaccine:Mothers-at-one-week-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_DOWN	NA	1755241	54007	172040	1796613	310297	821	1898204	33011	59617	1606	283923	1885016	876416
bsdb:835/6/1_Response-to-vaccine:Mothers-at-one-month-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_UP	NA	108980	204	1898207	1862672	420404	434084	34059	495	470565	28132	568898	257708	128780	244328
bsdb:835/6/2_Response-to-vaccine:Mothers-at-one-month-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_DOWN	NA	54007	70582	172040	1796613	817	1898204	225991	44008	59617	104608	1606	310298	283923	1885016	1265	876416	2301481
bsdb:836/1/2_Food-allergy:food-allergy-(FA)-group_vs_non-allergy-(NA)-group_DOWN	NA	1940338
bsdb:837/1/1_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Men-with-coronary-heart-disease-(CHD)_DOWN	NA	39492
bsdb:837/3/2_Cardiovascular-disease:Men-with-coronary-heart-disease-(CHD)_vs_Men-without-cardiovascular-disease_DOWN	NA	39492
bsdb:837/4/2_Cardiovascular-disease:Women-with-coronary-heart-disease-(CHD)_vs_Women-without-cardiovascular-disease_DOWN	NA	39492
bsdb:838/1/1_Asthma:Asthma-Samples_vs_Healthy-controls_UP	NA	562	480	349106
bsdb:838/1/2_Asthma:Asthma-Samples_vs_Healthy-controls_DOWN	NA	33034
bsdb:839/1/3_Epilepsy:pre-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	1622071	1940338
bsdb:839/2/1_Epilepsy:post-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	46503	626932	155900
bsdb:839/3/1_Response-to-oxcarbazepine:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_UP	NA	871666	573638	136703
bsdb:839/3/2_Response-to-oxcarbazepine:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_DOWN	NA	1940338
bsdb:839/4/1_Epilepsy:pre-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	1940338
bsdb:839/6/1_Response-to-oxcarbazepine:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_UP	NA	1940338
bsdb:840/1/1_Microbiome-measurement:2015-sampling-period_vs_2013-sampling-period_UP	NA	1831	472	1267	1872480	266128
bsdb:840/1/2_Microbiome-measurement:2015-sampling-period_vs_2013-sampling-period_DOWN	NA	252231	267	2201268	59405
bsdb:841/1/2_Breastfeeding-duration:Calves-without-dam-on-day-35_vs_Calves-with-dam-on-day-35_DOWN	NA	1940338
bsdb:841/2/2_Breastfeeding-duration:Calves-without-dam-on-day-65_vs_Calves-with-dam-on-day-65_DOWN	NA	3068309
bsdb:841/3/1_Breastfeeding-duration:Calves-without-dam-on-day-95_vs_Calves-with-dam-on-day-95_UP	NA	290054
bsdb:841/3/2_Breastfeeding-duration:Calves-without-dam-on-day-95_vs_Calves-with-dam-on-day-95_DOWN	NA	3068309
bsdb:842/1/1_Food-allergy:Food-Allergy_vs_Control-group_UP	NA	39778
bsdb:842/2/1_Dermatitis:Atopic-dermatitis_vs_Control-group_UP	NA	70346	40324	357276
bsdb:842/3/1_Food-allergy,Dermatitis:Atopic-dermatitis-and-Food-Allergy-(ADFA)_vs_Control-group_UP	NA	70346	39778	357276
bsdb:842/4/1_Food-allergy,Dermatitis:Infants-with-Allergy-Symptoms_vs_Control-group_UP	NA	1306	158787	43675	1596
bsdb:842/4/2_Food-allergy,Dermatitis:Infants-with-Allergy-Symptoms_vs_Control-group_DOWN	NA	472	1306	1596	726	28116	1660	55565
bsdb:844/2/1_Response-to-metformin:metformin-treated-T2D-patients_vs_metformin-naive-type-2-diabetes-(T2D)-patients_UP	NA	1940338
bsdb:844/3/1_Population:Denmark-(normoglycaemic-controls-and-T2D-patients)_vs_Indians-(normoglycaemic-controls-and-T2D-patients)_UP	NA	877420	2053608	41978	331630	297314	707003
bsdb:844/3/2_Population:Denmark-(normoglycaemic-controls-and-T2D-patients)_vs_Indians-(normoglycaemic-controls-and-T2D-patients)_DOWN	NA	416943	166486	707003	59823	2049024
bsdb:844/4/2_Metformin:metformin-treated-T2D-patients_vs_metformin-naive-type-2-diabetes-(T2D)-patients_UP	NA	29523
bsdb:844/5/1_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_DOWN	NA	41978	707003
bsdb:844/5/2_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_UP	NA	1955243	2049024	1263031
bsdb:844/6/2_Type-II-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_UP	NA	1263031
bsdb:845/1/1_Smoking-status-measurement:Current-smokers_vs_Never-smokers_UP	NA	169971
bsdb:845/1/2_Smoking-status-measurement:Current-smokers_vs_Never-smokers_DOWN	NA	297314	169971
bsdb:847/1/2_Obesity:Obese-Volunteers-(O)_vs_Normal-weight-volunteers-(N)_DOWN	NA	1409	1898204	1898207	1904861
bsdb:848/1/1_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_UP	NA	707003
bsdb:848/1/2_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_DOWN	NA	39497	39485	877420	35517	33038
bsdb:849/1/2_Age:type-2-diabetes-(T2D)_vs_Non-T2D(prediabetes)_DOWN	NA	853
bsdb:849/2/2_Cytokine:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_DOWN	NA	74426
bsdb:850/1/1_Population:Nasopharyngeal-swabs-from-China_vs_Nasopharyngeal-swabs-from-Canada-and-bronchoalveolar-lavage-from-Canada_UP	NA	152794	1718	225324	45361	480	334543	349106	470	573
bsdb:850/2/1_Population:Nasopharyngeal-swabs-from-Saskatoon,-Canada._vs_Nasopharyngeal-swabs-from-China-and-bronchoalveolar-lavage-from-Canada_UP	NA	152480	95486	152500	482957	87883	101571	60552	148447	36873
bsdb:850/3/1_Sampling-site:Bronchoalveolar-lavage-from-Alberta,-Canada_vs_Nasopharyngeal-swabs-from-Canada-and-Nasopharyngeal-swabs-from-China_UP	NA	715	67854	1502	738	727	731	75985	2111	2098	2102	2110	28903	28132	77095	28126	165179	28135	839	730	157673
bsdb:850/4/1_Transport:Before-loading-for-short-distance-transportation_vs_Non-transportation-(control)_UP	NA	37329	135577	645465	63612
bsdb:850/5/1_Transport:unloading-after-short-distance-transportation_vs_Non-transportation-(control)_UP	NA	29449	314277	245188
bsdb:850/6/1_Transport:7-days-after-placement-and-adaptive-feeding-(short-distance)_vs_Non-transportation-(control)_UP	NA	188626	351604	1027	2014	108	33903
bsdb:850/7/1_Transport:before-loading-for-long-distance-transportation_vs_Non-transportation-(control)_UP	NA	72	31998	294	160791	408
bsdb:850/8/1_Transport:unloading-from-long-distance-transportation_vs_Non-transportation-(control)_UP	NA	202950	51047	715	67854	225324	738	727	731	505	75985	480	485	486	487	754	747	334543	330922	349106	730	157673	34085
bsdb:850/9/1_Transport:7-days-after-placement-and-adaptive-feeding(long-distance)_vs_Non-transportation-(control)_UP	NA	1515	1377	39491	358	290399	74313	333990	155892	1491	1697	43765	169292	1717	152794	38289	1352	562	72000	66219	84030	69966	45361	2099	2100	196162	106588	300	384	1076	552398	1264	1836	1280	1282	29385	316	43305
bsdb:852/1/2_Acne:Acne-group_vs_Healthy-group_DOWN	NA	658062	61592	562
bsdb:852/3/1_Acne:Acne-group_vs_Healthy-group_UP	NA	76773
bsdb:852/3/2_Acne:Acne-group_vs_Healthy-group_DOWN	NA	76775	76776	4932
bsdb:852/4/1_Acne:Acne-group_vs_Healthy-group_UP	NA	76773
bsdb:852/4/2_Acne:Acne-group_vs_Healthy-group_DOWN	NA	76773	2173181
bsdb:855/1/2_Dry-eye-syndrome:Dry-Eye-Disease-patients_vs_Healthy-Controls_DOWN	NA	2010
bsdb:855/2/1_Dry-eye-syndrome:Sjogren's-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_UP	NA	77133
bsdb:855/3/1_Dry-eye-syndrome:Non-Sjogren's-Syndrome-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_UP	NA	257708	1366046
bsdb:856/1/1_Dry-eye-syndrome:Diabetic-children-with-Dry-Eye-Disease-(DM-DE)_vs_Normal-healthy-(NDM)-children_DOWN	NA	36809	378548	1739114	189426	1280	1302	153622
bsdb:856/1/2_Dry-eye-syndrome:Diabetic-children-with-Dry-Eye-Disease-(DM-DE)_vs_Normal-healthy-(NDM)-children_UP	NA	73501	539813	1403934	28901	672
bsdb:856/2/1_Dry-eye-syndrome:Diabetic-children-with-Dry-Eye-Disease-(DM-DE)_vs_Normal-healthy-(NDM)-children_UP	NA	813	562	1403934	1769	36330	28901
bsdb:856/2/2_Dry-eye-syndrome:Diabetic-children-with-Dry-Eye-Disease-(DM-DE)_vs_Normal-healthy-(NDM)-children_DOWN	NA	40214	1351	1280	1313
bsdb:857/1/1_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_UP	NA	1940338
bsdb:858/1/1_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_UP	NA	1965604
bsdb:858/1/2_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_DOWN	NA	487175
bsdb:863/1/2_Eczema,Urticaria:Atopic-dermatitis-(eczema)_vs_Chronic-urticaria-(hives)_DOWN	NA	310297
bsdb:863/2/2_Eczema,Allergic-rhinitis:Atopic-dermatitis-(eczema)_vs_Allergic-rhinitis_DOWN	NA	290054
bsdb:866/1/1_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_UP	NA	187327	1501391	2358141	28116	820	74426	1940338	1417852	33038	823
bsdb:866/1/2_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_DOWN	NA	649756	820	853	592978	40545
bsdb:866/2/1_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_UP	NA	33038	216816	40545	33025
bsdb:866/2/2_Intestinal-polyp:Patients-with-low-grade-colorectal-polyps-cohort_vs_Polyp-free-control-patients_DOWN	NA	46503	2682456
bsdb:867/1/2_Breast-cancer:Breast-cancer-patients_vs_Healthy-controls_DOWN	NA	3068309	877421	877428
bsdb:868/1/1_Ulcerative-colitis:Ulcerative-colitis_vs_Healthy-controls_UP	NA	877420	310298	626940	487173	40545	853
bsdb:868/1/2_Ulcerative-colitis:Ulcerative-colitis_vs_Healthy-controls_DOWN	NA	1150298
bsdb:870/1/1_Postmenopausal-osteoporosis:Postmenopausal-osteoporosis-(PMOP)-patients_vs_Healthy-controls_UP	NA	84024	1624
bsdb:870/1/2_Postmenopausal-osteoporosis:Postmenopausal-osteoporosis-(PMOP)-patients_vs_Healthy-controls_DOWN	NA	28111
bsdb:871/1/1_Head-and-neck-squamous-cell-carcinoma:Oral-mucositis-CTCAE-grade-3-(severe)_vs_Oral-mucositis-CTCAE-grade-1-2-(mild)_UP	NA	105841	1697794	29363	1531	154046	2015901	1776392	33038	1550024	1653434	1547
bsdb:871/1/2_Head-and-neck-squamous-cell-carcinoma:Oral-mucositis-CTCAE-grade-3-(severe)_vs_Oral-mucositis-CTCAE-grade-1-2-(mild)_DOWN	NA	39491	28117	1288121	419015	1715004	2293011	2067550	28052	204516	2479840	1473216	46228	2049043
bsdb:871/2/1_Head-and-neck-squamous-cell-carcinoma:Enteral-feeding-plus-mucositis-of-any-grade_vs_No-enteral-feeding-plus-mild-mucositis_UP	NA	105841	502558	1531	1351	1276	1965575	33038	1550024	1653434	1547	1522
bsdb:871/2/2_Head-and-neck-squamous-cell-carcinoma:Enteral-feeding-plus-mucositis-of-any-grade_vs_No-enteral-feeding-plus-mild-mucositis_DOWN	NA	28117	40520	1715004	2293011	116085	39486	39496	357276	204516	166486	1473216	40545
bsdb:871/3/1_Head-and-neck-squamous-cell-carcinoma:Enteral-feeding-tube-placement_vs_No-Enteral-feeding-tube-placement_UP	NA	105841	1322	33035	502558	2292348	1531	1351	39482	1912855	139208	1276	1965575	33038	1550024	1547	29466	1522
bsdb:871/3/2_Head-and-neck-squamous-cell-carcinoma:Enteral-feeding-tube-placement_vs_No-Enteral-feeding-tube-placement_DOWN	NA	28117	40520	1472416	1715004	2293011	116085	39486	2292041	39496	290055	357276	204516	166486
bsdb:872/1/2_NA:spinal-cord-injury-patient_vs_typically-healthy-control-group_DOWN	NA	877420	1940338
bsdb:873/1/1_Health-study-participation:Strength-athletes_vs_Non-athletes_UP	NA	2292991	1650661
bsdb:873/2/1_Health-study-participation:Endurance-athletes_vs_Non-athletes_UP	NA	2292961	88431
bsdb:873/3/1_Health-study-participation:Strength-athletes_vs_Non-athletes_UP	NA	116085	43675	2292069
bsdb:873/3/2_Health-study-participation:Strength-athletes_vs_Non-athletes_DOWN	NA	674529
bsdb:873/4/1_Health-study-participation:Endurance-athletes_vs_Non-athletes_UP	NA	1150298
bsdb:873/4/2_Health-study-participation:Endurance-athletes_vs_Non-athletes_DOWN	NA	674529
bsdb:873/5/1_Health-study-participation:Strength-athletes_vs_Non-athletes_DOWN	NA	204516
bsdb:873/6/1_Health-study-participation:Endurance-athletes_vs_Non-athletes_UP	NA	2292961
bsdb:873/6/2_Health-study-participation:Endurance-athletes_vs_Non-athletes_DOWN	NA	204516
bsdb:873/7/1_Health-study-participation:Strength-athletes_vs_Non-athletes_UP	NA	1898207
bsdb:873/8/1_Health-study-participation:Endurance-athletes_vs_Non-athletes_UP	NA	2292961	1597
bsdb:873/9/1_Health-study-participation:Strength-athletes_vs_Non-athletes_UP	NA	2709718
bsdb:873/10/1_Health-study-participation:Endurance-athletes_vs_Non-athletes_UP	NA	2292961
bsdb:876/1/1_Male-homosexuality:Men-with->3-sexual-partners_vs_Men-with-0-3-sexual-partners_DOWN	NA	1737424	2721136	2044939	28052	1906667
bsdb:876/1/2_Male-homosexuality:Men-with->3-sexual-partners_vs_Men-with-0-3-sexual-partners_UP	NA	2358141	2212467	52584	2268179	2137880	253257	2485925	1602169	1852370
bsdb:876/2/1_Male-homosexuality:No-Condom-use-(during-RAI)_vs_Condom-use-(Always-during-RAI)_UP	NA	1898207	1898203	2049048	301301	2049040
bsdb:876/2/2_Male-homosexuality:No-Condom-use-(during-RAI)_vs_Condom-use-(Always-during-RAI)_DOWN	NA	2500537	2044939	28052
bsdb:876/3/1_Male-homosexuality:Yes-Oral-Sex_vs_No-Oral-Sex_UP	NA	2212467	2044939	901	626940	1602169	59823	2485925	33039
bsdb:876/3/2_Male-homosexuality:Yes-Oral-Sex_vs_No-Oral-Sex_DOWN	NA	818	1681	35833	824	2720821	2044939	84024	2049044	1898203	33025	204516	1924094	1653435	2259133	46228	2485925
bsdb:876/6/1_Male-homosexuality:STI-Positive_vs_STI-Negative_DOWN	NA	301302	40545	1944635
bsdb:876/6/2_Male-homosexuality:STI-Positive_vs_STI-Negative_UP	NA	2044939	52584	2053569	2485925	2049045
bsdb:876/7/1_Male-homosexuality:Yes-RAI_vs_No-RAI_UP	NA	1506	626940
bsdb:876/7/2_Male-homosexuality:Yes-RAI_vs_No-RAI_DOWN	NA	214856	216816	2720821	2044939	2259133	2023991	2485925	29361
bsdb:876/8/1_Male-homosexuality:Westernized_vs_MSM_UP	NA	1913988	1903720	2212467	2030927	52584	2268179	2137880	2044939	1898204	1898207	1506	2049043	88431	1852381	2026772	2485925	1744	2137878	172901	2212472
bsdb:876/8/2_Male-homosexuality:Westernized_vs_MSM_DOWN	NA	239935	1501391	105841	817	329854	46506	371601	1681	35833	871665	40520	1955243	2044939	218538	88431	1720294	2049045	142586	342942	114527	1981510	310297	2479840	1776391	1653434	68892	28037	1306	154288	423477	2052159	2720820	29347	2763051	1512	2763053	46228	1776382	1871035	1547	1522
bsdb:876/9/1_Male-homosexuality:MSM_vs_Non-MSM_UP	NA	454154	1602169	59823
bsdb:876/10/1_Male-homosexuality:MSM_vs_Non-MSM_UP	NA	1879010	2212467	2044939	901	142586	853	850	1898203	1735	2053569	1906667	187979	626940	1602169	2049048	2049040	572010	1318	304215	2049022	59823	29522	2023260	1903720	2518605
bsdb:876/10/2_Male-homosexuality:MSM_vs_Non-MSM_DOWN	NA	2049052	1628085	2585118	1501391	328813	28117	2358141	47678	246787	338188	817	28116	818	820	487174	1681	216816	28026	871665	418240	2137880	2044939	1898204	1506	218538	2211183	853	292800	1150298	33038	2259133	28118	823	454154	487175	33025	310298	357276	310297	821	3062497	40519	46228	33039	2126740
bsdb:876/11/1_Male-homosexuality:Non-Westernized_vs_MSM_UP	NA	2321404	1871018	291644	1686	52584	2720823	2720824	2720825	2720820	2720834	2721132	2721137	2721139	2721148	2044939	1898204	1898207	1506	1099853	1432052	2049044	142586	2049025	61171	2764322	1673721	1689270	2028282	1898203	1987501	907	2897707	1653435	1945593	821	28125	1744	43675	1547597	2485925	1924111
bsdb:876/11/2_Male-homosexuality:Non-Westernized_vs_MSM_DOWN	NA	29317	2212467	1852370	59823	2137880	671231	1986206	2478488	1903720	1940789	1365	1306	2044939	84024	1506	114527	2049045	871665	116085	1898203	39485	46228	2049040	2485925	3062497	2049044	29466	423477	2053569	1499973	2053615
bsdb:877/2/1_Peri-Implantitis:Peri-implantitis-group-(case-samples)_vs_Healthy-group-(case-samples)_UP	NA	544580	43768	172042
bsdb:877/3/1_Peri-Implantitis:Peri-implantitis-group-(case-samples)_vs_Healthy-group-(case-samples)_DOWN	NA	851	837
bsdb:877/4/1_Peri-Implantitis:Mucositis-group-(contralateral-site-samples)_vs_Healthy-group-(contralateral-site-samples)_DOWN	NA	1303
bsdb:877/5/1_Peri-Implantitis:Peri-implantitis-group-(contralateral-site-samples)_vs_Healthy-group-(contralateral-site-samples)_DOWN	NA	29466
bsdb:877/6/1_Peri-Implantitis:Peri-implantitis-and-mucositis-groups-(contralteral-samples)_vs_Healthy-group--(contralteral-samples)_UP	NA	28131
bsdb:878/1/1_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_UP	NA	851	732
bsdb:878/1/2_Colorectal-carcinoma:Colon-Tumor_vs_Adjacent-normal-colonic-tissue_DOWN	NA	550	470	472
bsdb:880/1/1_Urinary-tract-infection:Culture-Positive_vs_No-Growth_UP	NA	562	571	573
bsdb:880/1/2_Urinary-tract-infection:Culture-Positive_vs_No-Growth_DOWN	NA	1747
bsdb:880/2/1_Urinary-tract-infection:Culture-Positive-Samples_vs_Insignificant-Samples_UP	NA	573
bsdb:880/2/2_Urinary-tract-infection:Culture-Positive-Samples_vs_Insignificant-Samples_DOWN	NA	28116	33039
bsdb:880/3/1_Urinary-tract-infection:Insignificant-Samples_vs_Asymptomatic_DOWN	NA	1280
bsdb:880/4/1_Urinary-tract-infection:No-Growth_vs_Asymptomatic_UP	NA	1747
bsdb:880/4/2_Urinary-tract-infection:No-Growth_vs_Asymptomatic_DOWN	NA	2053618
bsdb:882/1/1_Chronic-inflammatory-demyelinating-polyradiculoneuropathy:Chronic-inflammatory-demyelinating-polyradiculoneuropathy-(CIDP)_vs_Healthy-controls-(non-CIDP)_UP	NA	1304	907	39777	33038	33025	1604	437897	562	548	244366	47770	1624	573	158836	1463165	1343
bsdb:882/1/2_Chronic-inflammatory-demyelinating-polyradiculoneuropathy:Chronic-inflammatory-demyelinating-polyradiculoneuropathy-(CIDP)_vs_Healthy-controls-(non-CIDP)_DOWN	NA	214856	454155	821	151276	376805	28119	2162637	2025876	2763022	28116	2585119	823	357276	47678
bsdb:883/1/1_SARS-CoV-2-related-disease:COVID-19-patients_vs_Healthy-Controls_UP	NA	40324	1190813	1703256	42190	69392	306	29380	2703963	1435069	1871047	2609667	531813	287
bsdb:883/1/2_SARS-CoV-2-related-disease:COVID-19-patients_vs_Healthy-Controls_DOWN	NA	216816	2663009	729	33053	28132	2588991	2682456	1110546	41114	38284	60442	2819619	423477	28449	157687	39777
bsdb:883/2/1_SARS-CoV-2-related-disease:Delta-and-Omicron-infected-patients_vs_Healthy-Controls_DOWN	NA	729	33053	2663009	28449	423477	2682456
bsdb:883/3/1_SARS-CoV-2-related-disease:Delta-infected-patients_vs_Omicron-infected-patients_UP	NA	470	1871047	208224	539813	2529382	573	1463165	244366	69392	2819619
bsdb:883/3/2_SARS-CoV-2-related-disease:Delta-infected-patients_vs_Omicron-infected-patients_DOWN	NA	33053	42190	531813	28124	1583331	28132	287	306	43675	29380	1156431	1304	2588991	39777	2682456	1110546	1435069
bsdb:884/1/1_Diabetic-nephropathy:Diabetic-nephropathy-(DN)_vs_healthy-controls-(CON)_UP	NA	1470347	46506	2033407	469591	1032506	1262979
bsdb:884/2/1_Diabetes-mellitus:type-2-diabetes-mellitus-(T2DM)_vs_healthy-controls-(CON)_UP	NA	2763023	2162637	1262834	97478	2293114	1262936	39778
bsdb:885/1/1_COVID-19:Moderate-severity_vs_Mild-severity_UP	NA	239935	487174	208479	33945	1352	261299	1624	1613	33025	1550024
bsdb:885/1/2_COVID-19:Moderate-severity_vs_Mild-severity_DOWN	NA	853	209880	1776391	40518
bsdb:885/2/1_COVID-19:Severe/Critical-severity_vs_Mild-severity_UP	NA	239935	487174	208479	33945	1352	261299	1624	1613	33025	1550024
bsdb:885/2/2_COVID-19:Severe/Critical-severity_vs_Mild-severity_DOWN	NA	853	209880	1776391	40518
bsdb:885/3/1_COVID-19:Severe/Critical-severity_vs_Moderate-severity_UP	NA	239935	487174	1470355	208479	33945	1352	261299	1624	1613	33025	1550024
bsdb:885/3/2_COVID-19:Severe/Critical-severity_vs_Moderate-severity_DOWN	NA	853	209880	1776391	40518
bsdb:886/1/1_Ascariasis:Ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	2590211
bsdb:886/3/1_Ascariasis:Low-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	165179
bsdb:886/3/2_Ascariasis:Low-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_UP	NA	165179
bsdb:886/4/1_Ascariasis:High-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_DOWN	NA	165179
bsdb:886/4/2_Ascariasis:High-worm-burden-ascaris-suum-infected-piglets_vs_Uninfected-piglets_UP	NA	165179
bsdb:890/1/1_Premature-birth:Preterm-birth-(PTB)_vs_Term-birth-(TB)_UP	NA	1936062
bsdb:890/1/2_Premature-birth:Preterm-birth-(PTB)_vs_Term-birth-(TB)_DOWN	NA	649739	2047	113107	68892	28037	1303	1305	727	729	45634	84135	157687	1078480	109328	467210	824	1313	257758	1107316	483	487	28449	488	43675	726
bsdb:891/1/1_COVID-19-symptoms-measurement:moderate_vs_mild_DOWN	NA	1486246	52773
bsdb:891/2/1_COVID-19-symptoms-measurement:mortality_vs_mild_UP	NA	85698
bsdb:891/3/1_COVID-19-symptoms-measurement:severe_vs_moderate_UP	NA	40542
bsdb:891/4/1_COVID-19-symptoms-measurement:mortality_vs_moderate_UP	NA	1396
bsdb:891/4/2_COVID-19-symptoms-measurement:mortality_vs_moderate_DOWN	NA	29466
bsdb:891/5/1_COVID-19-symptoms-measurement:mortality_vs_severe_DOWN	NA	40542
bsdb:892/1/1_Diet:Pandas-in-leaf-eating-season_vs_Pandas-in-shoot-eating-season_UP	NA	1506
bsdb:893/1/1_Prostate-carcinoma:Prostate-Cancer-(PCa),--Cohort-1-(Discovery-Cohort)_vs_Benign-prostatic-hyperplasia-(BPH),--Cohort-1-(Discovery-Cohort)_UP	NA	495	83655	88688	68895	515489	40215	484	1325724	410	164546
bsdb:893/1/2_Prostate-carcinoma:Prostate-Cancer-(PCa),--Cohort-1-(Discovery-Cohort)_vs_Benign-prostatic-hyperplasia-(BPH),--Cohort-1-(Discovery-Cohort)_UP	NA	71999	39650	316	1290	38304	173362	29378	29382	54007
bsdb:894/1/1_Seasonal-gut-microbiome-measurement:Day-180_vs_Day-0_UP	NA	1366046
bsdb:895/1/1_Anxiety-disorder:Post-sleep-deprivation-samples-(7d-SD)_vs_Baseline-samples-(BSL)_UP	NA	446660	820	1694	2049043	562	90244	821	2033406	1337	81947
bsdb:895/1/2_Anxiety-disorder:Post-sleep-deprivation-samples-(7d-SD)_vs_Baseline-samples-(BSL)_DOWN	NA	2053495	239935	1796613	818	1705	33959	823	357276	671267	1262917	2024224	1945520
bsdb:895/2/1_Anxiety-disorder:Saline-supplementation---SA-(21d-SA)_vs_Baseline-samples-(BSL)_UP	NA	446660	2053495	1694	1705	2049043	90244	1262917	2033406	2024224	1337	81947
bsdb:895/2/2_Anxiety-disorder:Saline-supplementation---SA-(21d-SA)_vs_Baseline-samples-(BSL)_DOWN	NA	239935	1796613	818	820	1694	562	33959	823	357276	671267	821	1945520	81947
bsdb:895/3/1_Anxiety-disorder:Multi-probiotic-supplementation---MP-(21d-MP)_vs_Baseline-samples-(BSL)_UP	NA	446660	2053495	1694	1705	562	33959	90244	1262917	2033406	2024224	1945520	1337	81947
bsdb:895/3/2_Anxiety-disorder:Multi-probiotic-supplementation---MP-(21d-MP)_vs_Baseline-samples-(BSL)_DOWN	NA	239935	1796613	818	820	2049043	823	357276	671267	821
bsdb:895/4/1_Anxiety-disorder:Saline-supplementation---SA-(21d-SA)_vs_Post-sleep-deprivation-samples-(7d-SD)_UP	NA	2053495	1705	33959	1262917	2033406	2024224	1337
bsdb:895/4/2_Anxiety-disorder:Saline-supplementation---SA-(21d-SA)_vs_Post-sleep-deprivation-samples-(7d-SD)_DOWN	NA	446660	239935	1796613	818	820	1694	2049043	562	90244	823	357276	671267	821	1945520	81947
bsdb:895/5/1_Anxiety-disorder:Multi-probiotic-supplementation---MP-(21d-MP)_vs_Post-sleep-deprivation-samples-(7d-SD)_UP	NA	446660	2053495	1705	33959	90244	1262917	2033406	2024224	1945520	1337	81947
bsdb:895/5/2_Anxiety-disorder:Multi-probiotic-supplementation---MP-(21d-MP)_vs_Post-sleep-deprivation-samples-(7d-SD)_DOWN	NA	239935	1796613	818	820	1694	2049043	562	823	357276	671267	821
bsdb:895/6/1_Anxiety-disorder:Multi-probiotic-supplementation---MP-(21d-MP)_vs_Saline-supplementation---SA-(21d-SA)_UP	NA	446660	2053495	239935	818	1694	1705	562	33959	90244	1945520	1337	81947
bsdb:895/6/2_Anxiety-disorder:Multi-probiotic-supplementation---MP-(21d-MP)_vs_Saline-supplementation---SA-(21d-SA)_DOWN	NA	239935	1796613	818	820	2049043	823	357276	671267	821	1262917	2033406	2024224
bsdb:896/1/1_Health-study-participation:Day-7-participants_vs_Day-1-participants_UP	NA	1318	39777	39778	187328	29466	1343	1624	61646	299767	729	419208	43995	28125
bsdb:896/1/2_Health-study-participation:Day-7-participants_vs_Day-1-participants_DOWN	NA	626935
bsdb:896/3/1_Health-study-participation:Day-14_vs_Day-7_UP	NA	169435
bsdb:896/3/2_Health-study-participation:Day-14_vs_Day-7_DOWN	NA	182337	729	61646	1318	39777	419208	187328	859243	1624	43995	39778	29466	885040	879276
bsdb:896/4/2_Health-study-participation:Indian-participants_vs_Chinese-participants_DOWN	NA	169435	239935	77917
bsdb:896/6/1_Health-study-participation:Malay-participants_vs_Indian-participants_UP	NA	234908	39824
bsdb:896/7/1_Health-study-participation:Female-participants_vs_Male-participants_UP	NA	187327	626929	818	371601	28127	626343
bsdb:896/7/2_Health-study-participation:Female-participants_vs_Male-participants_DOWN	NA	859243	237576	77917
bsdb:897/1/1_Neonatal-death:Unsuccessful-breeders_vs_Successful-breeders_UP	NA	33025	1940338
bsdb:897/1/2_Neonatal-death:Unsuccessful-breeders_vs_Successful-breeders_DOWN	NA	33025
bsdb:898/1/1_Bladder-carcinoma:Bladder-cancer_vs_Non-neoplastic-(controls)_UP	NA	202950
bsdb:898/1/2_Bladder-carcinoma:Bladder-cancer_vs_Non-neoplastic-(controls)_DOWN	NA	39497
bsdb:898/2/2_Disease-recurrence:Higher-risk-of-recurrence-(HER)_vs_Lower-risk-of-recurrence-(LER)_DOWN	NA	1940338
bsdb:898/3/2_Disease-progression-measurement:Higher-risk-of-progression-(HEP)_vs_Lower-risk-of-progression-(LEP)_DOWN	NA	159447
bsdb:899/1/1_Restricted-to-specific-location:North-American-hive-microenvironments_vs_Brazilian-hive-microenvironment_UP	NA	1402	1409	1404	412384
bsdb:899/1/2_Restricted-to-specific-location:North-American-hive-microenvironments_vs_Brazilian-hive-microenvironment_DOWN	NA	1423	1591	28031
bsdb:901/1/1_Allergic-asthma:Allergic-asthma_vs_Healthy-control_UP	NA	216816	28026	74426	88431	457412	1304	55565	1660	84112	1379	59310	907	5476
bsdb:901/1/2_Allergic-asthma:Allergic-asthma_vs_Healthy-control_DOWN	NA	47678	246787	818	487174	28118	46503	310298	821	1099853	214856	1613
bsdb:901/2/1_Allergic-rhinitis:Allergic-rhinitis_vs_Healthy-control_UP	NA	1681	28026	469610	88431	562	1379	1304	1584	45634	237576	584
bsdb:901/2/2_Allergic-rhinitis:Allergic-rhinitis_vs_Healthy-control_DOWN	NA	214856	47678	46506	46503	310298	246787	1099853	1613
bsdb:905/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_UP	NA	41200
bsdb:905/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_DOWN	NA	1955243
bsdb:905/2/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_UP	NA	41200
bsdb:905/2/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Controls_DOWN	NA	1955243
bsdb:909/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	65403	239935	47678	35833	1816678	292800	1735	154046	823	46503	204516	84032	180332	438033	1309	47246	33039
bsdb:909/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	39488	645466	216816	871665	40520	1351	39490	853	1871029	39485	437897	1264
bsdb:911/1/1_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-2.3years-(mean-age--1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)-exposure-in-4.7years-(mean-age)_UP	NA	290054	39497	39492	297314
bsdb:911/1/2_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-2.3years-(mean-age--1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)-exposure-in-4.7years-(mean-age)_DOWN	NA	290054	1410626	297314
bsdb:911/2/1_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)--exposure-in-4.7years-old(mean-age)_UP	NA	290054	1410626	297314
bsdb:911/2/2_Response-to-glucocorticoid:Early-pregnancy-glucocorticoid-(Early-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Early-pregnancy-glucocorticoid(Early-preGC)--exposure-in-4.7years-old(mean-age)_DOWN	NA	290054	39497	39492	297314
bsdb:911/3/1_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-2.3years-old-(mean-age--1SD)_vs_Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-4.7years-old-(mean-age)_UP	NA	877406	84026	331630	159272
bsdb:911/3/2_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-2.3years-old-(mean-age--1SD)_vs_Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-4.7years-old-(mean-age)_DOWN	NA	438033	749906	297314
bsdb:911/4/1_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Late-pregnancy-glucocorticoid(Late-preGC)-exposure-in-4.7years-old(mean-age)_UP	NA	438033	749906	297314
bsdb:911/4/2_Response-to-glucocorticoid:Late-pregnancy-glucocorticoid-(Late-preGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Late-pregnancy-glucocorticoid(Late-preGC)-exposure-in-4.7years-old(mean-age)_DOWN	NA	877406	84026	331630	159272
bsdb:911/5/1_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-2.3years-old(mean-age--1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_UP	NA	290054	438033	749906	331630	297314
bsdb:911/5/2_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-2.3years-old(mean-age--1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_DOWN	NA	84026
bsdb:911/6/1_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_UP	NA	290054	84026
bsdb:911/6/2_Response-to-glucocorticoid:Post-pregnancy-glucocorticoid-(PostGC)-exposure-in-7.1years-old(mean-age-+1SD)_vs_Post-pregnancy-glucocorticoid(PostGC)-exposure-in-4.7years-old(mean-age)_DOWN	NA	438033	749906	331630	297314
bsdb:911/7/1_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-2.3-years-old-(mean-age--1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_UP	NA	290054	331630
bsdb:911/7/2_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-2.3-years-old-(mean-age--1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_DOWN	NA	2320511	290054	877406	749906	297314
bsdb:911/8/1_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-7.1-years-old-(mean-age-+1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_UP	NA	2320511	290054	877406	749906	297314
bsdb:911/8/2_Response-to-glucocorticoid:Offspring-glucocorticoid-(OffspringGC)-in-7.1-years-old-(mean-age-+1SD)_vs_Offspring-glucocorticoid-(OffspringGC)-in-4.7-years-old-(mean-age)_DOWN	NA	290054	331630
bsdb:912/5/1_Diet:April-Test-diet_vs_April-Reference-diet_UP	NA	2485925
bsdb:913/1/1_Myopia:L-group----Ok-Lens-group_vs_N-group----Non-wearer-group_UP	NA	1636152
bsdb:913/1/2_Myopia:L-group----Ok-Lens-group_vs_N-group----Non-wearer-group_DOWN	NA	1872421
bsdb:915/1/1_Breast-carcinoma:premenopausal-breast-cancer-patients-(Pre-BC)_vs_Premenopausal-female-controls-(Pre-C)_UP	NA	729	363265	40518	40519
bsdb:915/1/2_Breast-carcinoma:premenopausal-breast-cancer-patients-(Pre-BC)_vs_Premenopausal-female-controls-(Pre-C)_DOWN	NA	239935	626932	1680	1681	216816	74426	1735	823	43675	265312
bsdb:915/2/1_Breast-carcinoma:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Postmenopausal-female-controls-(Post-C)_UP	NA	729	52226
bsdb:915/2/2_Breast-carcinoma:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Postmenopausal-female-controls-(Post-C)_DOWN	NA	239935	265312	74426	1735	847	823	387090	626932	84112
bsdb:915/3/1_Menopause:Postmenopausal-female-controls-(Post-C)_vs_Premenopausal-female-controls-(Pre-C)_UP	NA	31971
bsdb:915/3/2_Menopause:Postmenopausal-female-controls-(Post-C)_vs_Premenopausal-female-controls-(Pre-C)_DOWN	NA	853	1680	216816
bsdb:915/4/1_Menopause:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Premenopausal-breast-cancer-patients-(Pre-BC)_UP	NA	40519	39778
bsdb:915/4/2_Menopause:Postmenopausal-breast-cancer-patients-(Post-BC)_vs_Premenopausal-breast-cancer-patients-(Pre-BC)_DOWN	NA	301302	1680	216816
bsdb:916/1/1_Vaginitis:Recurrent-vaginitis-(RV)_vs_Healthy-women-(control)_UP	NA	562	82135	2702	502393	187101	2130
bsdb:916/1/2_Vaginitis:Recurrent-vaginitis-(RV)_vs_Healthy-women-(control)_DOWN	NA	47770	1596	109790	1598
bsdb:916/2/1_Vaginal-microbiome-measurement:Community-state-type-(CST)-III-and-IV_vs_Community-state-type-(CST)-I_DOWN	NA	47770
bsdb:916/3/1_Vaginal-microbiome-measurement:Community-state-type-(CST)-III_vs_Community-state-type-(CST)-I-and-IV_UP	NA	147802	1598
bsdb:916/4/1_Vaginal-microbiome-measurement:Community-state-type-(CST)-IV_vs_Community-state-type-(CST)-I-and-III_UP	NA	82135	2702
bsdb:918/2/2_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_UP	NA	41978	39488
bsdb:918/3/1_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_DOWN	NA	1940338
bsdb:918/4/1_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_DOWN	NA	1940338
bsdb:918/5/1_Response-to-transplant:Parkinson's-disease-patients-after-fecal-microbiota-transplant-(FMT)_vs_Parkinson's-disease-patients-before-fecal-microbiota-transplant-(FMT)_DOWN	NA	1940338
bsdb:920/1/1_Diet:Participants-on-ketogenic-diet_vs_Participants-on-vegan-diet_UP	NA	35833	1472416	544645	1034346	208479	358743	39490	1358	2041842	28118	33025	671267	821	143393
bsdb:920/1/2_Diet:Participants-on-ketogenic-diet_vs_Participants-on-vegan-diet_DOWN	NA	39491	1628085	214853	649756	1879010	1685	1686	216816	28026	1737424	2049021	142586	39496	1150298	261299	1898203	301302	40518	41978	2053618	43997	1955243
bsdb:921/1/1_Depressive-disorder:Depressive-group_vs_Healthy-group_UP	NA	566	1792311	1522
bsdb:921/1/2_Depressive-disorder:Depressive-group_vs_Healthy-group_DOWN	NA	39491	1628085	2799636	208962	290054	1982626	2935520	745368	487175	40518	40519	36835	2763028	2020948
bsdb:921/2/1_Depressive-disorder:Depressive-group_vs_Healthy-group_UP	NA	1936059	89014	1308	33038	216816	536633	74426	1547	1550024	208479	84112	2040291	1531	1522	1720300	1673717	2358141	1318	2211183	292800
bsdb:921/2/2_Depressive-disorder:Depressive-group_vs_Healthy-group_DOWN	NA	39491	1628085	328814	2738446	1912894	820	1686	2025493	1917888	1414720	2161821	88431	2652274	208962	290054	1982626	2935520	2763655	745368	729	1673721	1917870	39485	706562	1852369	592978	487175	1792311	33025	204516	821	2779352	301301	360807	40518	2518605	2763665	2490633	1304	2714355	2763028	2020948
bsdb:923/1/1_Response-to-exercise:Aerobic-exercise-training-group-(AET)_vs_Sham-group-and-parkison's-disease-(PD)-group_UP	NA	159272
bsdb:923/3/1_Response-to-exercise:Sham-group_vs_Aerobic-exercise-training-group-(AET)-and-parkison's-disease-(PD)-group_DOWN	NA	297314
bsdb:925/1/1_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_UP	NA	549
bsdb:925/1/2_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_DOWN	NA	45498	877420	821	194843	349920
bsdb:925/2/1_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_UP	NA	29448	137993	220684	549	412384	91750	2735681
bsdb:925/2/2_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_DOWN	NA	45498	877420	821	13689	1197429	749906	194843	194926	297314	707003	271151
bsdb:925/3/1_Treatment:Ropinirole-treatment-group-(R)_vs_Vehicle-group-(VH)_DOWN	NA	85831	821	194843	331630
bsdb:925/4/1_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_UP	NA	1897037	877420	198431
bsdb:925/4/2_Treatment:Dopamine-treatment-group-(D)_vs_Vehicle-group-(VH)_DOWN	NA	1862672	1156038	397290	1235793	877420	671267	194843	345727	297314	707003
bsdb:925/5/1_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_UP	NA	1897037	3068309	749906	194926
bsdb:925/5/2_Treatment:Pramipexole-treatment-group-(P)_vs_Vehicle-group-(VH)_DOWN	NA	1151525	1862672	1156038	397290	1235793	877420	671267	194843	345727	297314	329911
bsdb:925/6/1_Treatment:Ropinirole-treatment-group-(R)_vs_Vehicle-group-(VH)_UP	NA	666559
bsdb:925/6/2_Treatment:Ropinirole-treatment-group-(R)_vs_Vehicle-group-(VH)_DOWN	NA	877420	297314
bsdb:926/1/1_Crohn's-disease:Crohn’s-disease-(CD)-patients_vs_Healthy-controls-(HC)_UP	NA	544580	1852377	712122	708131	756828	56426	85701	1685	6973	1912897	1660073	1495769	309868	234827	1705394	2751	1496	1492	1502	1747	53345	1351	1352	160453	53346	2049044	208962	562	564	1499973	29391	708126	548	571	33959	1382	1671721	2051552	65123	1254	584	28901	1292	1328	113107	45634	1334	1302	1338	1825069	1303	197614	82348	2021971	1305	1759399	712633	585425	1834196	2304606	1224749	67827
bsdb:926/1/2_Crohn's-disease:Crohn’s-disease-(CD)-patients_vs_Healthy-controls-(HC)_DOWN	NA	214856	328814
bsdb:926/2/1_Ulcerative-colitis:Ulcerative-colitis-(UC)-patients_vs_Healthy-controls-(HC)_UP	NA	43675	1852377	1302	45634	1305	712633	2021971	1685	1747	113107	1759399	69220	1304	29466	1318	1254
bsdb:926/2/2_Ulcerative-colitis:Ulcerative-colitis-(UC)-patients_vs_Healthy-controls-(HC)_DOWN	NA	328814	631220	2094242	28118	114615	239935
bsdb:926/3/1_Gut-microbiome-measurement:Crohn's-disease-(CD)-patients_vs_Ulcerative-colitis-(UC)-patients_UP	NA	67827	208962	562	564	1499973	28901	622	623	693444
bsdb:926/3/2_Gut-microbiome-measurement:Crohn's-disease-(CD)-patients_vs_Ulcerative-colitis-(UC)-patients_DOWN	NA	853	39485	1623	179636	41
bsdb:926/4/1_Crohn's-disease:Crohn's-disease-patients--Mild-group_vs_Health-controls-(HC)_DOWN	NA	182210	328814
bsdb:926/5/1_Crohn's-disease:Crohn's-disease-patients--Moderate-group_vs_Health-controls-(HC)_DOWN	NA	182210	328814
bsdb:926/5/2_Crohn's-disease:Crohn's-disease-patients--Moderate-group_vs_Health-controls-(HC)_UP	NA	1743168
bsdb:926/6/1_Ulcerative-colitis:Ulcerative-colitis-disease-patients--Mild,-moderate-and-severe-groups_vs_Health-controls-(HC)_DOWN	NA	239935	28123	328814
bsdb:926/6/2_Ulcerative-colitis:Ulcerative-colitis-disease-patients--Mild,-moderate-and-severe-groups_vs_Health-controls-(HC)_UP	NA	1235990
bsdb:926/7/1_Gut-microbiome-measurement:Ulcerative-colitis-disease-patients--Severe-group_vs_Ulcerative-colitis-disease-patients--Mild-group_DOWN	NA	239935	28123	328814
bsdb:926/7/2_Gut-microbiome-measurement:Ulcerative-colitis-disease-patients--Severe-group_vs_Ulcerative-colitis-disease-patients--Mild-group_UP	NA	1235990
bsdb:926/8/1_Gut-microbiome-measurement:Ulcerative-colitis-disease-patients--Severe-group_vs_Ulcerative-colitis-disease-patients--Moderate-group_DOWN	NA	328814
bsdb:926/8/2_Gut-microbiome-measurement:Ulcerative-colitis-disease-patients--Severe-group_vs_Ulcerative-colitis-disease-patients--Moderate-group_UP	NA	1235990
bsdb:926/9/1_Gut-microbiome-measurement:Ulcerative-colitis-disease-patients--Severe-group_vs_Ulcerative-colitis-disease-patients--Mild-group_DOWN	NA	453230	79604
bsdb:926/9/2_Gut-microbiome-measurement:Ulcerative-colitis-disease-patients--Severe-group_vs_Ulcerative-colitis-disease-patients--Mild-group_UP	NA	563169	6973
bsdb:927/1/1_Behcet's-syndrome:Untreated-active-Behcet's-disease-(BD)-patients_vs_Healthy-Control_UP	NA	1470347	908612	1262705	28111	1262751	693988	35833	74426	742722	1262850	1262884	1263013	1262992	1262901	52226	1226322	1226323	1232459	454154	387090	1627893	1211417
bsdb:927/1/2_Behcet's-syndrome:Untreated-active-Behcet's-disease-(BD)-patients_vs_Healthy-Control_DOWN	NA	1262689	1262693	1262700	1262770	1262774	1262797	1262843	1262863	218538	1262889	850	907	1262903	1291540	638849	1262970
bsdb:927/4/1_Behcet's-syndrome:Untreated-active-Behcet's-disease-(BD)-patients_vs_Healthy-Control_UP	NA	51582	170559	35725	1736233	1214573	80884	314127	858221	1182553	5465	216778	1118058	5480	40601	42817	212818	1156966	55565	40324	665115	5141
bsdb:927/4/2_Behcet's-syndrome:Untreated-active-Behcet's-disease-(BD)-patients_vs_Healthy-Control_DOWN	NA	1262690	79591
bsdb:928/1/1_Chronic-granulomatous-disease:Chronic-granulomatous-disease_vs_Healthy-controls_UP	NA	512314	77133
bsdb:928/1/2_Chronic-granulomatous-disease:Chronic-granulomatous-disease_vs_Healthy-controls_DOWN	NA	2049021	39496	1297617	39485	301301	331630	165185	446043	297314
bsdb:928/2/1_Chronic-granulomatous-disease:Chronic-granulomatous-disease-(CGD)-patients_vs_Healthy-individuals_UP	NA	512314	77133
bsdb:928/2/2_Chronic-granulomatous-disease:Chronic-granulomatous-disease-(CGD)-patients_vs_Healthy-individuals_DOWN	NA	39485	77133	297314	1297617	301301
bsdb:928/2/3_Chronic-granulomatous-disease:Chronic-granulomatous-disease-(CGD)-patients_vs_Healthy-individuals_UP	NA	512314	77133
bsdb:928/4/2_Cohort:NIHCC-Cohort-(CGD-without-IBD)_vs_PIDTC-Cohort-(CGD-without-IBD)_UP	NA	877420	33039
bsdb:928/5/2_Cohort:NIHCC-Cohort-(CGD-Patients)_vs_PIDTC-Cohort-(CGD-Patients)_UP	NA	1671661	290055	877420	33039
bsdb:928/6/1_Age:CGD-patients-above-12-years_vs_CGD-patients-less-than-or-equal-to-12-years_UP	NA	877420	33039
bsdb:929/1/1_Alzheimer's-disease:Alzheimer's-disease-FMT-mice_vs_Healthy-control-FMT-mice_UP	NA	817	329854	371601
bsdb:929/1/2_Alzheimer's-disease:Alzheimer's-disease-FMT-mice_vs_Healthy-control-FMT-mice_DOWN	NA	208479	328812
bsdb:932/1/1_Delivery-method:Elective-Cesarean-Section-(ECS)_vs_Vaginally-Delivered(VD)_UP	NA	544580	1689	57706	1502	40324	2077149	1560339	712122	2081702
bsdb:932/1/2_Delivery-method:Elective-Cesarean-Section-(ECS)_vs_Vaginally-Delivered(VD)_DOWN	NA	328814	290053	28113	28116	28026	2161821	2702	823
bsdb:932/2/1_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-0_vs_Vaginally-Delivered(VD)-at-Day-0_UP	NA	546
bsdb:932/2/2_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-0_vs_Vaginally-Delivered(VD)-at-Day-0_DOWN	NA	223967
bsdb:932/3/1_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-15_vs_Vaginally-Delivered(VD)-at-Day-15_UP	NA	1689	544580	2081702	638619
bsdb:932/3/2_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-15_vs_Vaginally-Delivered(VD)-at-Day-15_DOWN	NA	562	28026	630129	622	28113	545	1499973
bsdb:932/4/1_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-30_vs_Vaginally-Delivered(VD)-at-Day-30_UP	NA	550	571	2027919	1977566	1934254	57706	881260	69220	138072	617123
bsdb:932/4/2_Delivery-method:Elective-Cesarean-Section-(ECS)-at-Day-30_vs_Vaginally-Delivered(VD)-at-Day-30_DOWN	NA	28026	28116	823	1717	2161821	2702
bsdb:932/6/1_Delivery-method:An-experiment-for-group-1-(day-15)-vs.-group-0-(days-0-and-30)_vs_NA_UP	NA	1681	1685	1686	630129	216816	191610	562	548	47770	1613	1702287	28901	622	623	1282	1290	1318	197614
bsdb:932/6/2_Delivery-method:An-experiment-for-group-1-(day-15)-vs.-group-0-(days-0-and-30)_vs_NA_UP	NA	1685	562	216816	1681	28901	548	1702287	1282	623	1613	1290	197614	630129	622	1686	187327	881260	1318	47770	191610
bsdb:932/7/1_Delivery-method:An-experiment-for-group-1-(day-30)-vs.-group-0-(days-0-and-15)_vs_NA_UP	NA	818	1680	28026	1322	546	1502	33010	61645	550	2027919	158836	1977566	1351	1736	1134687	571	1463165	244366	54291	1335	1302	102684	28037	1304	1839799	1308	29466	248315	575	47715	2026240
bsdb:935/1/1_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	2054177
bsdb:935/2/1_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Diseased-Controls_UP	NA	1547	1757166
bsdb:935/2/2_Parkinson's-disease:Patients-with-Parkinson's-Disease_vs_Diseased-Controls_DOWN	NA	156456
bsdb:936/1/1_Vulvovaginitis:Vulvovaginal-symptoms_vs_Non-vulvovaginal-symptoms-(control)_UP	NA	419015	156976	2702	502393	40543	1938886	1971214
bsdb:936/1/2_Vulvovaginitis:Vulvovaginal-symptoms_vs_Non-vulvovaginal-symptoms-(control)_DOWN	NA	33033
bsdb:938/1/1_Gut-microbiome-measurement:Rumen-of-Tan-Sheep-(T_R)_vs_Rumen-of-Dorper-sheep-(D_R)_UP	NA	85698	853	292800	884684	2109687	40324	316
bsdb:938/1/2_Gut-microbiome-measurement:Rumen-of-Tan-Sheep-(T_R)_vs_Rumen-of-Dorper-sheep-(D_R)_DOWN	NA	230361	1789762
bsdb:938/2/1_Gut-microbiome-measurement:Duodenum-of-Tan-Sheep-(T_Du)_vs_Duodenum-of-Dorper-sheep-(D_Du)_UP	NA	358	656366	546871	477641	482462	2283195
bsdb:938/2/2_Gut-microbiome-measurement:Duodenum-of-Tan-Sheep-(T_Du)_vs_Duodenum-of-Dorper-sheep-(D_Du)_DOWN	NA	302406	446679	76853
bsdb:938/3/1_Gut-microbiome-measurement:Colon-of-Tan-Sheep-(T_Co)_vs_Colon-of-Dorper-sheep-(D_Co)_DOWN	NA	1515	1423	1400053	151276	1324352	152794	1223514	349751	546160	1679721	652787	1433126	1536775	823	1829	971	995	1309
bsdb:938/4/1_Gut-microbiome-measurement:Rumen-of-Tan-Sheep-(T_R)_vs_Rumen-of-Dorper-sheep-(D_R)_UP	NA	1394809	370804
bsdb:938/5/1_Gut-microbiome-measurement:Duodenum-of-Tan-Sheep-(T_Du)_vs_Duodenum-of-Dorper-sheep-(D_Du)_UP	NA	297314
bsdb:938/6/1_Gut-microbiome-measurement:Jejunum-of-Tan-Sheep-(T_J)_vs_Jejunum-of-Dorper-sheep-(D_J)_UP	NA	370804
bsdb:938/7/1_Gut-microbiome-measurement:Colon-of-Tan-Sheep-(T_Co)_vs_Colon-of-Dorper-sheep-(D_Co)_UP	NA	707003
bsdb:938/7/2_Gut-microbiome-measurement:Colon-of-Tan-Sheep-(T_Co)_vs_Colon-of-Dorper-sheep-(D_Co)_DOWN	NA	194843	297314
bsdb:938/8/1_Gut-microbiome-measurement:Cecum-of-Tan-Sheep-(T_C)_vs_Cecum-of-Dorper-sheep-(D_C)_UP	NA	707003
bsdb:940/1/1_COVID-19:Covid-19-group_vs_Control-group_UP	NA	2571388	2599739	2175223	2745882	1925498	2489165	1963375	756022	4932	935215	2698902	104670
bsdb:940/1/2_COVID-19:Covid-19-group_vs_Control-group_DOWN	NA	2040582	1664392	181171	278596	5054	308927	2016221	2682943	483707	76775	5480
bsdb:940/2/1_COVID-19:Post-Covid-19-group_vs_Covid-19-group_UP	NA	64647	41959	46472	5476	1206149	1173061	36080	2021227	5537	1400007	42659	42661
bsdb:940/2/2_COVID-19:Post-Covid-19-group_vs_Covid-19-group_DOWN	NA	935215	756022	2599739	2175223	2745882	104670	1925498	4932	2571388	2489165	1963375	2698902
bsdb:940/3/1_COVID-19:Post-Covid-19-group_vs_Control-group_UP	NA	64647	41959	46472	5476	1206149	1173061	36080	2021227	5537	1400007	42659	42661
bsdb:940/4/1_COVID-19:Covid-19-N-group_vs_Control-group_UP	NA	483707	2571388	2489165	5476
bsdb:940/4/2_COVID-19:Covid-19-N-group_vs_Control-group_DOWN	NA	2040582	181171	76775	308927	2016221
bsdb:940/5/1_COVID-19:Covid-19-C-group_vs_Control-group_UP	NA	5476	2489165
bsdb:940/5/2_COVID-19:Covid-19-C-group_vs_Control-group_DOWN	NA	2040582	308927	181171
bsdb:941/1/1_Abnormal-sperm-morphology:Asthenozoospermia_vs_Healthy-Control_UP	NA	817	216816	28026	546	1940338	1624	33025	28037
bsdb:941/1/2_Abnormal-sperm-morphology:Asthenozoospermia_vs_Healthy-Control_DOWN	NA	387090	59823
bsdb:942/1/1_Stroke:Cerebral-ischemic-stroke-patients_vs_Healthy-individuals_UP	NA	1262684	239935	1288121	328814	1262705	47678	626931	1262770	1262781	1262834	1262865	901	1262872	1736	363265	28118	1262911	1519439	419005	1262959	2485925
bsdb:942/1/2_Stroke:Cerebral-ischemic-stroke-patients_vs_Healthy-individuals_DOWN	NA	1262685	1262706	1796613	487174	1262894
bsdb:943/3/1_Gut-microbiome-measurement:Inflammatory-depression_vs_Healthy-controls-(HC)-and-non-inflammatory-depression-group_UP	NA	2066855	1260987
bsdb:943/5/1_Major-depressive-disorder:Inflammatory-depression_vs_Healthy-controls-(HC)_UP	NA	1852361	55565	936548	1262775	114527	1660	102148	1318	1313
bsdb:943/5/2_Major-depressive-disorder:Inflammatory-depression_vs_Healthy-controls-(HC)_DOWN	NA	853	745368	1267	1897022	390806	1262804	2292234	2292964	2293105	2585118	1502	39485	1492	2292960	2293108	1776391	1262796	1896976	2302955	2292958	2292980	2292967	2292962	2302956	1262803	2293234	2292959	2292357	2293107	1897011	1262941	1262883	1470347	1262911	1506	1945593	1650663	2302957	2292297	1897005	1897012	1150298	1262757
bsdb:944/1/1_Parkinson's-disease:Parkinson's-disease-group_vs_Healthy-control-(control-matched--CM)_UP	NA	41200
bsdb:944/1/2_Parkinson's-disease:Parkinson's-disease-group_vs_Healthy-control-(control-matched--CM)_DOWN	NA	853
bsdb:946/2/1_Parkinson's-disease:PD:-Individuals-with-Parkinson's-disease_vs_PC:-healthy-population-controls-without-Parkinson's-Disease_UP	NA	1432052	1550024
bsdb:946/2/2_Parkinson's-disease:PD:-Individuals-with-Parkinson's-disease_vs_PC:-healthy-population-controls-without-Parkinson's-Disease_DOWN	NA	853	1262988	39485
bsdb:948/2/1_Timepoint:Parkinson's-disease-patients-at-year-2_vs_Parkinson's-disease-patients-at-year-0_DOWN	NA	817
bsdb:948/4/1_Timepoint:Stable-group-at-year-2_vs_Stable-group-at-year-0_DOWN	NA	817
bsdb:949/8/1_Gut-microbiome-measurement:Ascaris-suum-(Females)_vs_Ascaris-summ-(Males)_UP	NA	187979
bsdb:949/8/2_Gut-microbiome-measurement:Ascaris-suum-(Females)_vs_Ascaris-summ-(Males)_DOWN	NA	701526
bsdb:949/9/1_Gut-microbiome-measurement:Parasite-(Ascaris-suum)-Microbiome_vs_Host-(Ascaris-suum-infected-Pigs)-Microbiome_UP	NA	1940338
bsdb:949/9/2_Gut-microbiome-measurement:Parasite-(Ascaris-suum)-Microbiome_vs_Host-(Ascaris-suum-infected-Pigs)-Microbiome_DOWN	NA	370804
bsdb:950/1/1_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_UP	NA	165179
bsdb:950/2/1_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_UP	NA	165179
bsdb:950/2/2_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	626935	29348
bsdb:950/3/1_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_UP	NA	165179
bsdb:950/3/2_Diarrhea:Acutely-diarrheic-British-Shorthair-cats-(BD)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	147207
bsdb:950/4/1_Breed:Healthy-American-Shorthair-(MH)_vs_Healthy-British-Shorthair-(BH)_UP	NA	165179
bsdb:950/4/2_Breed:Healthy-American-Shorthair-(MH)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	536633	36835
bsdb:950/5/2_Breed:Healthy-American-Shorthair-(MH)_vs_Healthy-British-Shorthair-(BH)_DOWN	NA	39488
bsdb:950/6/1_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_UP	NA	370804	2699758	2793154
bsdb:950/6/2_Diarrhea:Acutely-diarrheic-American-Shorthair-cats-(MD)_vs_Healthy-American-Shorthair-(MH)_DOWN	NA	3030912
bsdb:951/1/1_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_UP	NA	739	43997	2137877	1898207	851	33033	837	28129	43675	69710	1056807
bsdb:951/1/2_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_DOWN	NA	47671	596085
bsdb:951/2/1_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_UP	NA	45242	484	28132	936370	706435
bsdb:951/2/2_Type-II-diabetes-mellitus:Type-2-Diabetes-Mellitus-Patients_vs_Healthy-Control_DOWN	NA	544581	461393	1655	712117	1750	2718	61592	47671	641148	172042	1305
bsdb:955/2/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-controls_UP	NA	216816
bsdb:956/1/1_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_UP	NA	1940338
bsdb:956/1/2_Schizophrenia:Schizophrenia-patients-with-prominent-negative-symptoms-(SCH-N)_vs_Healthy-controls_DOWN	NA	42322	877420	33039
bsdb:957/5/1_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_UP	NA	328813	246787	28111	818	487174	35833	544645	45851	2093857	823	46503	33025	357276
bsdb:957/5/2_Parkinson's-disease:Patients-with-Parkinson's-Disease-(PD)_vs_Healthy-controls-(HC)_DOWN	NA	853	1150298	745368	301302	40519	165179
bsdb:958/1/1_Lung-transplantation:Lung-transplant-event-free-group-(EF)_vs_No-lung-transplant-group-(NT)_UP	NA	33038
bsdb:958/1/2_Lung-transplantation:Lung-transplant-event-free-group-(EF)_vs_No-lung-transplant-group-(NT)_DOWN	NA	363265	310298	357276	310297
bsdb:958/2/2_Lung-transplantation:Lung-transplant-chronic-rejection-group-(CR)_vs_No-lung-transplant-group-(NT)_DOWN	NA	363265	310298	357276	310297
bsdb:958/3/1_Lung-transplantation:Lung-transplant-chronic-rejection-group-(CR)_vs_Lung-transplant-event-free-group-(EF)_DOWN	NA	33038
bsdb:960/1/1_Curcumin:CUR-L_vs_MPTP_UP	NA	446660	1501391	1647659	76122	2039241	2028282	215530	2094151	35517	59620
bsdb:960/1/2_Curcumin:CUR-L_vs_MPTP_DOWN	NA	239935	1588	1598	1796646	165187
bsdb:960/2/1_Curcumin:CUR-M_vs_MPTP_UP	NA	85831	290054	2028282	2094151	1231603	83427
bsdb:960/2/2_Curcumin:CUR-M_vs_MPTP_DOWN	NA	1872090	1588	1598	165185
bsdb:960/3/1_Curcumin:CUR-H_vs_MPTP_UP	NA	215530	2094151	1231603	1187017	1757166
bsdb:960/3/2_Curcumin:CUR-H_vs_MPTP_DOWN	NA	290054	1468449	1588	1598	35518	162156	165185
bsdb:961/1/2_Parkinson's-disease:MPTP-(untreated-PD-mice)_vs_Control-(CON-groups)_DOWN	NA	287948	1869227
bsdb:961/2/1_Clinical-treatment:MPTP-(untreated-PD-mice)_vs_FGF21-+-MPTP-mice-(mice-treated-with-Fibroblast-growth-factor-21-(FGF21))_UP	NA	42858
bsdb:961/2/2_Clinical-treatment:MPTP-(untreated-PD-mice)_vs_FGF21-+-MPTP-mice-(mice-treated-with-Fibroblast-growth-factor-21-(FGF21))_DOWN	NA	29362	1869227
bsdb:962/1/1_Antimicrobial-agent:Antibiotic-(Ab)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_UP	NA	907	1598
bsdb:962/1/2_Antimicrobial-agent:Antibiotic-(Ab)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_DOWN	NA	2161821	562	158847	1675036	2144175	28118	971	69823	1884263
bsdb:962/2/1_Antimicrobial-agent:Therapeutic-Zinc-oxide-(Zn)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_UP	NA	1796613	2981780	817	290053	28113	28116	818	28119	1496	53442	292800	1291540	823	2025876	357276	376805	821	28112	712710
bsdb:962/2/2_Antimicrobial-agent:Therapeutic-Zinc-oxide-(Zn)-global-data-set_vs_Non-medicated-control-(CT)-global-data-set_DOWN	NA	2161821	562	158847	1675036	2144175	28118	971	1884263	69823
bsdb:962/3/1_Antimicrobial-agent:Therapeutic-Zinc-oxide-(Zn)-global-data-set_vs_Antibiotics-(AB)-global-data-set_UP	NA	1796613	2981780	817	290053	28113	28116	818	28119	1496	53442	292800	1291540	823	2025876	357276	376805	821	28112	712710
bsdb:962/3/2_Antimicrobial-agent:Therapeutic-Zinc-oxide-(Zn)-global-data-set_vs_Antibiotics-(AB)-global-data-set_DOWN	NA	1598	907
bsdb:962/7/1_Abnormal-sample:Diarrhoea_7dpw-CT(no-medication)-group_vs_Faecal_7dpw-CT(no-medication)-group_UP	NA	562	2494234
bsdb:962/7/2_Abnormal-sample:Diarrhoea_7dpw-CT(no-medication)-group_vs_Faecal_7dpw-CT(no-medication)-group_DOWN	NA	288965	1677857	33952	239935	461876	2507160	1805714	755731	84032	51515	61435	901	1352	1834198	252966	114527	1852373	712411	1264	3062497	1307
bsdb:962/8/1_Abnormal-sample:Diarrhoea_7dpw-AB(antibiotics)-group_vs_Faecal_7dpw-AB(antibiotics)-group_UP	NA	1598
bsdb:962/8/2_Abnormal-sample:Diarrhoea_7dpw-AB(antibiotics)-group_vs_Faecal_7dpw-AB(antibiotics)-group_DOWN	NA	2161821	1598	69823
bsdb:962/9/1_Abnormal-sample:Diarrhoea_7dpw-Zn(Zinc-Oxide)-group_vs_Faecal_7dpw-Zn(Zinc-Oxide)-group_UP	NA	28116	1297617	357276	821
bsdb:962/9/2_Abnormal-sample:Diarrhoea_7dpw-Zn(Zinc-Oxide)-group_vs_Faecal_7dpw-Zn(Zinc-Oxide)-group_DOWN	NA	2507160	1496	357276	821	971	1884263	143393
bsdb:962/10/1_Abnormal-sample:Diarrhoea_0dpw-AB(antibiotics)-group_vs_Faecal_0dpw-AB(antibiotics)-group_DOWN	NA	376805
bsdb:962/11/1_Abnormal-sample:Diarrhoea_14pw-CT(no-medication)-group_vs_Faecal_14dpw-CT(no-medication)-group_DOWN	NA	187327	1509	44742	2161821	562	2487118	1584	158847	907	1675036	2144175	1930071	365349	2173034	3062497	971	1884263	69823	901
bsdb:962/12/1_Abnormal-sample:Diarrhoea_14dpw-AB(antibiotics)-group_vs_Faecal_14dpw-AB(antibiotics)-group_DOWN	NA	905	1042156	39491
bsdb:962/13/1_Abnormal-sample:Diarrhoea_14dpw-Zn(Zinc-Oxide)-group_vs_Faecal_14dpw-Zn(Zinc-Oxide)-group_DOWN	NA	47678	1796613	246787	817	290053	28113	818	1496	1168034	1562970	1291540	28251	185300	823	33025	376805	28112	712710
bsdb:963/1/1_Tumor-stage:Pre-CT-Stage-II/III_vs_Pre-CT-Stage-I_UP	NA	820	1796652	487175	1262992	1358	1308	626929	291645	1034346	84112	1608898
bsdb:963/1/2_Tumor-stage:Pre-CT-Stage-II/III_vs_Pre-CT-Stage-I_DOWN	NA	52226	1547597	457421	172901	1263000	1965560	1262959	2108523	2049043	46228	45851	1965576	1262739	1472761	1262761	1262958	106588	487174	1965604	2173	901
bsdb:963/2/1_Tumor-stage:Post-CT-Stage-II/III_vs_Post-CT-Stage-I_UP	NA	471189	418240	1653434	626940	160404	626929	820	1547	1550024	358743	84112	166486	208479	1531	46503	1849041	358742	1720294	53345	33035	46506	291645	29466	1262777	1262756	1110546	1535	1262882	1308	100884	457421
bsdb:963/2/2_Tumor-stage:Post-CT-Stage-II/III_vs_Post-CT-Stage-I_DOWN	NA	158847	572010	1263000	1262911	1150298	674529	1262988	33039	246787	39491	40520	1262935	1965538	172901	84024	1262921	1965631	1499973	1262739	55565	745368	821	165179	1608898	544645	39485	28118	853	901	410072	116085
bsdb:963/3/1_Tumor-size:Pre-Chemo-tumor-size->pT1_vs_Pre-Chemo-tumor-size-<pT1_UP	NA	649756	871325	674529	371601	29363	487173	84112	1262992	729	1608898	261299	573	244366	301302	28037	1304	1308	39778	29466	29361	33039
bsdb:963/3/2_Tumor-size:Pre-Chemo-tumor-size->pT1_vs_Pre-Chemo-tumor-size-<pT1_DOWN	NA	1965604	28116	1262739	487174	544644	1262761	901	2049043	1720294	1263005	651822	2108523	2173	1262958	1547597
bsdb:963/4/1_Tumor-size:Post-Chemo-tumor-size->pT1_vs_Post-Chemo-tumor-size-<pT1_UP	NA	46506	371601	216816	501571	1502	100884	1531	562	1849041	261299	46503	626940	1262924	28139	166486	360807	1653434	1759399	1308	1343	29348	39777	29466	423477	1110546	1522	1535
bsdb:963/4/2_Tumor-size:Post-Chemo-tumor-size->pT1_vs_Post-Chemo-tumor-size-<pT1_DOWN	NA	1628085	239935	626932	1099853	1501392	116085	410072	901	1965537	1965538	1608898	28118	821	1262945	39492
bsdb:963/5/1_Tumor-grading:SBR-Gr3-Post-Chemo_vs_SBR-Gr1/2-Post-Chemo_UP	NA	116085	165179	39492	1849041	544645	28117	901	1965604	1351	84024	1262989	1263006	1262824	2137880	1965537	1262988	1263011	454155	1263005	1262739	2049043	1965562	208479
bsdb:963/5/2_Tumor-grading:SBR-Gr3-Post-Chemo_vs_SBR-Gr1/2-Post-Chemo_DOWN	NA	1262736	1432052	154046	270498	706562	1512	291645	371601	246787	33025	1262942	1653434	387661	28052	1308	33043	471189	216816	292800	358743
bsdb:963/6/1_Tumor-stage:pN+-pre-Chemo_vs_pN--pre-Chemo_UP	NA	1897011	1501392	487175	1262992	1796652	33039	820	1099853	33025	35833	569	1034346
bsdb:963/6/2_Tumor-stage:pN+-pre-Chemo_vs_pN--pre-Chemo_DOWN	NA	1262744	1262777	29348	172901	1532	55565	133448	546	1965576	571	158847	3062497	1262935	847	1472761	1262739	1262761	147206	1262958	45851	1965555	387090	2027459	33035	1965560	218538	1262882	1653434	1965604	901
bsdb:963/7/1_Tumor-stage:pN+-post-Chemo_vs_pN--post-Chemo_UP	NA	328813	160404	33035	1262756	418240	501571	1262831	1262873	84112	1720294	358742	208479	53345	1262889	471189	261299	46503	584	43675	1653434	28037	1759399	1308	1343	1547	29466	423477	1110546	1535	29361
bsdb:963/7/2_Tumor-stage:pN+-post-Chemo_vs_pN--post-Chemo_DOWN	NA	74426	706562	165179	1608898	40520	230143	39488	39483	158847	410072	1681	1262886	39485	901	328814	28118	116085	853	39491
bsdb:963/8/1_Breast-cancer:Breast-cancer-patients_vs_Healthy-volunteers_UP	NA	2585118	626932	328814	338188	291645	35833	457421	1226325	1245890	333367	208479	1531	2734131	2845183	376804	552398	28116	28118	166486	46503	573	39485	487174	853	823	817	1954380	818	28117	165179	820
bsdb:963/8/2_Breast-cancer:Breast-cancer-patients_vs_Healthy-volunteers_DOWN	NA	1680	39491	457412	216816	74426	39488	2173	45851	33039	88431	46506	363265	40520	1735	410072	39486	39492	501496	626940	1260	411489	100886	167	28026	1686	116085	28127	33043	1683	1304	33031	329854	1308	1623	39490	1161942	1328	33037	550	1351	102684	754330	322095	1226323	54005	154046	1287640	471189	281920
bsdb:963/9/1_Tumor-stage:Neoadjuvant_pN+_vs_Neoadjuvant_pN-_UP	NA	818	292800	1653434	418240	1720294	208479	1262756	1531	1512	1965604	1547	358743	358742
bsdb:963/9/2_Tumor-stage:Neoadjuvant_pN+_vs_Neoadjuvant_pN-_DOWN	NA	40520	39486	1150298	360807	821
bsdb:963/10/1_Tumor-stage:Neoadjuvant-stage-post-Chemo-(Stage-I/II)_vs_Neoadjuvant-stage-post-Chemo-(Stage-0)_UP	NA	358743
bsdb:963/10/2_Tumor-stage:Neoadjuvant-stage-post-Chemo-(Stage-I/II)_vs_Neoadjuvant-stage-post-Chemo-(Stage-0)_DOWN	NA	84135	28037	39496
bsdb:963/11/1_Response-to-combination-chemotherapy:Post-Chemotherapy_vs_Pre-Chemotherapy_UP	NA	1735	33039	39486	1263000	2173
bsdb:963/11/2_Response-to-combination-chemotherapy:Post-Chemotherapy_vs_Pre-Chemotherapy_DOWN	NA	84112	1099853	39777	1432052	820	333367	29466	821	2292352	166486	160404	471189	169435
bsdb:963/12/1_Adverse-effect:Yes---increased-BMI-(Pre-Chemo)_vs_No---increased-BMI-(Pre-Chemo)_UP	NA	46506	46503	1965604	338188	246787	1550024	1686	100884	1501392	28130	821	1262989	165179	544645	40520	28025	1262958	446660	28111	29363	1262882	1262988	487173	1262700	823	457421	2137880	1897011	394340	84024	1547	1262911	187979	1034346	39777	1965538	1796652	28118	1681	1262921
bsdb:963/12/2_Adverse-effect:Yes---increased-BMI-(Pre-Chemo)_vs_No---increased-BMI-(Pre-Chemo)_DOWN	NA	214856	328813	626929	329854	291645	28116	1262739	1197717	74426	147207	33043	901	1262873	562	33025	626940	357276	310297	1965576	1262942	1303	1318	437898	68892	39490	53443	40519	501571	1262944	29466	1263005	1855299	1472761	39778	1304	45851	2049043	387661	1520815	2027459	820	1911679	1531	28037	706562	817	1432052	46228	28052	84135	40518	1262886
bsdb:963/13/1_Adverse-effect:Yes---increased-BMI-(Post-Chemo)_vs_No---increased-BMI-(Post-Chemo)_UP	NA	1501391	1262700	46228	544645	1965537	1262989	1262948	53345	29348	33039	2137880	1262777	487175	649756	1965560	154288	84024	1150298	1965604	626932	28052	46503	1796652	823	216816	218538	28111	246787	626937	2108523	230143	160404	338188	28118	1965555	1099853	371601	853	1625	261299	1034346	106588	1262831	1535	454154	88431	1965576	1262935	1965538	1759399	487174	572010	40520	384639	187327	328813	1735
bsdb:963/13/2_Adverse-effect:Yes---increased-BMI-(Post-Chemo)_vs_No---increased-BMI-(Post-Chemo)_DOWN	NA	40518	187979	1303	43675	166486	1308	1502	1520815	28037	52226	55565	1343	745368	84135	363265	1262930	1304	1689	1911679	1262929	29466	209880	1432052	357276	39777	1262785	818	301301	1262919	39485	291644	1318	154046	68892	817	39491	729	358742	1531
bsdb:963/17/1_Adverse-effect:With-neurotoxicity-(Post-Chemo)_vs_Without-neurotoxicity-(Post-Chemo)_UP	NA	820	292800	169435	1512	84112	29348	358743	818	1550024	1547	1034346	1297617	358742	649756	208479	1965604	333367	53345
bsdb:963/17/2_Adverse-effect:With-neurotoxicity-(Post-Chemo)_vs_Without-neurotoxicity-(Post-Chemo)_DOWN	NA	437898	1262777	1911679	1262930	74426	410072	1318	43675	1897011	454155	1262929	1263005	1263011	544645	40519	28117	33039	1263000	2049043	45851	487174	1343	1262700	729	1628085	363265	901	68892	1262739	1262911	674529	33025	1262988	853
bsdb:963/18/1_Breast-cancer:Breast-cancer-mice_vs_Heathy-mice_UP	NA	39777	1358	1070699	333367
bsdb:963/18/2_Breast-cancer:Breast-cancer-mice_vs_Heathy-mice_DOWN	NA	328813	328814	1470347	216816	626932	74426	1660
bsdb:964/1/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-0_vs_Healthy-control-at-Zeitgeber-(ZT)-0_UP	NA	860	1226342	1540874
bsdb:964/1/2_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-0_vs_Healthy-control-at-Zeitgeber-(ZT)-0_DOWN	NA	470565
bsdb:964/2/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-6_vs_Healthy-control-at-Zeitgeber-(ZT)-6_UP	NA	860	1226342
bsdb:964/3/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-12_vs_Healthy-control-at-Zeitgeber-(ZT)-12_UP	NA	860
bsdb:964/3/2_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-12_vs_Healthy-control-at-Zeitgeber-(ZT)-12_DOWN	NA	470565
bsdb:964/4/1_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-18_vs_Healthy-control-at-Zeitgeber-(ZT)-18_UP	NA	1226342	860
bsdb:964/4/2_Polycystic-ovary-syndrome:PCOS-patients-at-Zeitgeber-(ZT)-18_vs_Healthy-control-at-Zeitgeber-(ZT)-18_DOWN	NA	34026	470565
bsdb:964/5/1_Polycystic-ovary-syndrome:PCOS-Patients_vs_Healthy-controls_DOWN	NA	1308	1680
bsdb:965/2/2_COVID-19:COVID-19-patients_vs_NO-COVID-19-(Patients-with-diagnosis-different-from-COVID-19)_DOWN	NA	32644
bsdb:966/5/1_Parkinson's-disease:Parkinson's-diease-patients-at-6-months_vs_Household-Control_DOWN	NA	1263031
bsdb:967/1/1_Parkinson's-disease:Parkinson's-Disease-(PD)-patients_vs_Healthy_UP	NA	446660	239935	328814	2030927
bsdb:967/1/2_Parkinson's-disease:Parkinson's-Disease-(PD)-patients_vs_Healthy_DOWN	NA	100886	1735	363265	626940	165179	1308	39777	1535	2710826
bsdb:968/1/1_Alzheimer's-disease:Alzheimer's-group_vs_Healthy-senior-group_UP	NA	256318	155900	164851
bsdb:968/1/2_Alzheimer's-disease:Alzheimer's-group_vs_Healthy-senior-group_DOWN	NA	749906	244328	331630
bsdb:968/2/1_Alzheimer's-disease:Alzheimer's-disease-group_vs_Healthy-senior-group_UP	NA	239935	290054	749906	152509	155900	164851	190530	244328
bsdb:968/2/2_Alzheimer's-disease:Alzheimer's-disease-group_vs_Healthy-senior-group_DOWN	NA	588454	1590	749906	155900	331630
bsdb:969/1/1_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	33029	43769	180282	566027	480	129817	75612	190721	1282
bsdb:969/1/2_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_DOWN	NA	290732	561521	266833	418240	13373	87883	101571	60552	449520	38285	191610	1121358	441501	598660	487732	230310	86182	2559073	322509	208962	4467	729	43995	1275	28052	879276	300019	1792	256	328812	420952	984307	252970	907224	411570	755171	183417	255984	374811	304	52773	635203	135080	1284	487698	248040	43948	419257	632	123820
bsdb:969/2/1_Parkinson's-disease:PD-(Parkinson's-Disease)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	106649
bsdb:969/3/1_Parkinson's-disease:SpHC-(Spousal-household-healthy-controls)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	33029	170994	156978	180282	566027	129817	75612	1282	204925
bsdb:969/3/2_Parkinson's-disease:SpHC-(Spousal-household-healthy-controls)_vs_rHC-(Random-non-household-healthy-controls)_DOWN	NA	418240	363631	101571	60552	38285	86182	363848	208962	340214	300019	256	420952	984307	252970	261302	273251	311230	157910	36873	183417	255984	148618	190721	37919	304	670293	42906	248040	419257	379893	168695
bsdb:969/4/1_Parkinson's-disease:SpHC-(Spousal-household-healthy-controls)_vs_rHC-(Random-non-household-healthy-controls)_UP	NA	106649
bsdb:969/4/2_Parkinson's-disease:SpHC-(Spousal-household-healthy-controls)_vs_rHC-(Random-non-household-healthy-controls)_DOWN	NA	36873
bsdb:969/5/1_Parkinson's-disease:SpPD-(Spousal-household-Parkinson's-Disease)_vs_SpHC-(Spousal-household-Healthy-Control)_UP	NA	36808	480
bsdb:969/5/2_Parkinson's-disease:SpPD-(Spousal-household-Parkinson's-Disease)_vs_SpHC-(Spousal-household-Healthy-Control)_DOWN	NA	33034	1280	46126	29382	1282	661498	68892	29484
bsdb:970/1/2_Alzheimer's-disease-biomarker-measurement:Endogenous-melatonin-reduction-(EMR)-mice_vs_Wild-type-(WT)-mice_DOWN	NA	3068309
bsdb:971/8/2_Parkinson's-disease:Parkinson's-Disease-Patients-treated-with-L-dopa_vs_Healthy-Controls_DOWN	NA	438033
bsdb:971/11/1_Parkinson's-disease:Parkinson's-disease-Patients-treated-with-entacapone_vs_Healthy-Controls_UP	NA	35517
bsdb:971/11/2_Parkinson's-disease:Parkinson's-disease-Patients-treated-with-entacapone_vs_Healthy-Controls_DOWN	NA	438033
bsdb:973/1/2_Parkinson's-disease:People-with-Parkinson's-Disease-(PWP)_vs_Healthy-Controls_DOWN	NA	1898207
bsdb:974/1/1_Ovarian-cancer:Immune-deficient-subtype-(clust1)_vs_Immune-enriched-subtype-(clust2)_UP	NA	196024	1423	2749996	2559073	80866	1274	851	1931241	472181	1774	28077	53407	2731681	2320867	53408	200452	157783	1149133	1785145	2745503	437900	1392877	485898	2054914	118613	1534110	1755504	2614442	1173283	1573712	2866277	2678257	1855380	317	2745495	2505979	2842356	2745510	382	29388	28037	2664899	1855331	2777367	450	1500687	2745511
bsdb:974/1/2_Ovarian-cancer:Immune-deficient-subtype-(clust1)_vs_Immune-enriched-subtype-(clust2)_DOWN	NA	287	470	2184519	40215	55601	363952	101571	2604941	119219	156980	406548
bsdb:975/1/2_Parkinson's-disease:Parkinson's-disease_vs_Healthy-controls_DOWN	NA	1898203
bsdb:977/1/2_COVID-19:COVID-19-patients_vs_local-controls_DOWN	NA	1940338
bsdb:977/2/2_Abnormality-of-the-respiratory-system:Non-Covid-19-Patients_vs_local-controls_DOWN	NA	1940338
bsdb:977/3/1_COVID-19:Covid-19-patients_vs_non-Covid-19-patients_UP	NA	2093824
bsdb:977/4/1_Pneumonia:Covid-19-with-Pneumonia_vs_Covid-19-with-no-Pneumonia_UP	NA	1940338
bsdb:977/5/1_Viral-load:viral-load-(>7.5)_vs_viral-load-(≤7.5)_UP	NA	35518
bsdb:977/5/2_Viral-load:viral-load-(>7.5)_vs_viral-load-(≤7.5)_DOWN	NA	416943
bsdb:977/6/2_COVID-19:Hospitalized-patients_vs_local-controls_DOWN	NA	1940338
bsdb:978/1/1_Digestive-System-Carcinoma:Responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Non-responders-to-anti–PD-1/PD-L1-immunotherapy_UP	NA	297314	707003
bsdb:978/1/2_Digestive-System-Carcinoma:Responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Non-responders-to-anti–PD-1/PD-L1-immunotherapy_DOWN	NA	707003
bsdb:978/2/1_Colorectal-cancer:Responders-(colorectal-cancer---CRC)_vs_Non-responders-(colorectal-cancer---CRC)_UP	NA	3068309	297314
bsdb:978/3/1_Esophageal-carcinoma:Responders-(esophageal-carcinoma)_vs_Non-responders-(esophageal-carcinoma)_UP	NA	877420	297314
bsdb:978/3/2_Esophageal-carcinoma:Responders-(esophageal-carcinoma)_vs_Non-responders-(esophageal-carcinoma)_DOWN	NA	707003
bsdb:978/4/1_Gastric-cancer:Responders-(gastric-cancer)_vs_Non-responders-(gastric-cancer)_UP	NA	3068309
bsdb:978/4/2_Gastric-cancer:Responders-(gastric-cancer)_vs_Non-responders-(gastric-cancer)_DOWN	NA	297314
bsdb:978/5/1_Digestive-System-Carcinoma:Non-responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Responders-to-anti–PD-1/PD-L1-immunotherapy_UP	NA	28038	100886	487173
bsdb:978/5/2_Digestive-System-Carcinoma:Non-responders-to-anti–PD-1/PD-L1-immunotherapy_vs_Responders-to-anti–PD-1/PD-L1-immunotherapy_DOWN	NA	39491	1502	39490	97478	823	2047	1328	1305	1343	116085	88431	469614	239935
bsdb:979/1/1_Parkinson's-disease:Male-Parkinson’s-disease-(PD_M)-patients_vs_Female-Parkinson’s-disease-(PD_F)-patients_UP	NA	239935
bsdb:979/1/2_Parkinson's-disease:Male-Parkinson’s-disease-(PD_M)-patients_vs_Female-Parkinson’s-disease-(PD_F)-patients_DOWN	NA	39491	562	166486	1262953	33039
bsdb:980/1/1_Non-alcoholic-fatty-liver-disease:Non-alcoholic-fatty-liver-disease-(NAFLD)_vs_Healthy-controls_UP	NA	1940338	33038	2053632
bsdb:980/1/2_Non-alcoholic-fatty-liver-disease:Non-alcoholic-fatty-liver-disease-(NAFLD)_vs_Healthy-controls_DOWN	NA	290054	39496	1486938	3023528	331630	707003	77133
bsdb:980/2/1_Non-alcoholic-steatohepatitis:NASH-(Non-alcoholic-steatohepatitis)-patients_vs_NAFL-(Non-alcoholic-fatty-liver)-patients_UP	NA	820	39496	658087
bsdb:981/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	2856521	1946507	41978
bsdb:981/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	2049044	1410629	438033	39497
bsdb:982/1/2_Prion-disease:Prion-infected-mice-(R)_vs_Healthy-Control-(C)_DOWN	NA	707003
bsdb:984/1/1_Parkinson's-disease:Parkinson's-Disease_vs_Healthy-Controls_UP	NA	35517
bsdb:985/1/1_Chronic-kidney-disease:Chronic-Kidney-Disease_vs_Healthy-Controls_UP	NA	46506	1499973	850	97478	197614	214851	1841857
bsdb:985/1/2_Chronic-kidney-disease:Chronic-Kidney-Disease_vs_Healthy-Controls_DOWN	NA	649756	971	187979	879612
bsdb:987/1/1_Cesarean-section:Cesarean-section-scar-diverticulum-(CSD)_vs_Control_UP	NA	1940338
bsdb:988/1/1_Mycobacterium-tuberculosis,Lung-cancer:Untreated-TB-Group-(UTG)-and-lung-cancer-patient-group-(LCG)_vs_Healthy-Control-Group-(HCG)_DOWN	NA	329	1283
bsdb:988/2/1_Mycobacterium-tuberculosis:Untreated-TB-Group-(UTG)_vs_Healthy-Control-Group-(HCG)-and-Lung-Cancer-Group-(LCG)_UP	NA	747	1280	305
bsdb:988/3/1_Lung-cancer:Lung-cancer-patient-group-(LCG)_vs_Healthy-Control-Group-(HCG)-and-Untreated-TB-Group-(UTG)_UP	NA	28131	2099584
bsdb:988/4/1_Mycobacterium-tuberculosis:Untreated-pulmonary-TB-group-(UTG)_vs_Treated-pulmonary-TB-group-(TTG)-and-cured-pulmonary-TB-group-(CTG)_UP	NA	747	1280
bsdb:989/1/1_Colitis:DSS-+-BAC-Group-(Day-7)_vs_DSS-Group-(Day-7)_UP	NA	28116	397865	28025	1796646	1622
bsdb:989/1/2_Colitis:DSS-+-BAC-Group-(Day-7)_vs_DSS-Group-(Day-7)_DOWN	NA	214856	328814	1694	1834205	2109688	1496	208479	853	1702221	292800	1297617	1871021	2109691	2109687	301301	28901
bsdb:990/1/1_Colorectal-cancer:Living-bacteria-group-(LB)_vs_Tumor-control-group-(CK)_UP	NA	1729795
bsdb:990/3/1_Colorectal-cancer:Living-bacteria-group_vs_Inactivated-bacteria-group_DOWN	NA	2485925
bsdb:991/1/1_Disease-staging:Melanoma-surface-of-pigs-with-Melanoma-progression_vs_Melanoma-surface-of-pigs-with-with-melanoma-regression_UP	NA	1151637
bsdb:991/1/2_Disease-staging:Melanoma-surface-of-pigs-with-Melanoma-progression_vs_Melanoma-surface-of-pigs-with-with-melanoma-regression_DOWN	NA	3068309	438033
bsdb:991/2/1_Disease-staging:Melanoma-tissue-of-pigs-with-Melanoma-progression_vs_Melanoma-tissue-of-pigs-with-with-melanoma-regression_UP	NA	1588753	1230734
bsdb:991/2/2_Disease-staging:Melanoma-tissue-of-pigs-with-Melanoma-progression_vs_Melanoma-tissue-of-pigs-with-with-melanoma-regression_DOWN	NA	604273
bsdb:991/3/1_Cutaneous-melanoma:melanoma-surface-from-black-pigs_vs_healthy-skin_UP	NA	3068309	438033
bsdb:991/3/2_Cutaneous-melanoma:melanoma-surface-from-black-pigs_vs_healthy-skin_DOWN	NA	1940338
bsdb:991/4/1_Cutaneous-melanoma:melanoma-tissue-from-black-pigs_vs_healthy-skin_UP	NA	3068309	438033
bsdb:991/5/1_Cutaneous-melanoma:Melanoma-progression_vs_controls-without-melanoma-and-melanoma-regression_UP	NA	1946507
bsdb:991/6/1_Cutaneous-melanoma:melanoma-regression_vs_controls-without-melanoma-and-melanoma-progression_UP	NA	1940338
bsdb:991/7/1_Cutaneous-melanoma:Melanoma-progression-and-regression_vs_Controls-without-melanoma_DOWN	NA	877420
bsdb:991/8/1_Breed:Homogenous-breed-MeLiM-piglets_vs_Crossbreed-between-MeLiM-and-white-piglets_UP	NA	1780378	1940338
bsdb:991/8/2_Breed:Homogenous-breed-MeLiM-piglets_vs_Crossbreed-between-MeLiM-and-white-piglets_DOWN	NA	3068309	877420	331630	438033
bsdb:992/1/1_Parkinson's-disease:Parkinson's-disease-patients-(PD)_vs_Healthy-controls-(HC)_UP	NA	1173061
bsdb:992/1/2_Parkinson's-disease:Parkinson's-disease-patients-(PD)_vs_Healthy-controls-(HC)_DOWN	NA	983299	4006	1979800	5082	88167
bsdb:993/1/1_Gut-microbiome-measurement:12-months_vs_3-months_UP	NA	239935	47678	820	165179
bsdb:993/1/2_Gut-microbiome-measurement:12-months_vs_3-months_DOWN	NA	28116
bsdb:993/2/1_Gut-microbiome-measurement:12-months_vs_3-months_DOWN	NA	5480
bsdb:993/2/2_Gut-microbiome-measurement:12-months_vs_3-months_UP	NA	4903	4932	4929
bsdb:995/1/1_Parkinson's-disease:MPTP-Group_vs_Control-Group_UP	NA	1702221	1849041	487175	1161942
bsdb:995/1/2_Parkinson's-disease:MPTP-Group_vs_Control-Group_DOWN	NA	31971
bsdb:995/3/1_Parkinson's-disease:MPTP-+-Acu-Group_vs_Control-Group_UP	NA	84032	384636	36832	301302	1348613
bsdb:995/3/2_Parkinson's-disease:MPTP-+-Acu-Group_vs_Control-Group_DOWN	NA	31971
bsdb:997/4/1_Memory-impairment:Positive-and-memory-deficit-(MD)-group_vs_Normal-health-group_DOWN	NA	626932	328813	820	358742	460384	37734	853	1633	574930	438033	1280	1512	33039
bsdb:997/5/1_Memory-impairment:Positive-group_vs_Normal-health-group-and-memory-deficit-(MD)-group_UP	NA	338188	216816	1694	74426	1598	214851
bsdb:997/6/1_Memory-impairment:Memory-deficit-(MD)-group_vs_Normal-health-group-and-positive-group_UP	NA	118967	674529	28116	36834	1502	358743	562	341220	97478	33038	1263547	823	1547
bsdb:998/1/1_Parkinson's-disease:PD-patients_vs_Controls_UP	NA	46125	507843
bsdb:999/1/1_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_UP	NA	1946507	244328
bsdb:999/1/2_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_DOWN	NA	77133	155900
bsdb:999/2/1_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_UP	NA	438033
bsdb:999/2/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-pups-(PD-15)_vs_Vehicle-control-supplemented-(CON)-pups_DOWN	NA	39497	877420	194843	584861	77133	155900	32644	59620
bsdb:999/3/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-pups-(PD-15)_vs_Ferrous-sulfate-(FS)-treated-pups-(PD-15)_DOWN	NA	39497	1946507	877420	194843	584861	244328	59620	77133	155900	32644
bsdb:999/4/1_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-(YA)-rats_UP	NA	344338	77133	32644
bsdb:999/4/2_Iron-biomarker-measurement:Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-(YA)-rats_DOWN	NA	1940338	290055	77133	32644
bsdb:999/5/1_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-rats_UP	NA	396504	155900	136703	60675
bsdb:999/5/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Vehicle-control-supplemented-(CON)-young-Adult-rats_DOWN	NA	194843	584861	297314	77133	42322	39496	39497	59620	1940338	32644
bsdb:999/6/1_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_UP	NA	290054	290055	1410626	396504	3068309	438033	35518	155900	136703	60675	32644
bsdb:999/6/2_Iron-biomarker-measurement:Ferrous-bis-glycinate-chelate-(FC)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_vs_Ferrous-sulfate-(FS)-treated-young-Adult--(YA)-rats-(PD-58-+/--4)_DOWN	NA	1141839	42322	39496	39497	194843	584861	344338	297314	220137	77133	136703	32644	59620
bsdb:1002/1/2_Colorectal-cancer:Colorectal-Tumor-Samples_vs_Patient-Matched-Normal-Colon-Tissue-Samples_DOWN	NA	820	853	552398
bsdb:1004/1/1_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-1_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-1_UP	NA	244366	46503	40520	1685	1463165	33039	74426	821	573	1115758	850	1352	823
bsdb:1004/1/2_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-1_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-1_DOWN	NA	823
bsdb:1004/2/1_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_UP	NA	1680	74426	39486	1351	160453	71452	853	1463165	1358	315405	39777
bsdb:1004/2/2_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_DOWN	NA	47678	1134687	47715	1596	907	165179	33039
bsdb:1004/3/1_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_UP	NA	74426	1463165	1680	315405	160453	1358	71452	39486	43769	853	1246	43675	1304	68891
bsdb:1004/3/2_Gut-microbiome-measurement:Infants-who-are-HIV-exposed-but-uninfected-(iHEU)-at-week-15_vs_Infants-who-are-HIV-unexposed-and-uninfected-(iHUU)-at-week-15_DOWN	NA	1633	1613	823	47715	160453	907	1134687	47678	29466	33039
bsdb:1007/1/1_Inflammatory-bowel-disease:Ulcerative-colitis-(UC)_vs_Healthy-controls-(HC)_UP	NA	218538	292800
bsdb:1007/1/2_Inflammatory-bowel-disease:Ulcerative-colitis-(UC)_vs_Healthy-controls-(HC)_DOWN	NA	239935	729
bsdb:1007/2/1_Inflammatory-bowel-disease:Crohn’s-disease-(CD)_vs_Healthy-controls-(HC)_UP	NA	218538	292800
bsdb:1007/2/2_Inflammatory-bowel-disease:Crohn’s-disease-(CD)_vs_Healthy-controls-(HC)_DOWN	NA	239935	729
bsdb:1007/4/2_Smoking-behavior:Smokers-(Yes)_vs_Non-Smokers-(No)_DOWN	NA	28116	357276
bsdb:1007/5/1_Smoking-behavior:Ex-smokers-(Ex)_vs_Non-Smokers-(No)_UP	NA	357276
bsdb:1007/5/2_Smoking-behavior:Ex-smokers-(Ex)_vs_Non-Smokers-(No)_DOWN	NA	28116
bsdb:1007/6/2_Smoking-behavior:Smokers-(Yes)_vs_Ex-smokers-(Ex)_DOWN	NA	28116	357276
bsdb:1008/1/1_Light:Dim-light-at-night-(dLAN)---Control-group_vs_Normal-light‐dark-cycle-(LD)---Control-group_UP	NA	423410
bsdb:1008/3/2_Light:Dim-light-at-night-(dLAN)---DTA-group_vs_Normal-light‐dark-cycle-(LD)---DTA-group_DOWN	NA	209265	1729795	423410	1932694	163601
bsdb:1009/1/1_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_UP	NA	1940338
bsdb:1009/2/2_Peutz-Jeghers-Polyp:With-Intussusception-(I-PJS)_vs_Without-Intussusception-(NI-PJS)_UP	NA	1940338
bsdb:1009/3/1_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_UP	NA	470	562	573	1463165	244366	363265	703	28901	621	622	623	624
bsdb:1009/3/2_Peutz-Jeghers-Polyp:Peutz-Jeghers-syndrome-(PJS)_vs_healthy-control-(family-members)_DOWN	NA	853	216816	649756	1896972	39488	1776391	1971605	88431	261299	46228	1304	39486	259315	84024	2292206	2292304	936548	1263010	411484	1262885
bsdb:1009/4/1_Peutz-Jeghers-Polyp:With-Intussusception-(I-PJS)_vs_Without-Intussusception-(NI-PJS)_UP	NA	654	2292211	218538	858	68766	2320108
bsdb:1009/4/2_Peutz-Jeghers-Polyp:With-Intussusception-(I-PJS)_vs_Without-Intussusception-(NI-PJS)_DOWN	NA	853	1971605	1897005	2293125	1288121	1099853	2302955	729
bsdb:1010/1/1_Environmental-exposure-measurement:Ferrous-bisglycinate-group_vs_Placebo-group_UP	NA	1940338
bsdb:1010/2/2_Environmental-exposure-measurement:Ferrous-sulfate-group_vs_Placebo-Group_DOWN	NA	1940338
bsdb:1013/1/1_Microbiome-measurement:Supragingival-plaque-from-severe-early-childhood-caries-(S-ECC)_vs_Oral-swab-from-severe-early-childhood-caries-(S-ECC)_UP	NA	46125	1019	61592	43768	504	505	47671	172042	2047	439703	28135	671224	69823	1328	1309	1304
bsdb:1013/1/2_Microbiome-measurement:Supragingival-plaque-from-severe-early-childhood-caries-(S-ECC)_vs_Oral-swab-from-severe-early-childhood-caries-(S-ECC)_DOWN	NA	29391	137732	727	729	425941	72	187101
bsdb:1013/2/1_Microbiome-measurement:Supragingival-plaque-from-caries-free_vs_Oral-swab-from-caries-free_UP	NA	46125	52769	732	824	203	1017	45242	327575	1019	2718	61592	43768	539	505	47671	554406	172042	2047	671224	69823	1338
bsdb:1013/2/2_Microbiome-measurement:Supragingival-plaque-from-caries-free_vs_Oral-swab-from-caries-free_DOWN	NA	29391	137732	729	1583331	28132	43675	187101
bsdb:1013/3/1_Microbiome-measurement:Supragingival-plaque-from-severe-early-childhood-caries-(S-ECC)_vs_Oral-swab-from-severe-early-childhood-caries-(S-ECC)_UP	NA	42374	5476	858342	29916	55358	1708540
bsdb:1013/3/2_Microbiome-measurement:Supragingival-plaque-from-severe-early-childhood-caries-(S-ECC)_vs_Oral-swab-from-severe-early-childhood-caries-(S-ECC)_DOWN	NA	76775	82508	76773
bsdb:1013/4/1_Microbiome-measurement:Supragingival-plaque-from-caries-free_vs_Oral-swab-from-caries-free_UP	NA	2874738	76775	82508	858342	29916	4929	1708540
bsdb:1013/5/1_Microbiome-measurement:Oral-swab-from-severe-early-childhood-caries-(S-ECC)_vs_Oral-swab-from-caries-free_UP	NA	42374	76775	5482
bsdb:1014/1/1_Response-to-diet:Prophylactic-oats-Day-5-Abx_vs_Always-Dextrose-Day-5-Abx_UP	NA	871325	28116	371601	1288	69824
bsdb:1014/1/2_Response-to-diet:Prophylactic-oats-Day-5-Abx_vs_Always-Dextrose-Day-5-Abx_DOWN	NA	328813	1871006	871325	28116	818	371601	57732
bsdb:1021/1/1_Smoking-behaviour-measurement:Early-infants-(3-months)-with-maternal-history-of--'YES'-'smoking_vs_Early-infants-(3-months)-with-maternal-history-of--'NO'-'smoking_UP	NA	33038	33039
bsdb:1021/2/1_Smoking-behaviour-measurement:Late-infants-(12months)-with-maternal-history-of--'YES'-'smoking_vs_Late-infants-(12months)-with-maternal-history-of--'NO'-'smoking_UP	NA	33039	297314
bsdb:1022/3/1_Fungal-infectious-disease:Substrate-(Environmental-swaps)_vs_Batsskin-swaps_UP	NA	234266
bsdb:1023/1/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	818
bsdb:1023/1/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	1680	216816	876	837	154288
bsdb:1023/2/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	739	76122	54007	938293	33037	1052257	204	827	1019	309120	82347	428988	505	1276757	501496	28125	470565	28132	28133	592378	228604
bsdb:1023/2/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	1283	147645	1706000	298163
bsdb:1023/3/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	1270	29388	28124	1288120
bsdb:1023/3/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	817	818	371601	28188	88431	484	228604	81950	273677	2033
bsdb:1023/4/1_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_UP	NA	46125	617123	189723
bsdb:1023/4/2_Insulin-sensitivity-measurement:Insulin-Resistant-(IR)-Individuals_vs_Insulin-Sensitive-(IS)-Individuals_DOWN	NA	143361	237576	157692
bsdb:1024/1/1_Alzheimer's-disease:Alzheimer's-disease_vs_Healthy-controls_UP	NA	33043	46507	471189	33038	501496	162156
bsdb:1024/1/2_Alzheimer's-disease:Alzheimer's-disease_vs_Healthy-controls_DOWN	NA	105841	85831	292800	856	1898203	1235800	823	310297	1547	77133	57498	626947
bsdb:1026/1/1_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(< 8-days)_vs_SARS-CoV-2-uninfected-PLWH-(< 8-days)_UP	NA	41978
bsdb:1026/1/2_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(< 8-days)_vs_SARS-CoV-2-uninfected-PLWH-(< 8-days)_DOWN	NA	42322	1904861
bsdb:1026/3/1_SARS-coronavirus:SARS-CoV-2-infected-PLWH-(>1-M)_vs_SARS-CoV-2-uninfected-PLWH-(>1-M)_UP	NA	1849603	1940338
bsdb:1027/1/2_Colorectal-carcinoma:Colorectal-cancer-(CRC)_vs_Healthy_DOWN	NA	39488	33039	290054	331630	39496	877420	39485
bsdb:1027/2/2_Leukopenia:Hypoleukocytes_vs_Normal-leukocytes_DOWN	NA	1940338	42322	33039	331630
bsdb:1028/1/1_Menopause:Postmenopausal-women-group_vs_Premenopausal-women-group_UP	NA	425941	28132
bsdb:1028/2/1_Microbiome-measurement:Poor-oral-health-group_vs_Adequate-oral-health-group_UP	NA	33053
bsdb:1028/2/2_Microbiome-measurement:Poor-oral-health-group_vs_Adequate-oral-health-group_DOWN	NA	1898207	28132	152509
bsdb:1028/3/1_Viral-load:High-SARS-CoV-2-viral-load-group_vs_Moderate-SARS-CoV-2-viral-load-group_UP	NA	425941	28124	28132	152509
bsdb:1029/1/1_Vaginal-microbiome-measurement:Bacterial-Vaginosis-(BV)-Infected-Women_vs_Normal-Healthy-Women-&-High‑risk-human-papillomavirus(HR-HPV)-Infected-Women-(HPV)_UP	NA	386414
bsdb:1029/2/1_Vaginal-microbiome-measurement:High‑risk-human-papillomavirus(HR-HPV)-Infected-Women-(HPV)_vs_Normal-Healthy-Women-&-Bacterial-Vaginosis-(BV)-Infected-Women_UP	NA	147802
bsdb:1031/1/1_SARS-coronavirus:Covid-19_vs_Controls_UP	NA	60133
bsdb:1031/1/2_SARS-coronavirus:Covid-19_vs_Controls_DOWN	NA	43675	1306
bsdb:1031/2/1_SARS-coronavirus:SARS-Cov-2-Saliva-Positive_vs_SARS-Cov-2-Saliva-Negative_UP	NA	60133	1328	68892	1305	166	712469	712118	651609	1984869
bsdb:1031/2/2_SARS-coronavirus:SARS-Cov-2-Saliva-Positive_vs_SARS-Cov-2-Saliva-Negative_DOWN	NA	28129	28135	68891	1306	713057
bsdb:1031/3/1_SARS-coronavirus:SARS-Cov-2-Low-Viral-Load_vs_SARS-Cov-2-Negative_UP	NA	860	60133	1328	68892	1305	651609	712118	712469	712631	1984869
bsdb:1031/3/2_SARS-coronavirus:SARS-Cov-2-Low-Viral-Load_vs_SARS-Cov-2-Negative_DOWN	NA	114702	155615	470565	28132	60133	28135	228604	712461	1306	713053	713057
bsdb:1031/4/1_SARS-coronavirus:SARS-CoV-2-High-Viral-load_vs_SARS-CoV-2-Negative_UP	NA	60133	1328	68892	1305	712469	712631	1984869	712118	29317
bsdb:1031/4/2_SARS-coronavirus:SARS-CoV-2-High-Viral-load_vs_SARS-CoV-2-Negative_DOWN	NA	155615	28129	470565	28135	228604	1302	68891	1306	713057	712459	712626
bsdb:1032/1/1_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_UP	NA	33038
bsdb:1032/1/2_Hepatocellular-carcinoma:Patients-with-Hepatocellular-carcinoma-(HCC)_vs_Healthy-controls_DOWN	NA	39488	877420
bsdb:1032/2/1_Hepatitis-virus-related-hepatocellular-carcinoma:non-hepatitis-B-,-non-hepatitis-C-related-Hepatocellular-carcinoma_vs_viral-related-Hepatocellular-carcinoma_UP	NA	33038
bsdb:1032/2/2_Hepatitis-virus-related-hepatocellular-carcinoma:non-hepatitis-B-,-non-hepatitis-C-related-Hepatocellular-carcinoma_vs_viral-related-Hepatocellular-carcinoma_DOWN	NA	438033
bsdb:1033/11/1_Hormone:Thyroxine-(T4)_vs_NA_DOWN	NA	1940338
bsdb:1034/1/1_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_UP	NA	1872398	1506	1955814	82135	2049026	1966354	1613	2023260	1944660	59823
bsdb:1034/1/2_Birth-measurement:High-vaginal-sialidase-activity_vs_Low-vaginal-sialidase-activity_DOWN	NA	36773	1886637	1890675	47770	109790	1917865
bsdb:1034/2/1_Birth-measurement:Leukocyte-high-(grades-III-IV)_vs_Leukocyte-low-(grades-I-II)_UP	NA	36773	1886637	147802	1971214
bsdb:1034/2/2_Birth-measurement:Leukocyte-high-(grades-III-IV)_vs_Leukocyte-low-(grades-I-II)_DOWN	NA	1872515	1328	150055	1981025
bsdb:1036/1/1_Behcet's-syndrome:Behcet's-disease-recipient-mice_vs_Healthy-controls-recipient-mice_UP	NA	562
bsdb:1037/1/1_Chronic-constipation:Constipated-women_vs_Healthy-women_UP	NA	310298
bsdb:1037/1/2_Chronic-constipation:Constipated-women_vs_Healthy-women_DOWN	NA	562	573
bsdb:1038/1/2_Response-to-radiation:Premenopausal-Pre-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_DOWN	NA	1940338
bsdb:1038/3/1_Response-to-radiation:Premenopausal-Post-treatment-group_vs_Premenopausal-healthy-controls-(HPV-Negative-women)_UP	NA	1230734
bsdb:1039/1/1_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_UP	NA	33038	1522
bsdb:1039/1/2_Diet:Urban-Xhosa-Cohort_vs_Rural-Xhosa-Cohort_DOWN	NA	370804	877406
bsdb:1041/1/2_Oral-cavity-carcinoma:Tumor-tissue-(TT)-samples_vs_Adjacent-normal-tissue-(AT)_DOWN	NA	293	488	28449	2047	43675
bsdb:1041/2/1_Oral-cavity-carcinoma:Precancer_vs_Adjacent-normal-tissue-(AT)_DOWN	NA	45242	327575	1018	1019	158	58231
bsdb:1041/2/2_Oral-cavity-carcinoma:Precancer_vs_Adjacent-normal-tissue-(AT)_UP	NA	2490633
bsdb:1041/3/1_Oral-cavity-carcinoma:Early-Stage-Cancer_vs_Precancer_UP	NA	1018	45242	327575	851	285729	158
bsdb:1041/3/2_Oral-cavity-carcinoma:Early-Stage-Cancer_vs_Precancer_DOWN	NA	2490633	2047	43675	1334
bsdb:1041/4/1_Oral-cavity-carcinoma:Late-Stage-Cancer_vs_Precancer_UP	NA	1018	45242	1019	327575
bsdb:1041/4/2_Oral-cavity-carcinoma:Late-Stage-Cancer_vs_Precancer_DOWN	NA	1334	2490633	43675	2047
bsdb:1041/5/1_Oral-cavity-carcinoma:Cancer_vs_Precancer_UP	NA	158	327575	1018	1019	45242
bsdb:1041/5/2_Oral-cavity-carcinoma:Cancer_vs_Precancer_DOWN	NA	2047	43675	1334	2490633
bsdb:1042/1/1_Insecticide:permethrin-resistant-mosquito_vs_permethrin-susceptible-mosquito_UP	NA	77133
bsdb:1043/3/1_Human-immunodeficiency-virus:Acute-HIV-infected-participants-(A12)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	29448
bsdb:1043/4/1_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-(B12)_vs_HIV-uninfected-MSM----controls-(D)_UP	NA	1852368	29448
bsdb:1043/4/2_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-(B12)_vs_HIV-uninfected-MSM----controls-(D)_DOWN	NA	735
bsdb:1043/5/1_Human-immunodeficiency-virus:Acute-HIV-infected-participants-on-Antiretroviral-Therapy-(A12)_vs_Acute-HIV-infected-participants-at-baseline-(A0)_UP	NA	29448
bsdb:1043/5/2_Human-immunodeficiency-virus:Acute-HIV-infected-participants-on-Antiretroviral-Therapy-(A12)_vs_Acute-HIV-infected-participants-at-baseline-(A0)_DOWN	NA	470565	28132
bsdb:1043/6/1_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-on-Antiretroviral-Therapy(B12)_vs_Chronic-HIV-infected-participants-at-baseline-(B0)_UP	NA	29448
bsdb:1043/6/2_Human-immunodeficiency-virus:Chronic-HIV-infected-participants-on-Antiretroviral-Therapy(B12)_vs_Chronic-HIV-infected-participants-at-baseline-(B0)_DOWN	NA	470565
bsdb:1046/1/2_Aging:PLWH-on-ART_vs_PLWOH_DOWN	NA	331630
bsdb:1046/2/2_Aging:PLWH-on-ART_vs_PLWOH_DOWN	NA	331630
bsdb:1046/3/2_Aging:PLWH-on-ART_vs_PLWOH_DOWN	NA	331630
bsdb:1046/4/1_Aging:Samples-PLWH-on-ART_vs_Samples-of-PLWOH_UP	NA	39488	438033	331630
bsdb:1046/4/2_Aging:Samples-PLWH-on-ART_vs_Samples-of-PLWOH_DOWN	NA	33038	33039	344338
bsdb:1046/5/1_Aging:Samples-of-PLWH-on-ART_vs_Samples-of-PLWOH_UP	NA	39488	438033	331630
bsdb:1046/5/2_Aging:Samples-of-PLWH-on-ART_vs_Samples-of-PLWOH_DOWN	NA	33038	33039
bsdb:1047/3/1_Major-depressive-disorder:CUMS + FLX-group_vs_Control-group_UP	NA	1454726
bsdb:1047/5/1_Major-depressive-disorder:CUMS + FLX-group_vs_CUMS-group_UP	NA	1454726
bsdb:1047/6/1_Major-depressive-disorder:CUMS + FLX-group_vs_CUMS-+-XYS-group_UP	NA	1454726
bsdb:1049/12/2_Atopic-eczema:cADpre-dogs_vs_Healthy_DOWN	NA	1940338
bsdb:1049/13/1_Atopic-eczema:cADpost-dogs_vs_cADpre_UP	NA	1940338
bsdb:1049/15/1_Atopic-eczema:cAD-Pre_vs_Healthy-controls_UP	NA	283734
bsdb:1049/16/1_Atopic-eczema:cAD-post_vs_cAD-Pre_DOWN	NA	283734	74706	1295
bsdb:1049/17/1_Atopic-eczema:cAD-Treat_vs_Healthy_DOWN	NA	246432
bsdb:1049/17/2_Atopic-eczema:cAD-Treat_vs_Healthy_UP	NA	1282
bsdb:1049/18/1_Atopic-eczema:cAD-Pre_vs_Healthy_UP	NA	283734
bsdb:1049/19/1_Atopic-eczema:cAD-post_vs_cAD-Pre_UP	NA	246432
bsdb:1049/19/2_Atopic-eczema:cAD-post_vs_cAD-Pre_DOWN	NA	1290
bsdb:1049/20/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_DOWN	NA	1282	1283
bsdb:1049/21/1_Atopic-eczema:cADPre-dogs_vs_Healthy-dogs_DOWN	NA	283734
bsdb:1049/22/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	246432	1295
bsdb:1049/23/2_Atopic-eczema:cAD-Pre_vs_Healthy-controls_DOWN	NA	283734
bsdb:1049/24/1_Atopic-eczema:cAD-Treat_vs_Healthy-controls_UP	NA	74706	246432	1295
bsdb:1049/24/2_Atopic-eczema:cAD-Treat_vs_Healthy-controls_DOWN	NA	1283
bsdb:1049/25/1_Atopic-eczema:cAD-Post_vs_cADpre_UP	NA	1290
bsdb:1049/26/2_Atopic-eczema:cAD-Pre_vs_Healthy-controls_DOWN	NA	283734
bsdb:1049/27/1_Atopic-eczema:cAD-Treat_vs_Healthy-controls_UP	NA	246432
bsdb:1049/28/1_Atopic-eczema:cAD-Post_vs_cADpre_UP	NA	74706	1295	1292
bsdb:1049/29/1_Atopic-eczema:cAD-Pre_vs_Healthy-controls_DOWN	NA	283734
bsdb:1049/30/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-controls_UP	NA	74706	1283	1295
bsdb:1049/31/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	29380	283734	1282	28035	1292
bsdb:1049/31/2_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_DOWN	NA	1280
bsdb:1049/32/1_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_DOWN	NA	283734
bsdb:1049/33/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	246432
bsdb:1049/34/1_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_UP	NA	246432	1292
bsdb:1049/35/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	246432	1295	1292
bsdb:1049/36/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_DOWN	NA	1292
bsdb:1049/37/1_Atopic-eczema:cADPre-dogs_vs_Healthy-dogs_UP	NA	1280	246432
bsdb:1049/37/2_Atopic-eczema:cADPre-dogs_vs_Healthy-dogs_DOWN	NA	283734
bsdb:1049/38/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	246432	1292
bsdb:1049/39/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	1290
bsdb:1049/40/1_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_UP	NA	1296
bsdb:1049/40/2_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_DOWN	NA	283734
bsdb:1049/41/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_UP	NA	74706	283734	1295
bsdb:1049/42/1_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_UP	NA	1292
bsdb:1049/43/1_Atopic-eczema:cADpre-dogs_vs_Healthy-dogs_DOWN	NA	283734
bsdb:1049/44/1_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_UP	NA	246432
bsdb:1049/44/2_Atopic-eczema:cADtreat-dogs_vs_Healthy-dogs_DOWN	NA	1282	1290
bsdb:1049/45/1_Atopic-eczema:cADpost-dogs_vs_cADpre-dogs_DOWN	NA	1290
bsdb:1051/1/2_Lung-cancer:Lung-cancer-(L-group)_vs_Benign-pulmonary-diseases-(N-group)_DOWN	NA	438033
bsdb:1052/1/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-control-(NC)_UP	NA	39496	1410626
bsdb:1054/1/1_Streptococcal-infection:GBS-culture-positive-pregnant-women_vs_GBS-culture-negative-pregnant-women_DOWN	NA	147802	181675
bsdb:1054/1/2_Streptococcal-infection:GBS-culture-positive-pregnant-women_vs_GBS-culture-negative-pregnant-women_UP	NA	2914924	134821	43771	1261
bsdb:1055/6/1_Vesicle-membrane:Feces-derived-extracellular-vesicles-(FE-EV)_vs_Maternal-feces-(FE)_UP	NA	290054	707003
bsdb:1056/2/1_Microbiome-measurement:Fecal-occult-blood-test-[FOBT]-cards---Day-0_vs_RNAlater---Day-0_UP	NA	1972561	2137877	39488	39496	39497	438033	33038	33039	707003	290054
bsdb:1056/2/2_Microbiome-measurement:Fecal-occult-blood-test-[FOBT]-cards---Day-0_vs_RNAlater---Day-0_DOWN	NA	256318	749906	370804	297314	39485	42322	707003
bsdb:1056/3/1_Microbiome-measurement:Scope-mouthwash---Day-4_vs_Scope-mouthwash---Day-0_UP	NA	707003
bsdb:1056/4/1_Microbiome-measurement:Scope-mouthwash_vs_OMNIgene-ORAL-kit_UP	NA	707003	1293577
bsdb:1056/4/2_Microbiome-measurement:Scope-mouthwash_vs_OMNIgene-ORAL-kit_DOWN	NA	35517	35518
bsdb:1058/1/1_Coronary-artery-disease:Patient-with-coronary-artery-disease_vs_Healthy-controls_UP	NA	1655	1720200	2109688	74426	308994	2109691	281920	102148	877420	39488
bsdb:1058/1/2_Coronary-artery-disease:Patient-with-coronary-artery-disease_vs_Healthy-controls_DOWN	NA	1736	46503
bsdb:1059/1/1_Diet:Participants-after-the-AWE-diet---D21_vs_Participants-before-the-AWE-diet---D0_UP	NA	818	371601	255248
bsdb:1059/1/2_Diet:Participants-after-the-AWE-diet---D21_vs_Participants-before-the-AWE-diet---D0_DOWN	NA	1105171	147207	1115758	1583
bsdb:1060/1/1_Population:Kwepe_vs_Kuvale_UP	NA	158877
bsdb:1060/1/2_Population:Kwepe_vs_Kuvale_DOWN	NA	545
bsdb:1060/2/1_Population:Himba_vs_Kuvale_UP	NA	1591	1750
bsdb:1060/2/2_Population:Himba_vs_Kuvale_DOWN	NA	546	545	599	158484
bsdb:1060/3/1_Population:Tjimba_vs_Kuvale_UP	NA	638849	133448
bsdb:1060/3/2_Population:Tjimba_vs_Kuvale_DOWN	NA	158484	546	1639133	1873498
bsdb:1060/4/1_Population:Kwisi_vs_Kuvale_UP	NA	133448	31973
bsdb:1060/4/2_Population:Kwisi_vs_Kuvale_DOWN	NA	158484	1639133	545	1896336
bsdb:1060/5/1_Population:Twa_vs_Kuvale_UP	NA	133448	31973	42895	562	143361	571	573	576	1383	306	599	616	158877
bsdb:1060/5/2_Population:Twa_vs_Kuvale_DOWN	NA	860	84135	454154	322095	1924944
bsdb:1060/6/1_Population:Tshwa_vs_Kuvale_UP	NA	194702	43997	133448	43768	31973	42895	562	143361	851	1873498	43995	505	571	573	576	1904861	306	599	158877	51123	652708	796937
bsdb:1060/6/2_Population:Tshwa_vs_Kuvale_DOWN	NA	55565	1078480	504	72	2049030
bsdb:1060/7/1_Population:!Xun_vs_Kuvale_UP	NA	133448	31973
bsdb:1060/7/2_Population:!Xun_vs_Kuvale_DOWN	NA	46125	546	1496	84135	736	76631
bsdb:1060/8/1_Population:Himba_vs_Kwepe_DOWN	NA	158484	546	573	576	1898203	599	158877
bsdb:1060/8/2_Population:Himba_vs_Kwepe_UP	NA	1591	1305	1750
bsdb:1060/9/1_Population:Tjimba_vs_Kwepe_UP	NA	133448
bsdb:1060/9/2_Population:Tjimba_vs_Kwepe_DOWN	NA	546	1873498	1639133
bsdb:1060/10/1_Population:Kwisi_vs_Kwepe_UP	NA	133448	479
bsdb:1060/10/2_Population:Kwisi_vs_Kwepe_DOWN	NA	29317	158484	1639133	1896336	1898203	1318	158877
bsdb:1060/11/1_Population:Twa_vs_Kwepe_UP	NA	42895	545	133448
bsdb:1060/12/1_Population:Tshwa_vs_Kwepe_UP	NA	545	133448	42895	562	851	137732	505	571	306	599	1313	257758	39498
bsdb:1060/12/2_Population:Tshwa_vs_Kwepe_DOWN	NA	55565	29317	504	1898203	1660
bsdb:1060/13/1_Population:!Xun_vs_Kwepe_UP	NA	133448
bsdb:1060/13/2_Population:!Xun_vs_Kwepe_DOWN	NA	546	1496	84135	573	33033	1885016
bsdb:1060/14/1_Population:Tjimba_vs_Himba_UP	NA	599
bsdb:1060/14/2_Population:Tjimba_vs_Himba_DOWN	NA	1873498
bsdb:1060/15/1_Population:Kwisi_vs_Himba_UP	NA	546	599	53418	573	133448
bsdb:1060/15/2_Population:Kwisi_vs_Himba_DOWN	NA	1639133	1896336
bsdb:1060/16/1_Population:Twa_vs_Himba_UP	NA	546	599	42895	158484	158877	133448	576	545	571	573	562
bsdb:1060/16/2_Population:Twa_vs_Himba_DOWN	NA	454154
bsdb:1060/17/1_Population:Tshwa_vs_Himba_UP	NA	1873498	1884818
bsdb:1060/17/2_Population:Tshwa_vs_Himba_DOWN	NA	55565	1750	1591
bsdb:1060/18/1_Population:!Xun_vs_Himba_UP	NA	1639133	1896336
bsdb:1060/18/2_Population:!Xun_vs_Himba_DOWN	NA	76631	1017	546	1496	1720	562	1379	84135	735	35517	1409
bsdb:1060/19/1_Population:Tshwa_vs_Twa_UP	NA	851	39498
bsdb:1060/19/2_Population:Tshwa_vs_Twa_DOWN	NA	72	55565
bsdb:1060/20/1_Population:!Xun_vs_Twa_DOWN	NA	158484	546	545	1720	42895	35783	571	573	576	52768	616	158877
bsdb:1060/21/1_Population:!Xun_vs_Tshwa_UP	NA	55565	504	72
bsdb:1060/21/2_Population:!Xun_vs_Tshwa_DOWN	NA	546	35783	571	576	562	172042	573	545	1496	1720	84135	599	158877	1304	158484	1379	851	47671	505	42895	33033
bsdb:1060/22/1_Population:Kwisi_vs_Tjimba_UP	NA	546	1873498
bsdb:1060/22/2_Population:Kwisi_vs_Tjimba_UP	NA	638849
bsdb:1060/23/1_Population:Twa_vs_Tjimba_UP	NA	158877	546	545	1639133	1896336	576	42895	571	158484	562	573
bsdb:1060/24/1_Population:Tshwa_vs_Tjimba_UP	NA	599	42895	505	562	573	158877	545	158484	1896336	546	571	576	1639133	1873498
bsdb:1060/24/2_Population:Tshwa_vs_Tjimba_UP	NA	55565
bsdb:1060/25/1_Population:!Xun_vs_Tjimba_UP	NA	1873498
bsdb:1060/26/1_Population:Twa_vs_Kwisi_UP	NA	158484	1639133	42895	158877	1896336	545	571
bsdb:1060/26/2_Population:Twa_vs_Kwisi_DOWN	NA	479	1017
bsdb:1060/27/1_Population:Tshwa_vs_Kwisi_UP	NA	158484	546	545	1639133	1896336	158877	42895	571	851	505	599	39498
bsdb:1060/27/2_Population:Tshwa_vs_Kwisi_DOWN	NA	1017	479	504	72
bsdb:1060/28/1_Population:!Xun_vs_Kwisi_UP	NA	1639133	1896336
bsdb:1060/28/2_Population:!Xun_vs_Kwisi_DOWN	NA	76631	1017	546	1496	1720	562	1379	84135	735	35517	1409
bsdb:1060/29/1_Socioeconomic-status:Foragers_vs_Pastoralists_UP	NA	133448	1685	31973	42895
bsdb:1060/29/2_Socioeconomic-status:Foragers_vs_Pastoralists_DOWN	NA	46125	76631	158484	1885016	546	1496	1720	35783	84135	2049028	43675	1304	1409	52768
bsdb:1060/30/1_Socioeconomic-status:Peripatetics_vs_Pastoralists_UP	NA	1873498	42895	158836	69218	306	31973	229037	133448	546	1639133	571	573	576	562	599	1134687	157688	43768
bsdb:1060/31/1_Socioeconomic-status:Foragers_vs_Peripatetics_UP	NA	1685
bsdb:1060/31/2_Socioeconomic-status:Foragers_vs_Peripatetics_DOWN	NA	46125	76631	1409	158484	546	545	1496	1720	69218	158836	35783	562	1379	84135	1134687	571	573	576	47671	43675	599	35517	52768	1885016
bsdb:1061/1/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)_vs_Cognitively-normal-(CN)-and-amnestic-mild-cognitive-impairment-(aMCI)_UP	NA	29466	851	28129	28132	1309	824	1303	156456	1328	56981	2117	187326	28136	48296	796942	1383	1382	59892	135080	1304
bsdb:1061/2/1_Alzheimer's-disease:Amnestic-mild-cognitive-impairment-(aMCI)_vs_Cognitively-normal-(CN)-and-Alzheimer’s-Disease-(AD)_UP	NA	495	2047	1018	329	61592	502	43675	1318	726	88688
bsdb:1061/3/1_Alzheimer's-disease:Alzheimer’s-Disease-(AD)-and-Amnestic-mild-cognitive-impairment-(aMCI)_vs_Cognitively-normal-(CN)_DOWN	NA	562	28449	729	40542	334542	1305	1750	204	1019	1547448	461393	1585976	43997	43995	157692
bsdb:1062/2/1_Gut-microbiome-measurement:Yes---antibiotics_vs_No---antibiotics_DOWN	NA	33033	158847
bsdb:1063/1/2_Oral-lichen-planus:Oral-lichen-planus-(both-erosive-and-non-erosive-)_vs_Healthy-Control_DOWN	NA	707003
bsdb:1065/1/1_Breast-cancer:pre-menopausal-breast-cancer-(BC)-patients_vs_pre-menopausal-controls_UP	NA	745368	1232426
bsdb:1065/2/1_Breast-cancer:post-menopausal-BC-patients_vs_post-menopausal-controls_UP	NA	147207
bsdb:1065/2/2_Breast-cancer:post-menopausal-BC-patients_vs_post-menopausal-controls_DOWN	NA	818	40520	1099853	823	33025
bsdb:1066/1/1_Polycystic-ovary-syndrome:Polycystic-ovary-syndrome-(PCOS)-patients_vs_Healthy-Controls_UP	NA	5353	4932
bsdb:1066/1/2_Polycystic-ovary-syndrome:Polycystic-ovary-syndrome-(PCOS)-patients_vs_Healthy-Controls_DOWN	NA	3072159
bsdb:1067/1/1_Acquired-primary-ovarian-failure:Primary-ovarian-failure-(POF)_vs_Healthy-controls_UP	NA	1940338
bsdb:1070/4/1_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_UP	NA	91928	5341	4944	1209926	209285
bsdb:1070/4/2_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_DOWN	NA	109264	203908	796027	1047171
bsdb:1070/5/1_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_UP	NA	63402	27337	1681229	453459	1708541	398673
bsdb:1070/5/2_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_DOWN	NA	5599	38033	5207	36779	393283	220672	4944	4924	4950
bsdb:1070/6/1_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_UP	NA	33178	109760	4950	80884	51453	460519	41061	746128	29875
bsdb:1070/6/2_Hypertension:Hypertension-(HTN)_vs_no-Hypertension-(no-HTN)_DOWN	NA	128442	80637
bsdb:1072/1/1_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_UP	NA	877406	438033	877420	33039	33038	77133
bsdb:1072/1/2_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV--MASLD+_DOWN	NA	1262798	1940338	39488
bsdb:1072/2/1_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV+-MASLD-_UP	NA	877406	438033	877420	33039	33038	77133
bsdb:1072/2/2_Non-alcoholic-fatty-liver-disease:HIV+-MASLD+_vs_HIV+-MASLD-_DOWN	NA	59823	1486938
bsdb:1072/3/1_Non-alcoholic-fatty-liver-disease:HIV--MASLD+_vs_HIV+-MASLD-_UP	NA	1262798	1940338	39488
bsdb:1072/3/2_Non-alcoholic-fatty-liver-disease:HIV--MASLD+_vs_HIV+-MASLD-_DOWN	NA	59823	1486938
bsdb:1073/6/1_Bacterial-disease:Diseased-sea-urchins_vs_Recovered-sea-urchins_UP	NA	329993	28229	55212	45248	1109740	168275
bsdb:1073/6/2_Bacterial-disease:Diseased-sea-urchins_vs_Recovered-sea-urchins_DOWN	NA	145373	174037	1381081	644221	454147	1088740	1323746
bsdb:1073/8/1_Bacterial-disease:Recovered-sea-urchins_vs_Healthy-sea-urchins_UP	NA	145373	174037	1381081	644221	454147	1323746
bsdb:1073/8/2_Bacterial-disease:Recovered-sea-urchins_vs_Healthy-sea-urchins_DOWN	NA	479650	1954466	151	1420917	335972	1486246	135626	50058	659824
bsdb:1074/12/1_Response-to-antiviral-drug:patients-with-HCV-monoinfection-at-baseline_vs_healthy-control_DOWN	NA	877420	331630
bsdb:1076/1/1_Allergic-rhinitis:Allergic-rhinitis-(AR)_vs_healthy-controls-(HC)_UP	NA	1211
bsdb:1077/10/2_Gut-microbiome-measurement:JAX-CH-fecal-pellets-group_vs_JAX-CH-colon-group_DOWN	NA	41978
bsdb:1077/11/2_Gut-microbiome-measurement:TAC-CH-fecal-pellets-group_vs_TAC-CH-colon-group_DOWN	NA	41978
bsdb:1077/12/2_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_DOWN	NA	49118
bsdb:1077/16/2_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_DOWN	NA	49118
bsdb:1077/19/2_Gut-microbiome-measurement:F1-mJAX-group_vs_F1-mTAC-group_DOWN	NA	49118
bsdb:1077/20/2_Gut-microbiome-measurement:P1-JAX-group_vs_P1-TAC-group_DOWN	NA	49118
bsdb:1078/1/1_High-fat-diet:Stachyose-treated-High-Fat-Diet-fed-Mice-(STA)_vs_High-Fat-Diet-fed-Mice-(HFD)_UP	NA	147206	2834459	2779519	2003188	604330
bsdb:1078/1/2_High-fat-diet:Stachyose-treated-High-Fat-Diet-fed-Mice-(STA)_vs_High-Fat-Diet-fed-Mice-(HFD)_DOWN	NA	1499973
bsdb:1079/4/2_Esophageal-adenocarcinoma:Cluster-2_vs_Cluster-1_DOWN	NA	729	43675
bsdb:1079/5/1_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-1_UP	NA	470565	60133	28137
bsdb:1079/5/2_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-1_DOWN	NA	729	43675
bsdb:1079/6/1_Esophageal-adenocarcinoma:Cluster-3_vs_Cluster-2_UP	NA	470565	60133	28137
bsdb:1079/7/2_Gastroesophageal-reflux-disease:GERD-(Gastroesophageal-reflux-disease)_vs_Normal-(Normal-esophagus)_DOWN	NA	1940338
bsdb:1079/8/2_Gastroesophageal-reflux-disease:Gastroesophageal-reflux-disease-GERD(within-subjects-classified-as-PPI-NO)_vs_Normal_DOWN	NA	1940338
bsdb:1079/13/1_Gastroesophageal-reflux-disease:GERD-(Gastroesophageal-reflux-disease)_vs_Normal-(Normal-esophagus)_UP	NA	28131	189723	496	487	729	58231
bsdb:1079/14/1_Gastroesophageal-reflux-disease:GERD-(Gastroesophageal-reflux-disease)within-subjects-classified-as-PPI-NO_vs_Normal-(Normal-esophagus)_UP	NA	487
bsdb:1079/14/2_Gastroesophageal-reflux-disease:GERD-(Gastroesophageal-reflux-disease)within-subjects-classified-as-PPI-NO_vs_Normal-(Normal-esophagus)_DOWN	NA	187326	60133
bsdb:1079/15/1_Barrett's-esophagus:Barrett’s-Esophagus-(BE)_vs_Normal_UP	NA	1305	671229
bsdb:1079/16/1_Esophageal-adenocarcinoma:Glandular-mucosa-(GM)_vs_Normal_UP	NA	46125	156456	712258	31973	859	210	28134	483	484	282402	113107	1302	53419
bsdb:1079/17/1_Esophageal-adenocarcinoma:Glandular-mucosa-(GM)_vs_GERD(Gastroesophageal-reflux-disease)_UP	NA	46125	732	31973	859	210	28134	483	837	135083	1302
bsdb:1079/21/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-1)_vs_Normal-(Cluster-1)_UP	NA	76122
bsdb:1079/22/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-2)_vs_Normal-(Cluster-2)_UP	NA	157687	28129	28133	43675	28135	1304	1343	56774
bsdb:1079/22/2_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-2)_vs_Normal-(Cluster-2)_DOWN	NA	735
bsdb:1079/23/1_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-3)_vs_Normal-(Cluster-3)_UP	NA	729	496	487	58231
bsdb:1079/23/2_Gastroesophageal-reflux-disease:GERD(Gastroesophageal-reflux-disease)-(Cluster-3)_vs_Normal-(Cluster-3)_DOWN	NA	1382
bsdb:1079/24/1_Esophageal-adenocarcinoma:Subjects-with-normal-esophagus-on-PPI-Yes_vs_Subjects-with-normal-esophagus-on-PPI-No_UP	NA	52227	1343
bsdb:1079/24/2_Esophageal-adenocarcinoma:Subjects-with-normal-esophagus-on-PPI-Yes_vs_Subjects-with-normal-esophagus-on-PPI-No_DOWN	NA	727	228604
bsdb:1079/25/1_Esophageal-adenocarcinoma:Subjects-with-GERD-on-PPI-Yes_vs_Subjects-with-GERD-on-PPI-No_UP	NA	55565	470565	60133	228604	29391	76860	796942	187326
bsdb:1079/25/2_Esophageal-adenocarcinoma:Subjects-with-GERD-on-PPI-Yes_vs_Subjects-with-GERD-on-PPI-No_DOWN	NA	487
bsdb:1080/1/2_Lower-respiratory-tract-disease:Chronic-Otitis-Media-With-Effusion-(COME)-with-asthma-or-bronchiolitis_vs_Chronic-Otitis-Media-With-Effusion-(COME)-without-asthma-or-bronchiolitis_DOWN	NA	1652	29321
bsdb:1083/2/2_Age:B-Group-(B45.2)_vs_B-Group-(B15.2))_DOWN	NA	56767
bsdb:1084/1/2_Recalcitrant-atopic-dermatitis:mild-atopic-dermatitis-(AD)_vs_healthy-controls_DOWN	NA	40215	61592	1270
bsdb:1085/2/1_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_UP	NA	41200
bsdb:1085/2/2_Gut-microbiome-measurement:High-Bifidobacterium-group_vs_Low-Bifidobacterium-group_DOWN	NA	1689	1869337
bsdb:1087/1/4_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_control-individuals-without-a-psychiatric-diagnosis-(past-or-present)_UP	NA	169435	33035	84112	562	1335613	1096246
bsdb:1087/1/5_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_control-individuals-without-a-psychiatric-diagnosis-(past-or-present)_DOWN	NA	1776391
bsdb:1087/3/1_Treatment-refractory-schizophrenia:TRS:-individuals-with-treatment-resistant-schizophrenia-taking-clozapine_vs_AAP:-individuals-with-treatment-responsive-schizophrenia-taking-atypical-antipsychotics-(not-clozapine)_UP	NA	84112	1432052	1096246	1550024
bsdb:1087/4/1_Treatment-refractory-schizophrenia:TRS:-individuals-with-treatment-resistant-schizophrenia-taking-clozapine_vs_control-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_UP	NA	169435	84112	562	1335613	1096246	1550024
bsdb:1087/4/2_Treatment-refractory-schizophrenia:TRS:-individuals-with-treatment-resistant-schizophrenia-taking-clozapine_vs_control-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_DOWN	NA	1776391
bsdb:1087/5/1_Response-to-clozapine:CR:-individuals-with-treatment-resistant-schizophrenia-responsive-to-clozapine_vs_control-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_UP	NA	84112	1096246
bsdb:1087/5/2_Response-to-clozapine:CR:-individuals-with-treatment-resistant-schizophrenia-responsive-to-clozapine_vs_control-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_DOWN	NA	1776391
bsdb:1087/6/1_Treatment-refractory-schizophrenia:CNR:-individuals-with-treatment-resistant-schizophrenia-nonresponsive-to-clozapine_vs_control-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_UP	NA	1550024
bsdb:1087/6/2_Treatment-refractory-schizophrenia:CNR:-individuals-with-treatment-resistant-schizophrenia-nonresponsive-to-clozapine_vs_control-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_DOWN	NA	1776391
bsdb:1091/1/1_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_UP	NA	47678	1689	116085	1613	97478	823	1328
bsdb:1091/1/2_Chronic-gastritis,Gastric-cancer:Gastric-Cancer_vs_Chronic-gastritis_DOWN	NA	216816	1352	1898203
bsdb:1091/4/1_Chronic-gastritis,Gastric-cancer:Intestinal-metaplasia_vs_Other-sub-groups-(NIM,-early-stage-gastric-cancer-and-late-stage-gastric-cancer))_UP	NA	39491
bsdb:1093/1/1_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_UP	NA	352152	40545	419015	246787	818	200448	256318	459526	1283315	159272	408170	292800	278064	907
bsdb:1093/1/2_Schizophrenia:SCZ:-individuals-with-a-psychiatric-diagnosis-of-schizophrenia_vs_HC:-individuals-without-a-psychiatric-diagnosis-of-schizophrenia_DOWN	NA	28117	28111	1516129	147206	290054	39496	84135	729	877420	28118	204516	54291	3068309	3062497	1304	163602	175646	33039	200446	286138	331630	316089	374604	1586779	297314	220137	707003	1757166	129703	165186
bsdb:1094/2/1_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_UP	NA	1470347	1262803	35787	1987501	158847	491921	907	2049047	1262952
bsdb:1094/2/2_Schizophrenia:SZ:-patients-with-schizophrenia_vs_NC:-normal-controls_DOWN	NA	384639	1262739	1737424	116085	410072	2292353	2652276	39485	28052	2049031	2293144	2763670
bsdb:1096/1/1_Gut-microbiome-measurement:Infants_vs_Mothers_UP	NA	41978
bsdb:1096/1/2_Gut-microbiome-measurement:Infants_vs_Mothers_DOWN	NA	1940338
bsdb:1096/2/2_Gut-microbiome-measurement:Infants_vs_Grandmothers_DOWN	NA	1940338
bsdb:1096/3/1_Gut-microbiome-measurement:Infants_vs_Mothers_UP	NA	446660	394340	1628085	2048138	1288121	328814	1924094	169435	1871018	1879010	338188	46506	1737424	673271	2044939	1898204	1650661	1955814	1034346	88431	2040332	853	290055	2049025	1918624	1673721	1987501	28118	1945593	2485925	106588	301302	360807	2049040	3062497	40519	1313	1306	214851	39777	1110546	29361
bsdb:1096/3/2_Gut-microbiome-measurement:Infants_vs_Mothers_DOWN	NA	2585118	1681	1685	216816	3062437	536633	1898207	410072	2591382	562	39490	142586	61171	1468449	39485	2021453	2316025	2049035	28037
bsdb:1096/4/1_Gut-microbiome-measurement:Infants_vs_Grandmothers_UP	NA	446660	394340	2585119	328813	1288121	328814	1924094	1871018	1879010	2044939	1898204	1898207	1650661	410072	2040332	853	290055	2049025	1918624	1702285	2028282	2049035	1945593	33025	2049046	106588	1776391	360807	2049040	40518	40519	1313	1306	214851	39777	1110546	29361
bsdb:1096/4/2_Gut-microbiome-measurement:Infants_vs_Grandmothers_DOWN	NA	28117	1681	1685	216816	2591382	1972561	562	1150298	2021453	2053569	2316025	28118
bsdb:1099/6/1_Response-to-risperidone:Schizophrenia-(SCH)-patients-at-Week-24-(S3)_vs_Schizophrenia-(SCH)-patients-at-Baseline-(S0)_UP	NA	2683682	1519439	1897037
bsdb:1100/1/1_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_UP	NA	39485	310298	821	301302	165179
bsdb:1100/1/2_Autism-spectrum-disorder:Autistic_vs_Healthy-controls_DOWN	NA	239935	817	218538	562	292800	729	1532
bsdb:1102/5/1_Alzheimer's-disease:APP/PS1_vs_Wild-type-(WT)_UP	NA	2049043
bsdb:1103/3/1_Dry-eye-syndrome:Moderate-to-severe-dry-eye_vs_mild-dry-eye_UP	NA	68895
bsdb:1105/1/1_Physical-activity:Professional-football-players_vs_Amateurs_UP	NA	824	43768	285729	157691	2047	135083	1305	29466	1110546
bsdb:1105/1/2_Physical-activity:Professional-football-players_vs_Amateurs_DOWN	NA	470565	28132	55565	1078480	1660
bsdb:1105/2/1_Physical-activity:Professional-football-players_vs_Amateurs_UP	NA	418240	1735	592978	1776382	387661	33025	1304	46228
bsdb:1105/2/2_Physical-activity:Professional-football-players_vs_Amateurs_DOWN	NA	1680	216816	487173	1898203	310298	387090	360807
bsdb:1105/4/2_Physical-activity:Professional-football-players-after-intensive-training_vs_Professional-football-players-before-intensive-training_DOWN	NA	33053
bsdb:1107/2/1_HIV-mother-to-child-transmission:Exclusively-breastfed-(EBF)-infants_vs_Non-exclusively-breastfed-(NEBF)-infants_UP	NA	684066
bsdb:1108/3/1_HIV-infection:HIV---infected_vs_HIV---uninfected_UP	NA	39485
bsdb:1108/4/1_HIV-infection:HIV---infected_vs_HIV---uninfected_UP	NA	39485
bsdb:1109/1/1_Autoimmune-type-1-diabetes:autoimmune-type-1-diabetes_vs_healthy-control_UP	NA	40518	165179
bsdb:1110/1/1_Acute-pancreatitis:Acute-Pancreatitis-(AP)_vs_Control-group_UP	NA	1694	1834205
bsdb:1110/2/1_Acute-pancreatitis:Caeurulein-group_vs_Control-group_UP	NA	47678	2715212	28116	818	1834205	2093856	2530390	1796646	357276	821	2606626
bsdb:1110/2/2_Acute-pancreatitis:Caeurulein-group_vs_Control-group_DOWN	NA	301301	2610895	2086584	166486	1496	2109688	33035	1834196	853	1871021	2109691	292800	29347	208479
bsdb:1110/3/1_Acute-pancreatitis:Caeurulein+LPS-group_vs_Control-group_UP	NA	1834205	2093856	562	2530390	1796646	823	821
bsdb:1110/3/2_Acute-pancreatitis:Caeurulein+LPS-group_vs_Control-group_DOWN	NA	2364787	328813	2585118	214856	2585119	2518971
bsdb:1110/4/1_Acute-pancreatitis:L-arginine-group_vs_Control-group_UP	NA	1834205	1596	33959	1622
bsdb:1110/4/2_Acute-pancreatitis:L-arginine-group_vs_Control-group_DOWN	NA	1496	2109688	33035	2610895	853	1871021	2109691	292800	29347	214856	2585118	208479	2364787	328813	2585119	328814	2715212
bsdb:1111/4/1_Relapsing-remitting-multiple-sclerosis:Multiple-Sclerosis-(MS)_vs_Healthy-Controls_UP	NA	446660	328813	214853	169435	33035	1226325	218538	84112	333367	208479	358743	1531	457422	469614	562	457402	2702	471189	386414	154046	261299	658086	658085	1358	33038	1261	28123	281920	28125	28130	457412	1309	665956	1547	1522	1535	84026	29361	1512
bsdb:1111/4/2_Relapsing-remitting-multiple-sclerosis:Multiple-Sclerosis-(MS)_vs_Healthy-Controls_DOWN	NA	469610	729	1288121	371601	28118	487174
bsdb:1115/1/1_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_UP	NA	1502	1522	297314	77133	155900
bsdb:1115/1/2_Ischemic-stroke:Patients-with-stroke-associated-pneumonia-(SAP)_vs_Patients-without-stroke-associated-pneumonia-(non-SAP)_DOWN	NA	136624	155900
bsdb:1118/1/1_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_UP	NA	1940338	33038
bsdb:1118/1/2_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_DOWN	NA	39488	2049024	290054	42322	39496	39485	877420	3068309	41978	39491
bsdb:1118/2/1_HIV-infection:immunological-non-responders-(INR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_UP	NA	3068309	33038
bsdb:1118/2/6_HIV-infection:immunological-non-responders-(INR)-HIV-infected-individual_vs_Healthy-HIV-negative-individual_DOWN	NA	39491	39488	2054177	116085	290054	42322	39496	1235800	877420	28125	3068309	1264
bsdb:1118/3/1_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_immunological-non-responders-(INR)-HIV-infected-individual_UP	NA	1940338
bsdb:1118/3/2_HIV-infection:Immunological-Responder-(IR)-HIV-infected-individual_vs_immunological-non-responders-(INR)-HIV-infected-individual_DOWN	NA	42322	2053608
bsdb:1124/1/1_Vaginal-microbiome-measurement:Main-group---CG,-Caucasian-German-women_vs_Combination-of-groups---AA,-AC,-AI-and-AK-women_UP	NA	1685	2702	502393	419005	187328
bsdb:1124/2/1_Vaginal-microbiome-measurement:AK,-African-Kenyan-women_vs_Combination-of-groups---AA,-AC,-AI-and-CG-women_UP	NA	598660
bsdb:1124/3/1_Vaginal-microbiome-measurement:AI,-Asian-Indonesian-women_vs_Combination-of-groups---AA,-AC,-AK-and-CG-women_UP	NA	1596	1328	216816	1304
bsdb:1124/4/1_Vaginal-microbiome-measurement:AC,-Afro-Caribbean-women_vs_Combination-of-groups---AA,-AI,-AK-and-CG-women_DOWN	NA	28127	28125	33037	33031
bsdb:1124/5/1_Vaginal-microbiome-measurement:AA,-African-American-women_vs_Combination-of-groups---AK,-AI,-CG-and-AC-women_UP	NA	47770
bsdb:1125/2/1_Glucose-metabolism-measurement:African-citizens_vs_Han-Chinese-citizens_DOWN	NA	28116	46506	1720194	487175	33025	310298	387090	204516
bsdb:1125/2/2_Glucose-metabolism-measurement:African-citizens_vs_Han-Chinese-citizens_UP	NA	239935	1680	1828554	74426	410072	88431	1852381	45851	290054	1703337	1735	363265	1852369	1816687	1519439	626940	83771	39778
bsdb:1126/1/1_Cutaneous-T-cell-lymphoma:Mycosis-fungoides(-ΔSA-positive)_vs_Healthy-control(-ΔSA-neutral-subgroup)_UP	NA	1280
bsdb:1126/1/2_Cutaneous-T-cell-lymphoma:Mycosis-fungoides(-ΔSA-positive)_vs_Healthy-control(-ΔSA-neutral-subgroup)_DOWN	NA	1282	1290	1747
bsdb:1130/1/1_Diarrhea:Diarrhea_vs_healthy-controls_UP	NA	1884818	729	39778
bsdb:1130/1/2_Diarrhea:Diarrhea_vs_healthy-controls_DOWN	NA	817	487173	853	745368	165179	83771	1623
bsdb:1130/2/1_Diarrhea:Acute-Diarrhea_vs_Healthy-Controls_UP	NA	1884818	729	39778
bsdb:1130/2/2_Diarrhea:Acute-Diarrhea_vs_Healthy-Controls_DOWN	NA	817	487173	853	745368	165179	83771
bsdb:1130/3/1_Diarrhea:Prolonged-or-Persistent-Diarrhea_vs_Healthy-Controls_UP	NA	1884818	97478	39778	33038
bsdb:1130/3/2_Diarrhea:Prolonged-or-Persistent-Diarrhea_vs_Healthy-Controls_DOWN	NA	817	487173	853	745368	360807	649756	363265
bsdb:1130/4/2_Diarrhea:Prolonged-or-Persistent-Diarrhea_vs_Acute-Diarrhea_DOWN	NA	853	649756
bsdb:1131/1/1_Multiple-sclerosis:Multiple-sclerosis-(MS),_vs_Healthy-subjects-(controls)_UP	NA	1308	84112	1304
bsdb:1131/1/2_Multiple-sclerosis:Multiple-sclerosis-(MS),_vs_Healthy-subjects-(controls)_DOWN	NA	39491	649756	46506	498621	1506	320882	354438	381849	853	28052	437897	310298	387090	1227508	165179	40545	706562	105839	245010
bsdb:1131/2/1_Multiple-sclerosis:Multiple-sclerosis-(MS),_vs_Healthy-subjects-(controls)_UP	NA	1308	84112	1304
bsdb:1131/2/2_Multiple-sclerosis:Multiple-sclerosis-(MS),_vs_Healthy-subjects-(controls)_DOWN	NA	39491	649756	46506	498621	1506	354438	381849	853	28052	437897	310298	387090	1227508	165179	40545	706562	105839	245010	320882
bsdb:1132/2/1_Type-II-diabetes-mellitus:T2DM-individuals-(subjects-with-Type-2-Diabetes)_vs_Non-T2DM-controls-(healthy-individuals)_UP	NA	55194
bsdb:1139/1/1_Gut-microbiome-measurement:Prebiotic-group_vs_Placebo-group_UP	NA	216816
bsdb:1139/1/2_Gut-microbiome-measurement:Prebiotic-group_vs_Placebo-group_DOWN	NA	2897707
bsdb:1139/2/1_NA:Prebiotic_vs_Placebo_DOWN	NA	33039	2897707
bsdb:1139/2/2_NA:Prebiotic_vs_Placebo_DOWN	NA	33039	2897707
bsdb:1139/2/3_NA:Prebiotic_vs_Placebo_UP	NA	216816
bsdb:1139/3/1_Fructose,Gut-microbiome-measurement:Prebiotic_vs_Placebo_UP	NA	216816
bsdb:1139/3/2_Fructose,Gut-microbiome-measurement:Prebiotic_vs_Placebo_DOWN	NA	2897707	33039
bsdb:1139/4/1_Gut-microbiome-measurement,Fructose:Prebiotic_vs_Placebo_UP	NA	239935	216816
bsdb:1139/4/2_Gut-microbiome-measurement,Fructose:Prebiotic_vs_Placebo_DOWN	NA	2897707	33039
bsdb:1141/1/2_Postnatal-growth-retardation:Colostrum-deprived-mice_vs_Control_DOWN	NA	290055
bsdb:1142/1/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Control_UP	NA	272548	156456	1018	194702	218538	29374	29391	137732	33033	28131	189723	28133	76860	178339	82987	1117645
bsdb:1142/1/2_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Control_DOWN	NA	82203	28136	840	467210
bsdb:1142/2/1_Hypertrophy:Adenotonsillar-hypertrophy-(ATH)_vs_Control_UP	NA	228604
bsdb:1142/2/2_Hypertrophy:Adenotonsillar-hypertrophy-(ATH)_vs_Control_DOWN	NA	82203	28136	840	467210
bsdb:1142/5/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Adenotonsillar-hypertrophy-(ATH)_UP	NA	137732	29391	33033	28131	218538	29374	1018	76860	178339	156456	28133	82987	189723	272548	194702	1117645
bsdb:1142/5/2_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Adenotonsillar-hypertrophy-(ATH)_DOWN	NA	228604
bsdb:1142/6/1_Hypertrophy:Tonsillar-hypertrophy-(TH)_vs_Adenoid-hypertrophy-(AH)_UP	NA	137732	29391	33033	28131	218538	29374	1018	76860	178339	156456	28133	82987	189723	272548	194702	1117645
bsdb:1143/1/1_Stroke:Post-Stroke-Patients_vs_Healthy-Control_UP	NA	38145
bsdb:1143/2/2_Stroke:Post-Stroke-Patients_vs_Healthy-Control_DOWN	NA	1869227
bsdb:1148/2/1_Eating-behaviour:High-feed-intake_vs_Low-feed-intake_UP	NA	47678	691816
bsdb:1151/1/1_Lactose-intolerance:Participants-with-Lactose-Intolerance(LI)_vs_Participants-without-Lactose-Intolerance(Non-LI)_UP	NA	2202144
bsdb:1151/1/2_Lactose-intolerance:Participants-with-Lactose-Intolerance(LI)_vs_Participants-without-Lactose-Intolerance(Non-LI)_DOWN	NA	2590211
bsdb:1151/2/1_Lactose-intolerance:Participants-with-Lactose-Intolerance(LI)_vs_Healthy-controls-(HC)_UP	NA	817	158836	562	1263017	2293114	2293146	1262952	28901
bsdb:1151/2/2_Lactose-intolerance:Participants-with-Lactose-Intolerance(LI)_vs_Healthy-controls-(HC)_DOWN	NA	2293014	142586	1262898	39485	165186
bsdb:1151/3/1_Lactose-intolerance:FMT-Lactose-Intolerance-group_vs_FMT-Healthy-Controls-group_UP	NA	1940338
bsdb:1151/3/2_Lactose-intolerance:FMT-Lactose-Intolerance-group_vs_FMT-Healthy-Controls-group_DOWN	NA	39488
bsdb:1151/4/1_Lactose-intolerance:Participants-with-Lactose-intolerance-(LI)_vs_Healthy-Controls_UP	NA	817	2161821	562	623	1304
bsdb:1151/4/2_Lactose-intolerance:Participants-with-Lactose-intolerance-(LI)_vs_Healthy-Controls_DOWN	NA	142586
bsdb:1156/1/1_Age,Erythrocyte-indices,Growth-protocol,Hemoglobin-A2-measurement,Abnormal-result-of-function-studies:Exposed_vs_Unexposed_UP	NA	1409
bsdb:1156/1/2_Age,Erythrocyte-indices,Growth-protocol,Hemoglobin-A2-measurement,Abnormal-result-of-function-studies:Exposed_vs_Unexposed_UP	NA	1409
bsdb:1161/1/1_Schistosomiasis:Schistosomiasis-positive_vs_Schistosomiasis-negative_UP	NA	331632
bsdb:1161/1/2_Schistosomiasis:Schistosomiasis-positive_vs_Schistosomiasis-negative_DOWN	NA	331630	220137	658143	136703
bsdb:1166/1/2_Diarrhea,Diarrhea,-Infantile,Malnutrition:Infants-who-are-breast-fed_vs_Infants-who-are-not-breast-fed_UP	NA	216816
bsdb:1166/1/3_Diarrhea,Diarrhea,-Infantile,Malnutrition:Infants-who-are-breast-fed_vs_Infants-who-are-not-breast-fed_DOWN	NA	573
bsdb:1166/2/3_Diarrhea,Diarrhea,-Infantile,Malnutrition:Infants-with-diarrhea_vs_Infants-without-diarrhea_UP	NA	623	1502
bsdb:1166/2/4_Diarrhea,Diarrhea,-Infantile,Malnutrition:Infants-with-diarrhea_vs_Infants-without-diarrhea_UP	NA	623	1502
bsdb:1168/2/1_Birth-weight:Infants-with-Low-birthweight-<2500g_vs_Infants-with-High-birthweight->2500g_UP	NA	2202144
bsdb:1170/1/1_Stroke:stroke-patients_vs_healthy-controls_UP	NA	858	1680	46506	39778	437897	1852375
bsdb:1177/1/1_Lower-respiratory-tract-disease:Lower-respiratory-tract-infections-(LRTIs)_vs_Non-lower-respiratory-tract-infections-(LRTIs)_UP	NA	746128	43770	727	548	573	480	42068	287	1313	2039
bsdb:1177/1/2_Lower-respiratory-tract-disease:Lower-respiratory-tract-infections-(LRTIs)_vs_Non-lower-respiratory-tract-infections-(LRTIs)_DOWN	NA	208480	2014528	143361	837	158	157688
bsdb:1178/1/2_Lactose-intolerance:lactose-intolerant_vs_healthy-control_DOWN	NA	2590211
bsdb:1178/2/2_Lactose-intolerance:lactose-intolerant_vs_healthy-control_DOWN	NA	39488
bsdb:1178/3/1_Lactose-intolerance:lactose-intolerant_vs_healthy-control_UP	NA	2722	564	817	28901
bsdb:1178/3/2_Lactose-intolerance:lactose-intolerant_vs_healthy-control_DOWN	NA	39485
bsdb:1180/1/2_HIV-1-infection:Follow-up_vs_Baseline_DOWN	NA	438033
bsdb:1182/1/1_Myostatin-related-muscle-hypertrophy:GEF(Gene-edited-female)_vs_WTF(Wild-type-female)_UP	NA	1852363	2049045	2211183	1852894	1263002	1263006	292800	154046	1945593	1898207
bsdb:1182/1/2_Myostatin-related-muscle-hypertrophy:GEF(Gene-edited-female)_vs_WTF(Wild-type-female)_DOWN	NA	2044936	821
bsdb:1182/2/1_Myostatin-related-muscle-hypertrophy:GEF(Gene-edited-female)_vs_WTF(Wild-type-female)_UP	NA	1898207
bsdb:1182/3/1_Myostatin-related-muscle-hypertrophy:GEM(Gene-edited-male)_vs_WTM(Wild-type-male)_UP	NA	1945593	1852363	2049045	2211183	1852894	1263002	1263006	292800	154046	1898207
bsdb:1182/3/2_Myostatin-related-muscle-hypertrophy:GEM(Gene-edited-male)_vs_WTM(Wild-type-male)_DOWN	NA	2044936	821
bsdb:1182/4/1_Myostatin-related-muscle-hypertrophy:GEM(Gene-edited-male)_vs_WTM(Wild-type-male)_UP	NA	1898207
